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Impaired muscle metabolic function and atrophy are closely linked to a wide range of 
conditions including cancer, diabetes, and aging. Exercise is known to improve muscle 
metabolism and increase muscle mass, thereby having protective and therapeutic effects 
against such conditions. During exercise the production of reactive oxygen species (ROS) 
within muscle increases. These highly reactive molecules are typically balanced by 
antioxidants and act as signalling molecules bringing about changes in gene expression. 
However, if the balance between production and detoxification is lost, they can cause 
oxidative damage. Chronic oxidative stress can cause muscle to atrophy and impair 
energy metabolism, contributing to the complications of the aforementioned conditions. 
Glutathione (GSH) is a three amino acid peptide and one of the most abundant antioxidant 
molecules in muscle, protecting against oxidative damage. In addition, when oxidised by 
ROS, GSH may interact with and change the activity of a range of other enzymes, 
affecting the activation of several signalling pathways that influence the expression of 
genes associated with energy metabolism and antioxidant capacity. This suggests that 
GSH may play a role in the magnitude of muscle adaptations to exercise through redox 
sensitive pathways.  
Aim 
The primary aim was to evaluate the involvement of endogenous GSH in the molecular 
adaptation of skeletal muscle to contractions induced by electrical stimulation (ES) in 
vitro.  
Methods 
C2C12 myoblasts were cultured and differentiated into myotubes. The experimental 
groups consisted of controls and those depleted of GSH by a 24-hour treatment with 1 
mM buthionine sulphoximine (BSO). These were then submitted to an electrical 
stimulation protocol of a 1 second pulse every other second of 10 V and 50 Hz for 24 
hours. Cell survival was tested using exclusion technique and trypan blue dye to 
determine if ES or treatment with BSO effected cell viability. Hydrogen peroxide release 
during ES was measured using a fluorescent probe (Amplex UltraRed©) and GSH content 
in the myotubes was quantified using a commercial kit. RT-PCR was conducted to 
measure the expression of key genes associated with muscle adaptation and metabolism 
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following contraction. The genes tested were Catalase, CPT-1B, Citrate Synthase, 
GLUT4, GPx1, HK2, NRF1. NRF2, PFK, PGC-1α, PPARα, PPARγ, SOD1, SOD2, 
Tfam, and VEGF-A. Baseline expression was compared to expression immediately 
following ES as well as 1 and 3 hours after stimulation had ended.   
Results 
The ES protocol nor treatment with BSO, alone or combined, caused any significant 
change in cell viability when compared to controls. Cellular concentrations of total GSH 
were successfully depleted in C2C12 myotubes treated with BSO. GSH depletion caused 
an increase in H2O2 concentrations of treated cells, both at baseline and during ES, in 
comparison to control groups. GSH depletion increased the expression of PPARγ across 
all time points when compared to control cells and tended to increase expression of 
multiple genes at baseline when compared to control groups (PFK p = 0.1149, PPARα p 
= 0.0654, and SOD1 p = 0.086; unpaired t-test). Electrical stimulation upregulated the 
expression of VEGF, GLUT4, and PGC-1α irrespective of GSH treatment, along with a 
tendency to increase the expression of CPT-1B (p = 0.0580; two-way ANOVA). Catalase 
mRNA levels increased over time following ES and were further increased in GSH 
depleted groups.   
Discussion  
GSH (or the absence of) may affect baseline expression of several genes known to be 
involved in the molecular adaptation of skeletal muscle to exercise but, following ES, 
GSH depletion only affected catalase expression. The effects of increased cellular H2O2 
concentrations, both at rest and during stimulation, along with the activation of signalling 
pathways by contraction (e.g., MAPK, AMPK, CaMK) are likely to play a role in the 
changes in mRNA expression seen in this study. This may contribute to the upregulation 
of genes associated with angiogenesis, fatty acid metabolism, antioxidant potential, and 
glucose uptake. The increased activity of these signalling pathways is not dependent on 
GSH or are sufficient to override the lack of GSH. 
Conclusion 
GSH depletion did not impair gene expression following ES. Although changes were seen 
in the absence of electrical stimulation, these may be due to acute redox signalling. 
Further investigation into the specific mechanisms is required to identify potential 
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contributing factors, such as altered levels of H2O2 and MAPK, AMPK and CaMK signals 
which arise from exercise, known to modulate gene expression.  
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1. Introduction  
1.1 Background  
Due to its mass, endocrine function, metabolic capacity, and role in movement, human 
skeletal muscle is important for protein turnover as well as the storage and metabolism of 
glucose and fatty acids. Consequently, skeletal muscle has a significant impact on the 
greater metabolic and functional health of the whole body (Kim & Kim, 2020). 
Accounting for ~40% of total body weight, muscle receives ~25% of cardiac output at 
rest, and any irregularities in function can lead to much wider negative implications. 
Pathologies affecting muscle can a have significant effect on an individual’s mobility and 
metabolic health (Baar & Hargreaves, 2011). Consequently, skeletal muscle mass is a key 
indicator for health and longevity, with loss of muscle and altered energy metabolism 
being linked to numerous disease conditions, such as diabetes and cancer. Ranging from 
neuromuscular to metabolic diseases, the most common causes of muscular disfunction 
are suggested to be abnormal ATP production, a lack of Ca2+ homeostasis and 
mitochondrial disfunction (Mukund & Subramaniam, 2020). These imbalances in energy 
metabolism also trigger muscle wasting, causing muscle mass loss. Along with the 
function of the muscle as a whole, the activity of key enzymes involved in glucose 
homeostasis, fatty acid metabolism, mitochondrial biogenesis and many other important 
metabolic processes have been shown to be important biomarkers for muscular disease 
progression (Santacatterina et al., 2015).  
Skeletal muscle is one of the most plastic tissues in the human body allowing it to adapt 
to stressors and stimuli, responding with physiological and biochemical changes within 
the muscle (Baldwin & Haddad, 2002; Chromiak & Antonio, 2008; Fluck & Hoppeler, 
2003). Proteomic screens showed that 562 proteins become phosphorylated in human 
skeletal muscle following exercise, suggesting that an extensive range of signalling 
pathways are affected by contraction (Hoffman et al., 2015). Chemical changes along 
with mechanical stress within the cell during and following accumulative bouts of 
exercise triggers a wide range of signalling pathways leading to changes in enzyme 
activity and gene expression. During exercise the production of reactive oxygen species 
(ROS) are significantly increased throughout the muscle cell (Frontera & Ochala, 2015; 
Packer, Cadenas, & Davies, 2008). These highly reactive molecules act as both 
destructive oxidisers as well as important signalling molecules (Allen & Tresini, 2000; 
Bauer, Elsen, & Bird, 1999; Jackson, Stretton, & McArdle, 2020; Le Moal et al., 2017). 
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Chronic elevation of ROS levels can lead to extensive cell damage and is an important 
factor in diseases, such as cancer and diabetes (Liguori et al., 2018). In order to maintain 
ROS homeostasis, skeletal muscle cells have an extensive antioxidant system which 
controls the redox state of the cell. Antioxidant capacity increases in response to exercise-
derived ROS. Glutathione (GSH), a three amino acid peptide and the most abundant 
antioxidant in muscle, helps maintain ROS homeostasis (Forman, Zhang, & Rinna, 2009). 
Recent research suggests that GSH may also play a role in the activation of enzymes and 
pathways known to change following exercise. Therefore, oxidised GSH may affect the 
magnitude of changes in gene expression and enzyme activity by S-glutathionylation and 
modulation of cellular redox status in a way that changes the physiology of the muscle 
cell. These adaptations can not only improve physical performance but can improve 
overall health and reduce the incidence of disease (Booth, Laye, Lees, Rector, & Thyfault, 
2008). 
A more in-depth understanding of the biological processes involved in muscle adaptation 
may lead to the ability to manipulate these processes in order to maximise beneficial 
responses to exercise. Current evidence suggests that these adaptations occur through 
multiple signalling pathways, such as AMPK and MAPK, activated during and following 
exercise. When the activity of these pathways is increased or changed, then changes in 
the expression of genes involved in biological processes can occur, including 
mitochondrial biogenesis, fibre type switching, energy metabolism and antioxidant 
capacity. GSH is suggested to play a role in affecting the magnitude of these changes. 
Further, total GSH levels and the ratio between oxidized and reduced glutathione 
(GSSG/GSH) may be an important indicator for some medical conditions while also 
being a useful target for intervention and utilised in conjunction with other interventions.  
The following literature review will present the current knowledge on the molecular 
adaptations of skeletal muscle to exercise, focusing on improved glucose and fatty acid 
metabolism, mitochondrial biogenesis, fibre-type switching, angiogenesis and improved 
antioxidant potential. Emphasis is placed on GSH and its role as an antioxidant as well as 
the role it may play in muscle adaptations. This review aims to outline the potential 




1.2 Objective and Hypothesis 
The aim of this study is to evaluate the role of endogenous GSH in skeletal muscle 
adaptation to contraction induced by electrical stimulation (ES) in vitro. We hypothesise 
that GSH plays a role in contraction-induced gene expression in C2C12 myotubes. 
Measurable differences in gene expression will be seen following ES of differentiated 
C2C12 myotubes when comparing GSH depleted cell groups to control groups. GSH 
depletion will impair signalling pathways involved in skeletal muscle adaptation and 
attenuate induced increases in gene expression.  
1.3 Specific objectives 
1.3.1 Obtain a time course of C2C12 myotube gene expression at baseline 
and after electrical stimulation (ES):  
- The expression of genes will be measured at three timepoints, immediately 
following stimulation, one hour after and three hours after stimulation, as well as 
for a non-stimulated control. These time points were designed to display the 
expression of targeted genes known to be involved in muscle adaptation. Genes 
of interest are known to peak around the specific time points used in this study 
(Bickel et al., 2005; Pilegaard et al., 2002; Yang, Creer, Jemiolo, & Trappe, 2005). 
The target genes cover various aspects of adaptation including oxidative stress 
response, mitochondrial biogenesis along with fatty acid and glucose metabolism.  
1.3.2 Measure ROS production during the first three hours of electrical 
stimulation:  
- This was done through the measurement of H2O2 released by C2C12 myotubes 
and provides an indicator as to the overall ROS production of the cell and levels 
of oxidative stress which the cells are under.  
1.3.3 Assess GSH content of the cells following stimulation and at baseline: 
-  In order to determine the success of the GSH depletion treatment as well as 
assessing GSH production in response to stimulation.  
1.3.4 Analyse the survival rate of cells: 
- Asses the percentage of cells still viable following ES and/or GSH depletion to 
ensure survival rates of ~95%. 
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1.3.5 Measure the effect of GSH depletion on contraction-stimulated gene 
expression 
- Determine if GSH depletion has any effect on the expression of genes related to 
adaptation following contraction and, if so, to what extent are they effected.  
2. Literature Review 
2.1 Signals from Muscle Contraction Trigger Exercise Adaptation  
Skeletal muscle mass is a key indicator for health and longevity (McLeod, Breen, 
Hamilton, & Philp, 2016). Muscle atrophy and impaired metabolism has been linked to 
increased risk of cancer and diabetes. It may also lead to reduced mobility, further 
increasing the incidences of comorbidities such as cardiovascular disease and causing a 
loss of independence and quality of life. Exercise promotes beneficial changes in both 
muscle mass and metabolism, potentially leading to protective effects against a range of 
pathological conditions.  
Research has shown a distinction in the way which skeletal muscle adapts to endurance 
training in comparison to resistance training. The signalling pathways activated and 
physiological adaptations which follow these different training stimuli cause different 
responses. Resistance/strength training primarily stimulates processes such hypertrophy 
and protein synthesis and turnover resulting in greater muscle volume and strength (Fry, 
2004). In contrast, endurance training elicits a range of metabolic adaptations such as 
increased mitochondrial content and respiratory capacity leading to increased tolerance 
to fatigue (Holloszy, 1967). These adaptations to exercise are brought about through 
changes in gene expression within the muscle. Over time, the accumulative effect of 
multiple exercise bouts results in different genes being activated and supressed, changing 
metabolic and physiological properties of the muscle and allowing it to better cope with 
similar stresses in the future.  
2.1.1 ATP  
ATP is required for many actions within skeletal muscle, with large amounts being 
consumed by the actin-myosin cross-bridge cycle and ion pumps. The amount of ATP 
required by the cell during exercise is dependent on the intensity and duration of 
contraction. Similarly, the way in which ATP is produced and levels are maintained varies 
depending on the same factors that affect ATP requirement, primarily intensity and 
duration of contraction (Frontera & Ochala, 2015). While the phosphagen pathway 
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(phosphocreatine and adenylate kinase) restores ATP stores for a very short period 
(seconds), the oxidative metabolism of lipids and carbohydrates are an important source 
of ATP production during short-term and extended exercise (Spriet & Watt, 2003). The 
contribution of carbohydrates to ATP production increases as energy expenditure and 
exercise intensity increase (Sahlin, Tonkonogi, & SÖDerlund, 1998), while glycogen 
phosphorylase regulates glycogen breakdown, one of the main systems of anaerobic ATP 
production within skeletal muscle (Komoda & Matsunaga, 2015). Muscle glycogen is the 
predominant source of carbohydrates with extracellular glucose utilisation increasing as 
the exercise period extends. 
Another key source of fuel is fatty acids. They provide their most significant contribution 
to energy production at lower levels of contraction (around 60% V̇O2 max exercise 
intensity) and as exercise progresses. Long duration moderate exercise at ~65% V̇O2 max 
is primarily fuelled by oxidative ATP production from both fatty acid and carbohydrates 
while yields from amino acids are significantly lower (5-15% of ATP production) (Baker, 
McCormick, & Robergs, 2010). As the period of moderate exercise extends over several 
hours, there is a measurable shift in metabolism towards increased lipid oxidation, while 
carbohydrate oxidation and the contribution of muscle glycogen to ATP production 
decreases (Hargreaves & Spriet, 2020). During exercise, the utilisation of ATP can exceed 
production, causing ATP depletion which is a cause of peripheral fatigue. 
5' AMP-activated protein kinase (AMPK) is an enzyme which plays a key role in energy 
homeostasis within cells acting as a sensor of low intracellular ATP levels (Herzig & 
Shaw, 2018). AMPK responds to metabolic stress by switching off anabolic pathways, 
reducing ATP consumption, while switching on catabolic pathways therefore increasing 
ATP production. AMPK works over both the short and long-term, changing enzyme 
activity to affect metabolism quickly, while also modifying gene expression to bring 
about longer-term effects. There is now an extensive body of research surrounding 
AMPK activation and its role in maintaining energy homeostasis within cells (Carling, 
Mayer, Sanders, & Gamblin, 2011; Hardie, Carling, & Gamblin, 2011; Hardie, Ross, & 




2.1.2 Depolarisation (Calcium Signalling)  
Skeletal muscle depolarisation triggers the coupling of dihydropyridine receptors 
(DHPRs), located on the muscle cell surface, with ryanodine receptors (RyR) of the 
sarcoplasmic reticulum, releasing Ca2+ from within the sarcoplasmic reticulum into the 
intracellular space (Lanner, Georgiou, Joshi, & Hamilton, 2010). There are three different 
isoforms of ryanodine receptor with RyR1 being the major form found in skeletal muscle 
(Inui, Saito, & Fleischer, 1987; Takeshima et al., 1989). The interaction between RyRs 
and DHPRs after membrane depolarisation causes a conformational change in the RyR 
allowing the rapid release of calcium into the cytosol and increasing cytosolic calcium 
concentrations by ~100 fold (Nelson et al., 2013; Rios & Brum, 1987). At this high 
concentration calcium binds to troponin C on the thin filament of the muscle fibre and 
contraction is activated. Along with contraction, Ca2+ also regulates a wide range of 
molecular processes, through calcium binding proteins, involved in cell differentiation, 
protein metabolism and gene expression (discussed later in the Literature Review) 
(Berchtold, Brinkmeier, & Müntener, 2000). The levels of intracellular calcium are 
monitored and in part controlled by the sarcoplasmic reticulum (SR). Following 
depolarisation, RyR/DHPR interaction, the release of calcium into the cytosolic space, 
and the activation of downstream signalling pathways, the calcium is then cleared from 
the cytosol. The primary pathway for Ca2+ reuptake in skeletal muscle is into the 
sarcoplasmic reticulum via sarco(endo)plasmic reticulum Ca2+‐ATPase (SERCA) (Rossi 
& Dirksen, 2006). This pump controls muscle relaxation following contraction and limits 
the activation of any downstream signalling pathways which are activated by the acute 
increase in cytosolic calcium concentration. This calcium transient is a major second 
messenger in muscle, activating pathways such as CaMK and calmodulin. These 
pathways contribute to adaptations following exercise, including the upregulation of 
angiogenesis and mitochondrial biogenesis, which are discussed in detail later in the 
review.  
2.1.3 Mechanical Stress 
Skeletal muscle responds to mechanical stress during contraction. The extracellular 
matrix allows the force of contraction to reach the surface of the cell and interact with 
integrins (Sakamoto & Goodyear, 2002). Activated integrins have been shown to mediate 
a wide range of molecular responses through an integrin linked kinase leading to 
activation of the Mitogen-Activated Protein Kinase (MAPKs), c-Jun NH2-terminal 
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kinase (JNK) and Extracellular Signal-Regulated kinase (ERK) (Miyamoto et al., 1995). 
Signals from within the cytoskeleton are also crucial for the transduction of mechanical-
related stimuli within skeletal muscle. Costameres are composed of Z-line associated 
proteins that play a key role in transmitting mechanical signals between the sarcomere, 
extracellular matrix, and sarcolemma. These structures provide a two-way signalling 
pathway between the extracellular matrix and the Z-line, allowing for the transduction of 
external mechanical stress signals to a range of intracellular signalling pathways (Peter, 
Cheng, Ross, Knowlton, & Chen, 2011). 
Mechanical signals are required to maintain and develop skeletal muscle. 
Mechanotransduction is the processes that allows signals such as physical shape changes 
in the muscle to be converted into intracellular biochemical signals (Burkholder, 2007). 
Muscle adaptation to exercise relies on the ability for the resulting stimuli to trigger 
biochemical changes within the cell. Conversely, a lack of stimuli can cause muscle 
wasting and a decrease in muscular function. One of the key players in 
mechanotransduction in skeletal muscle is focal adhesion kinase (FAK). FAK is a non-
receptor tyrosine kinase which directly translates the mechanical stress placed on muscle 
transmitted through the cytoplasmic membrane via integrins (Graham, Gallagher, & 
Cardozo, 2015). When the levels of FAK expression or phosphorylation within a muscle 
changes, this directly effects protein synthesis, cell growth, anti-apoptotic pathways and 
mechanotransduction (Carson & Wei, 2000). The most prominently affected of these is 
the Phosphoinositide 3-kinase (PI3K) pathway which includes the mammalian target of 
rapamycin (mTOR) and Akt/protein kinase B (PKB). Together these signalling pathways 
act as master regulators of protein synthesis and cell size. PI3K pathways are also 
involved in energy metabolism within skeletal muscle, helping to regulate insulin-
stimulated glucose uptake (Huang, Khoe, Ilic, & Bryer-Ash, 2006). Although the 
molecular details of the mechanotransduction pathways affecting skeletal muscle 
adaptation are not yet fully understood, it has been suggested that physical stresses can 
directly and rapidly effect gene expression leading to significant physiological and 
biochemical changes to the muscle. Further research is required to help uncover the role 
mechanotransduction plays in adaptation as well as muscle-related diseases (Olsen, 
Nicoll, & Fry, 2019).  
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2.1.4 Reactive Oxygen Species  
Free radicals are atoms/molecules that contain one or more unpaired valency electrons 
(Powers, Ji, Kavazis, & Jackson, 2011). The nature of this unpaired electron causes free 
radicals to be unstable and reactive. Radicals are produced in cells through a multitude of 
different reactions constantly taking place as a part of normal physiological function. 
Reactive oxygen species (ROS) is the general term given to oxygen based free radicals 
as well as other reactive derivatives of oxygen (Powers et al., 2011). Two of the main 
ROS produced in cells are superoxide (O2
•-) and hydrogen peroxide (H2O2). Their 
production increases during exercise, when they act modulating contractile function and 
as signalling molecules (Droge, 2002). These molecules and the signalling pathways they 
are involved in are detailed further below.  
2.2 Main Sources of ROS in the Muscle 
Reactive oxygen species (ROS), such as O2
•- and H2O2, are produced in all eukaryotic 
cells. Skeletal muscle is no different with ROS production occurring during a wide range 
of physiological processes. The mitochondrial electron transport chain is a key producer 
of ROS in muscle (Powers & Jackson, 2008). Complexes I and III of the electron transport 
chain have been shown to be the primary producer of ROS in skeletal muscle, with levels 
of production increasing by up to 187% from baseline during exercise (Saborido, Naudi, 
Portero-Otin, Pamplona, & Megias, 2011). Although mitochondria have long been 
considered the main source of ROS during exercise this has, more recently, been 
challenged. Studies show that mitochondria produce significantly less ROS than 
previously thought during intense aerobic contractile activity (Di Meo & Venditti, 2001; 
Herrero & Barja, 1997; Mason, Morrison, McConell, & Wadley, 2016; Merry & Ristow, 
2016). Other significant sources of intracellular ROS include NADPH oxidases (NOXs), 
phospholipase A2 (PLA2), and xanthine oxidase (XO) (Gomez-Cabrera et al., 2005; Piao 
et al., 2005; Powers & Jackson, 2008; Powers, Nelson, & Hudson, 2011).   
2.2.1 NADPH Oxidases 
The NADPH oxidase (NOX) protein family consists of five members NOX1-5. They 
have both electron-transporting and catalytic functions and generate superoxide. NADPH 
and oxygen are converted into O2
•- via these partially membrane-bound protein 
complexes. In skeletal muscle only the NOX2 and 4 isoforms are present, located on 





•- +NADP++H+), while NOX4 produces both 
O2
•- and H2O2 (Nisimoto, Diebold, Cosentino-Gomes, & Lambeth, 2014; Serrander et al., 
2007). Some O2
•- produced by NOX is converted into H2O2 by superoxide dismutases 
(SODs) (2H++ O2
•- →H2O2+O2). The overactivity of NOX within skeletal muscle has 
been shown to lead to atrophy (Cunha et al., 2017). This effect was significantly reduced 
by aerobic exercise which caused reductions in NOX2 activity resulting in decreased 
ROS. Chronic excessive ROS, including that produced by NOX, has also been directly 
linked to progressive muscle damage and aging (Mansouri et al., 2006). The H2O2 
produced by SODs from the O2•
- of NOX plays an important role in redox signalling 
within skeletal muscle. The ability for H2O2 to diffuse outside of membranes allows it, 
along with its relatively long half-life, to interact with a range of molecules and affect a 
range of physiological processes from enzyme activity to gene expression. This diffusion 
allows for the measurement of H2O2 produced in cells by assaying the concentration of 
H2O2 in samples of extracellular fluid. During both rest and exercise NOX2 and 4 have 
been shown to contribute to ROS production to a larger extent than mitochondria 
(Cherednichenko et al., 2004; Espinosa et al., 2006; Hidalgo, Sanchez, Barrientos, & 
Aracena-Parks, 2006; Sakellariou et al., 2013; Steinbacher & Eckl, 2015). Specifically, 
the activity of NOX2 increases during and following exercise, increasing the levels of 
ROS within the muscle, while NOX4 is constitutively active.  
The difference in ROS production between fibre types was originally suggested to be due 
to the differences in mitochondrial content of each fibre. However, more recent research 
has shown that the mitochondria are not the primary site of ROS production in skeletal 
muscle and that differences in ROS production may be due to other factors such as 
varying NOX levels. Type I oxidative fibres have been shown to have higher activity of 
the ROS producing NOX enzymes along with increased NOX2 and 4 mRNA levels 
(Loureiro et al., 2016). These variations may account for the difference in ROS levels 
between muscle fibre types beyond mitochondrial density. Type I fibres also showed 
higher levels of antioxidant enzyme activity such as glutathione peroxidase (GPx) which 




2.3 Uncontrolled ROS in Skeletal Muscle 
In the normal physiological state, ROS within skeletal muscle are kept at a level where 
they act as signalling molecules without causing significant oxidative damage. But when 
the production of ROS increases or antioxidant levels decrease, the antioxidant-oxidant 
balance is no longer maintained, resulting in a wide range of oxidative damage throughout 
the muscle. Acute increases in ROS may cause no significant damage to the cell and is in 
fact required for the activation of some signalling pathways. Chronic elevation of ROS 
levels is likely to lead to disrupted redox signalling and cellular metabolism along with 
misregulation and damage of cellular constituents (Lushchak, 2011). Hydrogen peroxide 
(H2O2) is a nonradical weak oxidant with a relatively long half-life in comparison to other 
ROS produced within muscle. The ability of H2O2 to diffuse across cell membranes, 
means it works well as a signalling molecule. Other ROS, such as the highly reactive O2
•- 
produced by NOX and the mitochondria, react immediately with surrounding molecules 
such as nitric oxide. This reaction results in the production of the anion peroxynitrite 
(ONOO-), another signalling molecule utilised in muscle. Although useful for signalling, 
excessive levels of peroxynitrite within a cell leads to significant oxidative damage and 
apoptosis (Lin, Xue, Sun, & Wong, 1997).  
High concentrations of ROS can cause lipid peroxidation in cell membranes, triggering a 
chain reaction which can lead to the degradation of cell integrity. This is discussed in 
more detail later in this Literature Review. The reactive hydroxyl radical (OH•) affects 
DNA, damaging pyrimidine bases and deoxyribose, potentially causing mutations and 
leading to numerous pathological conditions, such as cancer (Packer et al., 2008). These 
hydroxyl radicals can be formed via metal-catalysed reactions of H2O2 such as the Fenton 
reaction (H2O2 + Fe
2+ → Fe3+ + OH• + OH-). Another common reaction in skeletal muscle 
is the Haber-Weiss reaction which sees iron or copper being held in a reduced state by 
O2
•- allowing the formation of OH• from H2O2 (O2
•- + H2O2 → OH
• + OH- + O2). ROS 
within the cell also react with proteins, targeting various amino acids and forming protein 
carbonyls. These effects can result in mitochondrial disfunction along with apoptosis and 
necrosis (Steinbacher & Eckl, 2015). Contractile disfunction and reduced force 
generation caused by oxidative damage contribute to muscle atrophy, aging, as well as a 
range of other pathophysiological conditions (Mecocci et al., 1999). The combination of 
these forms of oxidative damage over time are significant contributors to conditions such 
as diabetes, cancer, and aging. Therefore, the reduction of this damage by antioxidants 
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can help reduce the rates of these conditions in humans (Blokhina, Virolainen, & 
Fagerstedt, 2003; Kurutas, 2016; Liguori et al., 2018).   
2.4 Impaired Exercise Response due to Antioxidants 
Antioxidant loading, the supplementation of high levels of antioxidants prior to physical 
activity, may benefit training and performance if the stress exerted on the muscle is 
enough to elevate ROS levels to a point where they begin to impair function during 
exercise (Bentley, Ackerman, Clifford, & Slattery, 2015; Braakhuis & Hopkins, 2015). 
However, antioxidant supplementation has also been suggested to have no effect on, or 
even potentially increase, the incidence of disease in humans (Ristow, 2014). This is due 
to the non-targeted and non-specific antioxidants, such as vitamins C and E, which are 
typically used in human intervention studies. These antioxidants aim to scavenge ROS 
throughout the body in comparison to the endogenous cellular redox defences which are 
highly compartmentalised and regulated by complex signalling pathways (Merry & 
Ristow, 2016; Ristow, 2014). The supplementation or over supplementation of exogenous 
antioxidants does not specifically target the potentially harmful ROS but all ROS 
including those which play an important role in the signalling required for muscle 
adaptation to exercise.  
A range of studies have shown that antioxidants attenuate muscle adaptations, such as 
mitochondrial biogenesis, following exercise (Gomez-Cabrera et al., 2005; G. D. Wadley, 
Nicolas, Hiam, & McConell, 2013). Animal studies found that antioxidants blunted the 
increase in markers of mitochondrial biogenesis, such as peroxisome proliferator-
activated receptor gamma co-activator 1α (PGC-1α) and nuclear respiratory factor 1 
(NRF1), but without measurable effects on mitochondrial biogenesis. There appears to be 
decreased signalling in animals treated with antioxidants yet no direct impact on 
mitochondrial number or mitochondrial mass (Abadi et al., 2013; Meier, Renga, 
Hoppeler, & Baum, 2013). These findings suggest that although antioxidants do affect 
the signalling pathways related to mitochondrial biogenesis following exercise, there is 
some redundancy in the signalling which can allow for biogenesis to take place even when 
ROS signalling has been depleted (Merry & Ristow, 2016). The effect which antioxidants 
have on skeletal muscle biogenesis is likely to be affected by a range of factors including 
the timing and duration of supplementation as well as the type of antioxidants and the 
exercise protocol.  
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2.5 Main Antioxidant Molecules/Systems in Muscle 
2.5.1 Superoxide Dismutases 
Superoxide dismutases (SODs) are enzymes which catalyse the dismutation of O2
•- into 
H2O2 (Le Moal et al., 2017). There are three isoenzymes SOD1, 2, and 3. These enzymes 
require redox-active transition metals such as copper and zinc, in their active site in order 
to catalyse dismutation (Powers et al., 1994). SOD1 is located in the mitochondrial 
intermembrane space and the cytosol, SOD2 is also found in mitochondria, while SOD3 
is extracellular (Folz & Crapo, 1994; Godenschwege et al., 2009; Nagahisa, Okabe, Iuchi, 
Fujii, & Miyata, 2016).  
2.5.2 Catalase 
Catalase catalyses the dismutation of H2O2 producing H2O and O2. Located primarily in 
the peroxisome, catalase has four subunits and requires iron as a cofactor in its reaction 
(Christie & Stoward, 1979; Van Der Vliet & Janssen-Heininger, 2014). Studies have 
shown that decreased catalase activity and therefore increased oxidative stress in skeletal 
muscle is associated with the age-related loss of muscle mass (Sullivan-Gunn & 
Lewandowski, 2013).  
2.5.3 Glutathione 
Glutathione (GSH) is a tripeptide (cysteine, glycine, and glutamic acid) that is the most 
abundant antioxidant molecule in skeletal muscle and functions to maintain intracellular 
redox status and prevent oxidative damage (Pizzorno, 2014). GSH is primarily located in 
the cytosol where it is involved in a wide range of reactions which help buffer muscle 
oxidant levels. It is a substrate for glutathione peroxidases (GPxs) which catalyse the 
reduction of H2O2 by GSH to H2O and glutathione disulphide (GSSG) (2GSH + H2O2 → 
GS–SG + 2H2O) (Brigelius-Flohe, 1999; Forman et al., 2009). The resulting GSSG is then 
reduced by glutathione reductase (GR) back to GSH using the reducing power of NADPH 
(GS–SG + NADPH + H+ → 2 GSH + NADP+), as shown in Figure 1. Type I skeletal 
muscle fibres contain higher levels of GSH in comparison to type II fibres as their 
oxidative/aerobic metabolism produces higher levels of ROS (Leeuwenburgh et al., 
1997b). GPx1 is a particularly important member of the GPx family found in skeletal 
muscle within the cytoplasm and mitochondria, playing a significant role in reducing the 
accumulation of H2O2 in the cell (Brigelius-Flohé & Maiorino, 2013). Its role as an 
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antioxidant enzyme also means that it contributes to the control of downstream redox-
sensitive pathways.  
GPx3 also works to maintain the antioxidant balance of skeletal muscle, scavenging 
extracellular hydrogen peroxide in the presence of reduced GSH (Takebe et al., 2002). 
Known as a plasma GPx, GPx3 also catalyses reactions with organic and lipid 
hydroperoxides alongside hydrogen peroxide (Maddipati & Marnett, 1987).  
The involvement of GSH in physiological processes is often studied by inhibiting its 
production thereby depleting the endogenous GSH within the muscle. Glutathione is 
synthesised in muscle cells through two ATP dependant reactions. The first of which 
involves the production of gamma-glutamylcysteine from L-glutamate and cystine, 
carried out by gamma-glutamylcysteine synthetase (γ-GCS). Buthionine sulfoximine 
(BSO) is an amino acid which directly and irreversibly inhibits γ-GCS, therefore 
depleting GSH levels within the cell. It does this by acting as an analogue of the transition-
state in the γ-GCS reaction (Ardite, Barbera, Roca, & Fernández-Checa, 2004). This 
method of depleting GSH within muscle is used in the current study to investigate the 
antioxidant`s involvement in the regulation of genes associated with muscle adaptation 
following contraction.  
 
 
Figure 1. The GSH antioxidant system. Within skeletal muscle, glutathione peroxidases 
(GPx) catalyse the reduction of H2O2 by oxidising GSH and producing 2H2O and GSSG. 
This neutralises the potentially harmful H2O2 reactive oxygen species. The oxidised 
GSSG is able to be recycled via a reduction by glutathione reductase (GR) and donation 
of a electrons from NADPH + H+. This reaction results in 2GSH and NADP+. The GSH 
is then able to continue this cycle and provide its antioxidant function within the muscle. 
2.5.4 Glutaredoxins and Peroxiredoxin 
Along with GSH and GPx, glutaredoxins play an important part in the maintenance of the 
oxidative state of cells. Glutaredoxins are redox enzymes which deglutathionylate 
proteins, being glutathionylated in the process (Fernandes & Holmgren, 2004). 
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Glutaredoxins are able to react with other oxidised proteins, restoring them to their 
reduced form by utilizing the reducing power of GSH, regenerating glutaredoxin while 
reverting the GSH to its oxidised form GSSG (Lillig, Berndt, & Holmgren, 2008). GSSG 
is then reduced through the reaction with GR and NADPH as previously described. 
Glutaredoxins provide additional antioxidant capability to skeletal muscle and are an 
important part of the redox regulatory mechanism.  
Peroxiredoxins are a family of potent antioxidant proteins present within skeletal muscle, 
located in the cytosol, endoplasmic reticulum, and mitochondria. These thiol peroxidases 
catalyse the reduction of peroxides and have been shown to be play a key role in linking 
increased H2O2 production during exercise to the physiological adaptations which follow 
(A. J. Wadley, Aldred, & Coles, 2016). The resulting sulfenic acid produced from the 
reduction of H2O2 by peroxiredoxin may act as a signalling molecule, able to form mixed 
disulphide bonds with transcription factors. This reaction may allow peroxiredoxin to 
mediate signals produced by exercise-induced oxidants and translate them into effects on 
downstream transcription factors. Currently, p38 MAPK is one of the primary signalling 
pathways known to be sensitive to phosphorylation by peroxiredoxin-mediated signalling 
via apoptosis signalling kinase 1 (ASK1) (Jarvis, Hughes, & Ledgerwood, 2012). 
Peroxiredoxin can also be inactivated by glutathionylation, resulting in a build-up of H2O2 
in specific cellular regions, therefore redirecting the H2O2 signal (Kil et al., 2012).   
2.5.5 Vitamins C and E 
Vitamin C can minimise damage from radical chain reactions within the cell caused by 
ROS. Lipid peroxidation is the oxidative degradation of lipids which commonly occurs 
within skeletal muscle. Due to many ROS producing enzymes being located within lipid 
bilayers along with the relative weakness of the bisallylic C-H bond in comparison to 
other C-H bonds, lipids are one of the primary targets of ROS in muscle. The reaction 
targeting lipids is initiated by a free radical attacking a lipid-hydrogen (LH) compound 
which is converted into a lipid peroxyl radical (LOO•), which then converts another LH 
into a carbon-centred lipid radical (L•) (El-Aal, 2012). This process can initiate a chain 
reaction of lipid peroxidations, leading to the accumulation of chemically unstable lipid 
hydroperoxides (LOOH) within the muscle. Lipid peroxidation is known to contribute to 
an increased progression of many chronic diseases, such as cardiovascular disease 
(Mattson, 2009), diabetes (Traverso et al., 1998) and neurodegenerative disease 
(Butterfield, Yatin, Varadarajan, & Koppal, 1999). 
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Both vitamins C and E play a role in diminishing the effects of lipid peroxidation on 
muscle. The LOO• produced during lipid peroxidation reacts 1000-times faster with 
vitamin E than it does with polyunsaturated fatty acids (PUFA) causing it to be 
preferentially oxidised (Buettner, 1993). This allows vitamin E to react with the radical 
LOO• producing the oxidised Vit E-O• and the corresponding LOOH. At this stage 
vitamin C is able to donate an electron to the Vit E-O•, oxidising the vitamin C while 
returning vitamin E to its reduced state (Neuzil, Witting, & Stocker, 1997). This series of 
reactions has been termed as ‘vitamin E recycling’, and the constant renewal of the 
antioxidant function of vitamin E through its reaction with other antioxidants creates an 
antioxidant network within the muscle (Figure 2). 
Along with its reaction with oxidised vitamin E, vitamin C can also scavenge free ROS 
by donating electrons to potentially harmful ROS. In this case and that involving vitamin 
E recycling, oxidised vitamin C is a product of these reactions. There are multiple 
enzymatic pathways which allow vitamin C to be returned to its reduced state and once 
again take part in the antioxidant network within the muscle (Padayatty et al., 2003). In 
humans the reduction back to ascorbic acid is only partial as some is lost to hydrolysis. 
As vitamin C is not synthesised within the body, supplementation may have a protective 
effect against oxidative damage by lipid peroxidation. A range of studies have shown 
vitamin C supplementation decreased lipid peroxidation levels as well other biomarkers 
of oxidative stress (Harrison, Meredith, Dawes, Saskowski, & May, 2010; Kuiper, Bruno, 








Figure 2. The antioxidant activity of vitamins E and C. Lipid peroxidation is a major 
form of oxidative damage caused by ROS. It begins with the oxidation of a lipid substrate 
(LH) into a lipid peroxyl radical (LOO•) by a ROS. This lipid radical can go onto convert 
another LH into LOO•, itself converting to a lipid hydroperoxide (LOOH). This begins a 
chain reaction which can work its way throughout the lipid membrane of a muscle cell 
causing extensive damage to the function and structural integrity of the membrane. 
Vitamin E works as an antioxidant which is preferentially oxidised by LOO• over lipid 
molecules. This breaks the chain of lipid peroxidation helping to prevent further damage. 
The vitamin E is oxidised (Vit. E-O•). Vitamin C also has antioxidant capabilities 
allowing it to be oxidised by the reactive Vit. E-O• into Vit. C•, effectively passing on the 
donated electron, returning vitamin E to its base state where it can again react with LOO•. 
Vitamin C can also be directly oxidised by other ROS also producing Vit. C•. GSH then 
allows vitamin C to be reduced back to its base state and be reused through its own 
oxidation to GSSG. As previously described GSSG is reduced to GSH via NAD(P)H in 
a reaction catalysed by glutathione reductase (GR). 
2.5.6 Exogenous Antioxidant Molecules 
There are many molecules with antioxidant properties which are not produced within the 
cell. These can be generally classified into vitamins, trace elements, and phytochemicals. 
One of the most prominent being the aforementioned vitamin E, which refers to four 
tocopherols and four tocotrienols (α, β, δ, γ) primarily found in the plasma membrane in 
skeletal muscle (Brigelius-Flohe & Traber, 1999). These molecules react with oxidants 
in a process which encompasses GSH, the products of this reaction are then further 
reduced by vitamin C (Khor, Abdul Karim, Ngah, Yusof, & Makpol, 2014). Increased 
local vitamin E levels have been associated with protective effects against exercise-
induced oxidative stress (Meydani, Fielding, & Martin, 1998). 
A range of trace elements including copper, zinc, and manganese play a protective role 
in skeletal muscle cells. These are typically used as cofactors in redox reactions as 
previously mentioned regarding SODs. Studies have shown that these trace elements can 
be equally as important as other antioxidant molecules in maintaining the cellular redox 
status and minimising oxidative damage (Gaetke & Chow, 2003; Oteiza, 2012). 
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2.6 ROS Increase in Muscle During Exercise and Antioxidant Response 
Skeletal muscle is one of the most plastic and responsive organs in regards to adaptation 
to exercise (Bassel-Duby & Olson, 2006). Following exercise, the muscle responds and 
adapts in a way which allows it to better cope with future exercise stress. The positive 
effects of this adaptation extend beyond benefits to physical exercise also allowing 
muscle to better deal with similar stressors such as those related to disease development 
(Merry & Ristow, 2016). One of the main stressors present during exercise is an increase 
in ROS within muscle (Davies, Quintanilha, Brooks, & Packer, 1982). Previously thought 
of as an unavoidable biproduct of exercise, ROS, and the resulting oxidative damage were 
originally thought to have a negative effect on health and the effectiveness of exercise. 
This led to a wide range of research into methodologies and supplementation regimes 
which aim to reduce the production of ROS during exercise and bolster the effectiveness 
of the multifaceted antioxidant defence system present within skeletal muscle. 
Antioxidant treatments, such as antioxidant loading of skeletal muscle, affect a wide 
range of signalling pathways both during and immediately following exercise (Merry & 
Ristow, 2016; S. K. Powers & Jackson, 2008). Studies investigated the effects of 
antioxidant loading on the adaptive response of skeletal muscle to exercise in order to 
help understand the way in which the reduction in oxidative stress affects muscular 
response.  
High levels and long exposure to ROS within skeletal muscle is known to contribute to 
contractile dysfunction that occurs during fatigue (Reid, 2016). The low levels of ROS 
present within muscle at rest are required for normal force production, while a modest 
rise in ROS levels can increase muscle force production through an increase in Ca2+ 
transients and inhibiting Ca2+-dependent ATPase (Reid, 2001b; Reid, Khawli, & Moody, 
1993). At higher concentrations, these effects are reversed and ROS causes a decrease in 
contraction force and contributes to exercise-induced muscular fatigue (Reid, 2001a). 
This is brought about due to ROS causing decreased Ca2+ sensitivity in the muscle, 
inhibiting Ca2+ release and reuptake along with increased Ca2+ leak from the sarcoplasmic 
reticulum, and inhibiting the activity of metabolic enzymes. The knowledge of ROS 
involvement in fatigue led to research in which scavenging of ROS was upregulated in 
the hope to delay the onset of fatigue. Studies have shown that overexpression of 
antioxidant enzymes, as well as antioxidant treatments significantly delayed fatigued, 
allowing for greater contractile force over a longer period of time with effects being most 
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noticeable during endurance exercise (Bruton et al., 2008; Davis, Murphy, Carmichael, 
& Davis, 2009; Novelli, Bracciotti, & Falsini, 1990).   
Both at rest and during exercise, transient oxidative bursts allows ROS to act as signalling 
molecules. Redox regulation of proteins within muscle cells typically occurs through the 
reversible oxidation of cysteine thiols on the target, changing its activity, protein-protein 
interactions or cellular localisation (Holmstrom & Finkel, 2014). Many redox-sensitive 
signalling pathways are activated by ROS in muscle, including the AMPK, MAPK and 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathways, which 
control a range of metabolic and physiological adaptations (Ji, 2007). The activation of 
these pathways can lead to increases in muscle antioxidant capacity, protein synthesis and 
metabolic capacity. In this regard, exercise can have beneficial effects during 
immobilisation and aging and help prevent the onset of many pathological conditions 
such as diabetes and cancer by triggering these positive adaptations (Bajotto & 
Shimomura, 2006; Chopard, Hillock, & Jasmin, 2009; Ji & Yeo, 2019). 
2.7 Antioxidant and Enzyme Interactions 
2.7.1 AMPK S-glutathionylation 
Studies have shown that the activity of AMPK is able to be modified by S-
glutathionylation (Dong et al., 2016; Klaus et al., 2013). S-glutathionylation is a post-
translational modification made to proteins which involves the formation of a mixed 
disulphide bond between an oxidised cysteine residue and glutathione (Corcoran & 
Cotter, 2013). Klaus et al. (2013) showed that several forms of mammalian glutathione 
S-transferases (GST) can interact with and activate AMPK through glutathionylation in 
vitro. This study focused on the activation of AMPK when the redox state of the cell was 
relatively low. Zmijewski et al. (2010) investigated changes in AMPK activity during 
more oxidative redox states and showed that higher concentrations of H2O2 were able to 
directly activate AMPK through oxidative modification of the AMPKα subunit. This is 
likely one of the many mechanisms and modifications, along with glutathionylation, that 
increases AMPK activity within muscle cells in response to increased levels of ROS 
following exercise.  
The mammalian -Mu and -Pi classes of GSTs were further investigated and found not to 
interact with the α-subunit of AMPK (Klaus et al., 2013). Results showed that GST 
interacts with the very N-terminal part of the β-subunit of AMPK. The study concluded, 
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using in vitro and in vivo models, that these GSTs interacted and bound with AMPK 
directly at the β-subunit, forming a complex which activates the enzymatic activity. This 
leads to the GST-facilitated S-glutathionylation of AMPK, activating signalling cascades 
within the cell in response to mildly oxidative intracellular conditions. The conclusions 
drawn from the Aranda et al. (2009) study are limited due to the yeast cell models and rat 
liver in vivo models it used, but the study also proposed a model of glutathionylation-
dependent AMPK activation. Further studies are required to explore the importance of 
this mechanism in muscle, in vivo. Furthermore, the involvement of GSH and GSSG as a 
part of the S-glutathionylation reaction involved in the activation of AMPK needs to be 
explored.  
Together, the interaction of GSTs with the α- and β-subunits of AMPK in HEK293 cells; 
the direct interaction of GST complexes with the β-subunit promoting S-
glutathionylation; and kinase activity in vitro, provides strong evidence of the 
involvement of GSH in the regulation of muscle cell responses and adaptation to 
increased intracellular ROS by AMPK glutathionylation following exercise.  
2.7.2 MEKK1 Glutathionylation  
MAPK/ERK kinase kinase 1 (MEKK1) is an upstream activator of the stress-activated 
protein kinase (SAPK) signalling cascade (a member of the MAPK family) (Minden et 
al., 1994; M. Yan et al., 1994). MEKK1 is known to play a crucial role in the activation 
of many intracellular signalling pathways, including ERK, in response to extracellular 
stimuli. Research has shown that MEKK1 is redox sensitive, being inhibited through 
glutathionylation at a cysteine residue in its ATP-binding site (Cross & Templeton, 2004). 
This inhibition is suggested to be dominant over activation through the kinase 
phosphorylation cascade activated during exercise. This appears to allow for stimuli 
which cause oxidative stress in the cell to activate some pathways, while the increase in 
GSH, and therefore glutathionylation, inhibits others, as is the case with MEKK1.  
2.8 Muscle Adaptations Following Exercise 
2.8.1 Improved Fatty Acid Metabolism 
A range of fatty acids are available and utilised as metabolic fuel by muscle during 
exercise. Initially intramyocellular triglycerides are the primary source. As the duration 
of exercise extends, the cell switches to ATP production from free fatty acids in plasma 
(Baker et al., 2010; Hargreaves & Spriet, 2020; Jeukendrup, 2002; Sidossis, Gastaldelli, 
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Klein, & Wolfe, 1997). Other sources include very-low-density lipoprotein-triglycerides 
(VLDL-TG) which contribute around only 5% of total energy expenditure during 
exercise. The hydrolysis of VLDL-TGs is regulated by the activity of lipoprotein lipase 
(LPL). Skeletal muscle LPL, required to maintain energy balance and availability in the 
muscle, is known to be upregulated following exercise (Seip & Semenkovich, 1998). 
Strenuous or prolonged physical activity increases enzymatic activity, transcription, and 
translation of LPL, contributing to the restoration of energy balance by providing fatty 
acids as fuel while glycogen is depleted or being resynthesized (Kiens, 2006).  
Various fatty acid transport proteins facilitate the uptake of free fatty acids. Transport of 
fatty acids into the mitochondria depends on the regulation of two carnitine palmitoyl 
transferases (CPT-1/CPT-2). CPT-1 enables the transport of long-chain fatty acids 
through the addition of carnitine. The fatty acid is then able to be transported by acyl 
carnitine transporters. This is the initiating and rate limiting step for oxidation of fatty 
acids within the mitochondria (Song et al., 2010). The activity of these transferases, 
specifically CPT-1, are upregulated during exercise as a result of upstream AMPK 
signalling. This, along with the availability of glycolytic products and free carnitine 
required for CTP-1 function, also increase the uptake, and consequently oxidation, of 
fatty acids into the mitochondria during exercise (Melanson, MacLean, & Hill, 2009).  
Peroxisome proliferator activated receptor (PPAR) alpha is a transcription factor 
expressed in skeletal muscle. PPARα is lipid-activated and controls a range of genes 
involved in β-oxidation within the mitochondria (Minnich, Tian, Byan, & Bilder, 2001). 
Following exercise, PPARα expression is increased in muscle, this is facilitated by the 
activation of AMPK, directly leading to increased mRNA expression of PPARα target 
genes along with PGC-1α (Lee et al., 2006). This link between PPAR and PGC-1α 
expression shows one of many links between the increase of a cell’s oxidative capacity 
and increased mitochondrial biogenesis. Endurance exercise is known to increase AMPK 
activity which leads to an acute increase fatty acid oxidation within the muscle. Along 
with these acute changes, the elevated AMPK activity causes long-term improvements in 
fatty acid metabolism due to altered gene expression including PPARα, PGC-1α and 




Another isoform of PPAR, PPARδ, has also been found to increase the oxidative capacity 
of skeletal muscle following exercise. The expression of PPARδ is known to be increased 
in human skeletal muscle following endurance exercise. Muscle-specific overexpression 
studies have shown significant increases in fatty acid utilisation within the muscle 
(Luquet et al., 2003). Along with increased oxidative capabilities, other adaptive 
responses to exercise, such fibre type switching towards type 1 fibres, were also present 
(Y. X. Wang et al., 2004). This indicates that the PPARδ nuclear receptor therefore plays 
a central role in muscle adaptation following exercise and may be beneficial for the 
prevention of metabolic disorders such as diabetes and obesity (Lopez-Soriano, Chiellini, 
Maffei, Grimaldi, & Argiles, 2006; Luquet et al., 2003). 
A third form of PPAR, PPARγ, is known to regulate lipid and glucose metabolism, 
helping protect skeletal muscle from excessive lipid overload (Phua, Wong, Liao, & Tan, 
2018). Ligands for PPARγ such as polyunsaturated fatty acids, and many type 2 diabetes 
(T2D) medications, such as thiazolidinediones (TZDs), are known to improve glucose 
metabolism in muscle by activating PPARγ, leading to downstream PPARγ-mediated 
gene activation. The basal level of PPARγ activation maintains normal physiological 
insulin signalling, whereas in T2D patients the activity of PPARγ is significantly lowered 
(Janani & Ranjitha Kumari, 2015). Lack of PPARγ activity is linked to abnormal glucose 
metabolism and can lead to increased lipid storage within muscle. PPARγ modulates the 
transcription of a number of genes involved in glucose metabolism within muscle, most 
notably GLUT4. PPARγ activation leads to an increase in GLUT4 transcription and 
therefore increases insulin-stimulated glucose transport into the cell (Leonardini, Laviola, 
Perrini, Natalicchio, & Giorgino, 2009).   
Calcium/Calmodulin Dependent Protein Kinase II (CaMKII) has been shown to regulate 
lipid metabolism in skeletal muscle in response to exercise (Mukwevho, 2017). Following 
exercise, increased CaMKII expression leads to beneficial changes, including increasing 
the expression of genes responsible for fatty acid metabolism in muscle (Joseph, Ayeleso, 
& Mukwevho, 2017). The accumulation of various lipids within the cell is associated with 
a wide range of pathological conditions including type 2 diabetes and obesity (Kinfe, 
Belay, Joseph, & Mukwevho, 2013). Increased CaMKII expression, in comparison to 
basal levels, has been shown to promote the breakdown of these lipids and restore a 
healthier level of lipids within cell membranes. CaMKII activation also leads to a 
decrease in the expression of acetyl-CoA carboxylase (ACC)-1, an enzyme that 
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modulates the balance between lipid synthesis and oxidation within muscle. The 
combination of increased CPT-1 and decreased ACC-1 expression is known to decrease 
lipid accumulation and increase the oxidative capacity of muscle mitochondria. CaMKII 
activation resulting from exercise also stimulates mitochondrial biogenesis (details in 
section 2.8.6 Mitochondrial Biogenesis), which increases the mitochondrial density of 
muscle cells and activity of related enzymes. This is thought to increase the capacity of 
the cell to oxidise fat, also during exercise. Studies are yet to conclude if there is a direct 
correlation between mitochondrial density and lipid oxidation (Galgani et al., 2012). 
2.8.2 Improved Glucose Metabolism 
The glucose transporter GLUT4 is the most abundant GLUT protein in skeletal muscle. 
At rest a small portion of GLUT4 is located on the cell surface (~20%), while the 
remainder is stored in vesicles within the cell. Following stimulation by insulin or 
exercise, these vesicles translocate and fuse to the plasma membrane increasing the 
number of GLUT4 transporters therefore increasing the transport of glucose into the cell. 
The total levels of GLUT4 have been shown to increase between 20-70% in both human 
and rodent skeletal muscle following exercise.  
The expression of GLUT4 within skeletal muscle is tightly regulated. Its upregulation 
following exercise means GLUT4 is involved in a wide range of adaptations to 
contraction. There are several signalling pathways involved in this upregulation. Two of 
the main signalling kinases known to regulate its expression are AMPK, and CaMKII. 
The activity of both enzymes increases during and following exercise. This response leads 
to the binding of the myocyte enhancer factor 2 (MEF2) family of transcription factors to 
the GLUT4 promoter and increased transcription. Several isoforms of MEF2 are 
expressed in skeletal muscle with MEF2A, MEF2C, and MEF2D being the most active. 
A heterodimer of these transcription factors is known to be involved in the normal 
regulation of GLUT4, binding to the GLUT4-MEF2 domain (Thai, Guruswamy, Cao, 
Pessin, & Olson, 1998).  
The transcriptional coactivator PGC-1α also plays a role in the regulation of GLUT4 
within skeletal muscle, including its response to exercise. PGC-1α directly binds to and 
coactivates MEF2C. Studies have shown that activation of MEF2C requires the 
coactivation of PGC-1α to enable control of the level of endogenous GLUT4 through 
binding to the promoter of the GLUT4 gene and inducing transcription (Michael et al., 
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2001). As previously stated, the expression and activity of PGC-1α is significantly 
increased following exercise, suggesting that its interaction with MEF2 may play a role, 
along with AMPK and CaMKII, in the increase in GLUT4 expression observed post-
exercise. It is important to note that another downstream target gene of PGC-1α, NRF1, 
has also been suggested to affect the expression of GLUT4. Overexpression studies have 
also shown that NRF1 increased both GLUT4 expression and glucose transport in muscle 
(Baar et al., 2003). 
The MEF2 binding site in the GLUT4 promoter is also subject to transcriptional 
repression by histone deacetylases (HDACs) 4, 5, and 7 (McKinsey, Zhang, & Olson, 
2000). Under normal conditions HDAC5 is not a substrate for CaMKII, but upon 
dimerisation with HDAC4, it is capable of receiving signals from CaMKII (Backs, Backs, 
Bezprozvannaya, McKinsey, & Olson, 2008). The nuclear export of HDAC4/5, triggered 
by CaMKII and AMPK following exercise, allows for hyperacetylation of the GLUT4 
promoter encouraging the binding of MEF2 (Mukwevho et al., 2008). This leads to an 
increase in GLUT4 expression further demonstrating the complex regulation of glucose 
metabolism in skeletal muscle.  
HDAC5 is also known to be an AMPK substrate (Ojuka, Jones, Han, et al., 2002; Ojuka, 
Jones, Nolte, et al., 2002). The increase in AMPK activity during and following exercise 
acts in a similar way to CaMKII, working via HDAC4/5. Following exercise, active 
AMPK directly phosphorylates HDAC5, allowing for the acetylation of the MEF2 
binding site in the GLUT4 promoter (Holmes, Sparling, Olson, Winder, & Dohm, 2005). 
Endurance exercise has been shown to increase the phosphorylation of AMPK and result 
in changes in gene expression favouring the translocation of GLUT4 in skeletal muscle 
(Rohling, Herder, Stemper, & Mussig, 2016). These changes improve the capacity for the 
muscle to effectively utilise glucose during exercise and shows an adaptation which 
extends past the acute effects of exercise on GLUT4. 
Phosphofructokinase-1 (PFK-1) is a key enzyme involved in glucose breakdown within 
skeletal muscle, often termed as the pacemaker or rate-limiting step of glycolysis. PFK-
1 catalyses the phosphorylation of fructose 6-phosphate to fructose 1,6-bisphosphate and 
requires ATP for this process (Lavorato, Andrade, Silva, Alves, & Oliveira, 2012). The 
breakdown of glucose is key for the rapid production of ATP during exercise when the 
muscle is under maximum contraction. PFK-1 activity has been shown to increase 
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immediately following intense exercise as well as chronically following endurance 
exercise training (Abernethy, Thayer, & Taylor, 1990). These properties make PFK-1 a 
useful indicator of metabolic status within muscle following exercise.  
Along with PFK-1, hexokinase (HK) plays a key role in the utilisation of glucose as an 
ATP source in skeletal muscle. HK catalyses the conversion of glucose to glucose-6-
phosphate, transferring a phosphate group from ATP to the glucose molecule. HK activity 
is known to increase during and following exercise much like PFK-1 (Rockl et al., 2007). 
Skeletal muscle has been shown to maintain and/or increase HK expression following 
exercise (Lamb, Peter, Jeffress, & Wallace, 1969). Together, PFK-1 and HK are the key 
regulators of glycolysis and glucose utilisation within skeletal muscle. Alongside the 
increase in glucose transport via GLUT4, their elevated activity during exercise is crucial 
for the supply of ATP. 
2.8.3 AMP-Dependent Regulation of AMPK 
AMPK is one of the key regulators of skeletal muscle plasticity and energy metabolism, 
regulating the balance between anabolic and catabolic processes (Hardie & Carling, 1997; 
Jensen, Wojtaszewski, & Richter, 2009). AMP-dependent regulation is caused by the 
increase in AMP and ADP levels due to ATP hydrolysis, typically occurring during 
strenuous exercise. When cellular levels of AMP increase, it binds to the AMPK γ-subunit 
and allosterically increases the enzymatic activity of AMPK. This also induces 
phosphorylation of AMPK by liver kinase B1 (LKB1), further activating the enzyme 
(Long & Zierath, 2006). This leads to the downstream phosphorylation by AMPK of a 
wide range of target proteins, resulting in changes in metabolism and gene expression 
(Garcia & Shaw, 2017). Increased levels of AMPK activity following contraction was 
first documented by Winder and Hardie (1996). Many of the downstream targets of 
AMPK allow the cell to respond to increased energy requirement and there is now an 
extensive body of research surrounding AMPK activation and its role in maintaining 
energy homeostasis within cells (Carling et al., 2011; Hardie et al., 2011; Hardie et al., 
2012). AMPK responds to metabolic stress, redirecting cellular metabolism towards 
increased catabolism and decreased anabolism resulting in reduced ATP consumption 
and increased ATP production (Herzig & Shaw, 2018). This is achieved in the short-term 
by phosphorylating rate-limiting enzymes while also having long-term effects by bringing 
about changes in gene expression (mentioned throughout 2.8 Muscle Adaptations 
following Exercise). During and immediately following contraction the AMPK pathway 
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induces GLUT4 translocation resulting in increased glucose uptake. Furthermore, AMPK 
inhibits the synthesis of fatty acids, via ACC inhibition, while increasing their 
transportation to the mitochondria for ATP production through fatty acid oxidation (Long 
& Zierath, 2006). Alongside its effects on ATP production, AMPK also inhibits mTOR, 
reducing protein synthesis during and following periods of heightened ATP demand 
(Thomson, 2018).  
2.8.4 AMP-Independent Regulation 
Recent research has found that AMPK can also be activated independently of AMP/ADP 
concentration within the cell, known as AMP-independent regulation (Hardie, 2016; Xiao 
et al., 2013; Zhang et al., 2017). The first instances of AMPK activation without the direct 
effect of AMP were seen in a range of natural and synthetic small molecule activators. 
Molecules such as salicylate bind at what has become known as the Allosteric Drug and 
Metabolite (ADaM)-binding site of AMPK (Hawley et al., 2012). This is located at the 
interface of the α- and β-subunits of AMPK and is independent of the AMP binding site. 
When salicylate binds at this site it causes a conformational change in AMPK which 
transforms it into its active state, completely independently of cellular AMP levels. 
Further research has suggested that ROS can also act as a form of AMP-independent 
regulation (Auciello, Ross, Ikematsu, & Hardie, 2014; Emerling et al., 2009; Shao et al., 
2014). Zmijewski et al. (2010) showed that AMPK activation increased in response to 
exogenous H2O2 without any changes in AMP concentrations. Initially the mitochondria 
were suggested as one of the key locations for ROS production in muscle cells and 
therefore became a primary target for redox signalling studies (Chouchani et al., 2014). 
Although this was an attractive concept, similar studies were published which suggested 
that the only redox control, which AMPK was subject to, was due to the associated change 
in AMP levels within the cell (Auciello et al., 2014; Shao et al., 2014). This would suggest 
that redox signalling falls into the category of AMP-dependent regulation. Some of these 
contradictory points between studies are likely in part due to methodological differences 
including the cell types used, varying levels of ROS which the cells were exposed to, and 
differing methods of measuring adenine nucleotide levels. One of the more recent studies 
conducted by Hinchy et al. (2018), aimed to investigate whether AMPK was directly 
activated through interactions with ROS, or if the resulting intracellular changes in the 
ATP/AMP ratio indirectly lead to its activation. This study focused on ROS produced 
from the mitochondria along with exogenous H2O2 and used differentiated C2C12 mouse 
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skeletal myotubes. Through simulated mitochondrial ROS production, they found no 
significant activation of AMPK. Although exogenous H2O2 stimulated AMPK activity, 
this was found not be the through direct redox signalling but was due to secondary 
changes in ATP/AMP ratios within the cell. The same study also explored these ideas 
using HEK 293T cells. In this model the exogenous H2O2 was found to activate AMPK 
independent of ATP/AMP ratios. These findings suggest that, along with indirect effects 
through changes in ATP/AMP ratios, there may be a direct way in which ROS stimulates 
AMPK signalling which is yet to be identified. 
2.8.5 Mitochondrial Biogenesis 
Exercise increases the volume, number and function of mitochondria within skeletal 
muscle (Leeuwenburgh & Heinecke, 2001; Safdar et al., 2011; Julie St-Pierre, 2003). This 
occurs through a process known as mitochondrial biogenesis. Muscle with a higher 
number of more efficient mitochondria has an increased oxidative capacity allowing for 
better performance as well as a range of protective health benefits (Hood, 2009).  
PGC-1α was first identified as being involved in the differentiation of white fat to brown 
(Puigserver et al., 1998). The overexpression of PGC-1α in white fat gave the tissue some 
of the characteristics which are typically associated with brown fat such as a greater 
number of mitochondria and the stimulation of the expression of uncoupler proteins found 
in brown fat mitochondria. Since these initial findings it has been found that PGC-1α 
coactivates and binds to a wide range of transcription factors (Lindholm, Eriksson, 
Makela, Belluardo, & Korhonen, 2012).  
PGC-1α is tightly regulated in skeletal muscle by a range of mechanisms both 
transcriptionally and post-transcriptionally, leading to the transcription of various genes 
involved in mitochondrial biogenesis. PGC-1α can be directly phosphorylated by p38 
MAPK, AMPK, protein kinase A (PKA), Akt/PKB (Figure 3), or have its expression 
increased via cAMP-Response Element Binding Protein (CREB), and MEF2/NFAT 
(Figure 4) (Fernandez-Marcos & Auwerx, 2011).  
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Figure 3. Control of mitochondrial biogenesis via PGC-1α.  PGC-1α induces the 
expression of NRF1/2 and Tfam. These are the key genes which initiate mitochondrial 
biogenesis. PGC-1α also interacts with and co-activates NRF1, increasing its activity and 
enabling the maintenance of mitochondrial biogenesis in skeletal muscle. PGC-1α 
activity can be enhanced in multiple ways. CaMKs and AMPK are activated during 
exercise. In brief, CaMKs in skeletal muscle are phosphorylated by upstream CaMKK in 
response to increased sarcoplasmic calcium concentrations. This leads to the downstream 
phosphorylation of p38 MAPK. Both AMPK and p38 MAPK increase the stability of 
PGC-1α through phosphorylation. SIRT1 deacetylates PGC-1α effecting its localisation 
in the cell, enabling it to interact with a range of transcription factors within the nucleus, 
inducing the expression of genes including Tfam, NRF1 and 2. 
The relatively short half-life of PGC-1α (two-three hours) is significantly increased upon 
phosphorylation by p38 MAPK and AMPK (Fernandez-Marcos & Auwerx, 2011; Jäger, 
Handschin, St-Pierre, & Spiegelman, 2007; D. Lindholm et al., 2012; Lira, Benton, Yan, 
& Bonen, 2010; Sano et al., 2007). This increased stability is crucial to allow PGC-1α to 
play its part in the regulation of mitochondrial biogenesis. The p38 MAPK elicits a dual 
action of regulation over PGC-1α by also blocking the interaction between PGC-1α and 
the co-repressor p160MBP (Fan et al., 2004). Displacement of the p160MBP co-repressor 
allows increased transactivation, further increasing the activity of PGC-1α.  
Increased levels of phosphorylated (active) AMPK have been shown following 
contractile exercise (Takekoshi et al., 2006), first documented by Winder and Hardie 
(1996). This causes the downstream phosphorylation of a wide range of target proteins, 
including PGC-1α. Active AMPK directly phosphorylates the CREB transcription factor. 
The PGC-1α gene possess a binding site for CREB causing increased PGC-1α expression 
following the phosphorylation of CREB by AMPK (Fernandez-Marcos & Auwerx, 
40 
 
2011). Phosphorylation of PGC-1α by the active AMPK, increases the stability of the 
molecule, PGC-1α dependent activation of its own promoter is enhanced, and the protein 
interacts with other transcription factors such as MEF2 and PPARγ (Handschin & 
Spiegelman, 2006; Jäger et al., 2007). A similar increase in PGC-1α expression is seen 
following the phosphorylation of CREB by PKA. During exercise PKA is activated by 
the binding of cAMP to its regulatory subunits, causing these inhibitory subunits to 
dissociate and therefore activating the catalytic subunits of the enzyme (Taylor et al., 
2004). This activation leads to the subsequent phosphorylation of CREB and an increase 
in PGC-1α expression within the cell.   
 
Figure 4. The expression of PGC-1α is regulated in various ways at the transcriptional 
level. PKA, AMPK and CaMK are activated in muscle following exercise and activate 
the CREB transcription factor by phosphorylation. When phosphorylated by AMPK and 
CaMK, histone deacetylases (HDAC) dissociate from MEF2 allowing it to bind to the 
PGC-1α gene and initiate transcription. PGC-1α causes an increase of its own 
transcription creating a positive feedback loop following exercise through the 
upregulation of MEF2 expression. Calcineurin is a Ca2+/calmodulin dependent protein 
phosphatase and can directly dephosphorylate MEF2 and NFAT, inducing translocation 
of NFAT to the nucleus and binding of NFAT and MEF2 to the PGC-1α promoter 
inducing its transcription along with other genes, such as troponin, myoglobin and MHCI. 
Along with phosphorylation by AMPK, PGC-1α can also undergo acetylation. This is 
carried out by the histone acetyl transferase, general control of amino acid synthesis 5 
(GCN5) (Dominy, Lee, Gerhart-Hines, & Puigserver, 2010). The acetylation of PGC-1α 
causes it to localise from the promotor regions to the nuclear foci inhibiting its 
transcriptional activity (Lerin et al., 2006; Tang, 2016). One of the primary ways in which 
the total activity of PGC-1α is modulated within skeletal muscle is the balance between 
the acetylation activity of GCN5 and the deacetylation activity of sirtuin 1 (SIRT1). The 
protein deacetylase SIRT1 can be activated by AMPK, directly interacts with, 
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deacetylates and activates PGC-1α, changing its localisation within the nucleus, allowing 
it to interact with and initiate the transcription of target genes involved in mitochondrial 
biogenesis (Cantó et al., 2009; Li et al., 2011).  
Calcium is one of the most important second messengers in skeletal muscle, triggering 
muscle contraction as well as a range of signal transduction pathways including those 
leading to mitochondrial biogenesis (Pette & Staron, 1990). Intracellular levels of calcium 
correlate directly to contractile activity, and this allows Ca2+ to modulate the activity of 
downstream signalling pathways in proportion to contraction. Calmodulin is an 
intermediate calcium-binding messenger protein which undergoes conformational 
changes in response to changes in intracellular calcium concentrations (Stevens, 1983). 
Following these conformational changes, calmodulin activates a range of downstream 
signalling proteins. These include phosphatases such as calcineurin, as well as a number 
of CaMKs, which play a key role in the increasing the number and function of 
mitochondria in skeletal muscle following exercise (Swindells & Ikura, 1996). 
CaMKII pathways are involved in the upregulation of mitochondrial biogenesis following 
exercise. CaMKII is phosphorylated in response to increases in cytosolic calcium and 
calmodulin concentrations (Jain et al., 2014). Such activity has been shown in studies 
where muscle placed under metabolic stress through the uncoupling of SERCA pump 
activity showed direct increases in CaMKII, recruitment of PGC-1α and stimulation of 
mitochondrial biogenesis (Maurya et al., 2018). CaMKII is one of the primary enzymes 
responsible for the phosphorylation of CREB and HDAC. CaMKII directly 
phosphorylates CREB, leading to the induction of PGC-1α along with other genes 
involved in the upregulation of mitochondrial biogenesis. Furthermore, CaMKII also 
phosphorylates HDAC. The histone deacetylase inhibits MEF2 activity when 
unphosphorylated, repressing PGC-1α transcription. When phosphorylated by CaMKII, 
HDAC dissociates from MEF2, allowing MEF2 to bind to the PGC-1α gene and initiate 
transcription (Lira et al., 2010).  
CaMKIV has been shown to increase mitochondrial biogenesis in skeletal muscle as well 
as promoting a low level of fast to slow fibre type transition (Wu et al., 2002). 
Mitochondrial biogenesis is upregulated through the enhanced expression of PGC-1 by 
CaMKIV, via the phosphorylation of MAPK. This was shown in a study via the in vitro 
and in vivo upregulation of CaMKIV in skeletal muscle (Wu et al., 2002). This 
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demonstrates another pathway through which calcium signalling is involved in the 
adaptive response of skeletal muscle through the expression of PGC-1α. Although 
CaMKIV is not highly expressed in skeletal muscle, other isoforms including CaMKII 
may have similar effects on the upregulation of target genes in muscle (Rose, Kiens, & 
Richter, 2006). This suggests that although CaMKIV can play a role in the physiological 
responses to exercise and is involved in muscle plasticity, it is not essential, with 
phenotypic changes able to take place without an increase in CaMKIV expression.  
Calcineurin is a serine/threonine phosphatase activated in skeletal muscle by elevations 
in intracellular calcium levels during exercise (Sakuma & Yamaguchi, 2010). The 
downstream effects of activated calcineurin includes the expression of various genes 
involved in cell growth, maintenance, remodelling and mitochondrial biogenesis (Chin, 
2004; Chin et al., 1998; Ryder, Bassel-Duby, Olson, & Zierath, 2003; Schulz & Yutzey, 
2004). Overexpression of calcineurin in skeletal muscle has been shown to increase the 
expression of PGC-1α along with increasing the activity of mitochondrial enzymes (Naya 
et al., 2000; Ryder et al., 2003). Studies have also found that animals treated with a 
calcineurin inhibitor, Cyclosporin A, still maintain regular increases in PGC-1α 
expression following exercise, suggesting that calcineurin is not necessary for PGC-1α 
expression. Calcineurin affects PGC-1α expression by dephosphorylating nuclear factor 
of activated T cells (NFAT) c1. NFAT c1 is a transcription factor which was first 
characterised in the immune system with its activation requiring nuclear translocation, 
controlled by calcineurin. (Flanagan, Corthésy, Bram, & Crabtree, 1991; Schulz & 
Yutzey, 2004). Once dephosphorylated, NFAT is able to bind to the promoter region and 
induce transcription of PGC-1α (Jung & Kim, 2014). Furthermore, studies have shown 
that calcineurin is involved in mediating mitochondrial biogenesis following exercise via 
the activation of MEF2, another potent inducer of PGC-1α expression (Handschin, Rhee, 
Lin, Tarr, & Spiegelman, 2003; Wu et al., 2001b). MEF2 is also coactivated by PGC-1α, 
creating a positive feedback loop upregulating its own expression (Handschin et al., 
2003).  
NRF 1 and 2 are transcription factors directly upregulated by PGC-1α (Mootha et al., 
2004; Wu et al., 1999). Following exercise, PGC-1α is upregulated and binds to and 
coactivates NRF1, significantly increasing its transcriptional activity on downstream 
target genes. These include the mitochondrial transcription factor A (Tfam). Once 
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produced, Tfam enters the mitochondria where it directly stimulates mitochondrial DNA 
(mtDNA) replication and mitochondrial gene expression (Tang, 2016; Z. Wu et al., 1999).  
The tumour suppressor protein p53 is involved in the rapid response to exercise within 
skeletal muscle (Beyfuss, Erlich, Triolo, & Hood, 2018). Its general function is to 
maintain cellular homeostasis during these periods of physiological stress. During 
exercise, p53 is activated by AMPK and p38 MAPK, which phosphorylate specific 
residues on p53 and increase the protein’s stability. Once p53 is phosphorylated its 
mitochondrial and nuclear localisation increases. In mitochondria, p53 interacts with 
Tfam, causing induction of mitochondrial genes involved in mitochondrial biogenesis 
(Saleem, Carter, Iqbal, & Hood, 2011; Yoshida et al., 2003). In the nucleus p53 induces 
the expression of PGC-1α, contributing to increased mitochondrial biogenesis in response 
to exercise (Park et al., 2009).  
Citrate synthase (CS) is a key enzyme involved in the first step of the Krebs cycle which 
is coded for by nuclear DNA and then transported into the mitochondrial matrix after 
synthesis. Following endurance exercise CS expression is increased in skeletal muscle 
and it is commonly used as a metabolic marker of mitochondrial density and oxidative 
capacity (Siu, Donley, Bryner, & Alway, 2003). This increase is likely due to increased 
CS synthesis rather than decreased degradation following exercise, with oxidative 
capacity of a muscle increasing in proportion to increases in CS activity (Vigelso, 
Andersen, & Dela, 2014). Long-term increases in muscle CS levels (e.g. following an 8-
week endurance protocol) suggest that CS plays an important role in muscle adaptations 
to exercise allowing for increase oxidative capacity.  
2.8.5.1 The Effects of Antioxidants on Mitochondrial Biogenesis 
One of the first studies directly linking antioxidant supplementation with a decrease in 
mitochondrial biogenesis in response to exercise when compared to controls was 
published in 2008 (Gomez-Cabrera et al., 2008). This study was later supported by 
Strobel et al. (2011) who showed that daily antioxidant supplementation decreased 
markers for mitochondrial biogenesis, including PGC-1α and NRF1, and mitochondrial 
enzyme activity following treadmill training in rats. In the following years, further studies 
were published on this topic exploring the link between antioxidants and their effect on 
mitochondrial adaptation to exercise. After more in depth investigation, it was found that 
although antioxidants do decrease the markers of mitochondrial biogenesis following 
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exercise this did not translate into a decrease in mitochondrial mass, which still increased 
compared to controls following exercise (Abadi et al., 2013; Meier et al., 2013). Results 
from targeted antioxidant treatments as well as general antioxidant loading experiments 
suggest that the effect of antioxidants on muscle mitochondrial responses to exercise was 
dependent, not only on the method and duration of antioxidant supplementation but also 
the volume of training (Higashida, Kim, Higuchi, Holloszy, & Han, 2011; Merry & 
Ristow, 2016).  
Evidence from animal models suggest that in many cases antioxidant treatment decreases 
the markers of mitochondrial biogenesis, such as PGC-1α, in skeletal muscle in response 
to exercise. This finding was supported in human trials. Paulsen et al. (2014) found that 
increases in PGC-1α mRNA seen following endurance training were prevented by 
supplementation with vitamins C and E (Padayatty et al., 2003; X. Wang & Quinn, 1999). 
However, a study by Yfanti et al. (2010) came to opposing conclusions, finding that the 
administration of vitamins C and E had no effect on the physical adaptations to exercise. 
Although this study did not find differences between control groups and those treated 
with antioxidants, it did not directly measure markers of mitochondrial biogenesis but 
instead measured CS activity. This limits the ability to draw conclusion from this study 
as to the effects within Krebs cycle activity, which while although linked to mitochondrial 
volume, it may not accurately reflect muscle mitochondria number and activity (Siu et 
al., 2003; Srere, 1969) 
This potentially conflicting data surrounding the effects of antioxidants on mitochondrial 
biogenesis in response to exercise suggests that, although antioxidants are capable of 
supressing this response in skeletal muscle, there are most likely other mechanisms at 
work along with redox signalling which allow for a normal physiological response. Until 
more recently, studies were conducted with global antioxidants which scavenge free 
radicals in a non-specific manner. These include vitamins E and C which were widely 
used when looking at the effects of antioxidants in skeletal muscle adaptation to exercise. 
These studies provided a solid foundation of knowledge on the potential effects of 
antioxidants on signalling pathways involved in adaptation of skeletal muscle. Further 
research utilising targeted site-specific antioxidants is required in order to understand the 
specific effects and changes caused by antioxidants in skeletal muscle due to the highly 
compartmentalised nature of redox signalling within muscle.  
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2.8.6 Fibre Type Switch (glycolytic to oxidative) 
Skeletal muscle is highly plastic and exercise is known to induce changes in fibre type 
composition (Yan, Okutsu, Akhtar, & Lira, 2010). Fibre type composition of skeletal 
muscle has been well researched as it directly affects both physical performance and the 
incidence of disease (Hickey et al., 1995; Inbar, Kaiser, & Tesch, 1981). Changes in the 
expression of a wide variety of genes are involved in the transition of muscle fibres from 
one type to another and many of these are influenced by exercise (Chin et al., 1998). 
Endurance exercise promotes an increase in the proportion of type I slow-twitch oxidative 
muscle fibres and type II fast-twitch oxidative fibres (type IIa). These are mitochondria 
dense and use oxidative production of ATP to supply a steady energy source during long 
periods of aerobic exercise (Wang et al., 2004).  
The role which CaMK plays in muscle remodelling has been widely researched as it is 
suggested to activate MEF2 and NFAT regulated genes by alleviating the repression of 
HDACs (McKinsey et al., 2000). MEF2 is a transcription factor which is highly expressed 
in skeletal muscle and neurons while also being expressed at lower levels in a wide range 
of other cell types (Black & Olson, 1998). In skeletal muscle, MEF2 transcription factor 
binds to the promoter regions of genes involved in proliferation and differentiation, such 
as the MyoD family, along with genes controlling the formation of slow-twitch oxidative 
muscle fibres, which includes PGC-1α. Following endurance exercise, MEF2 expression 
has been shown to increase as the muscle adapts to the prolonged contraction resulting in 
a higher percentage of slow-twitch fibres in skeletal muscle (Wu et al., 2001a). 
PGC-1α is suggested to be involved in the transition of muscle fibres from type II to type 
I (Handschin et al., 2007). Endurance exercise and overexpression studies of the protein 
have shown that it is directly involved in the increase of type I muscle fibres (Calvo et 
al., 2008; J. Lin et al., 2002). Although evidence showing the involvement of PGC-1α in 
the promotion of mitochondrial biogenesis is substantial, both it and the evidence 
surrounding the role in fibre-type switching has been challenged (Gouspillou et al., 2014; 
Rowe, El-Khoury, Patten, Rustin, & Arany, 2012). These challenges arise from potential 
disparities between PGC-1α function, in regard to fibre specific function, in human and 
rodent models. Variance between fibre type-specific PGC-1α regulated genes in humans 
and rodents along with a study which shows that PGC-1α may not be required for 
metabolic remodelling of skeletal muscle provoke questions around the transcriptional 
coactivator’s role in adaptation and fibre type switching (Gouspillou et al., 2014; Pérez-
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Schindler, Summermatter, Santos, Zorzato, & Handschin, 2013). Another study showed 
that PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal 
muscle, rather than only being required for developmental mitochondrial biogenesis and 
for the response to acute physiological stress (Gan, Fu, Kelly, & Vega, 2018; Rowe et al., 
2012). 
Rockl et al. (2007) and Yan et al. (2010) showed that AMPK signalling is required for 
muscle fibre type switch following exercise. The study of muscle tissue in mice following 
an endurance exercise protocol showed that muscle type transition from IIb to IIa/x was 
significantly decreased in transgenic mice with an inactive AMPKα2 subunit compared 
to wild type mice. The shift in fibre type towards more oxidative types of muscle fibre 
was not completely blunted by the inactive AMPKα2 subunit suggesting that AMPK is 
not solely responsible for this muscle adaptation. The significant difference in these two 
groups provides strong evidence that AMPK is directly involved in and required for 
normal muscle fibre type adaptation following contraction.  
Levels of PPARβ/δ increase in muscle following repeated bouts of exercise and 
overexpression of PPARβ/δ leads to an increase in the percentage of type I fibres, whilst 
its deletion caused a decrease in type I muscle fibre gene expression (Schuler et al., 2006; 
Spangenburg, Brown, Johnson, & Moore, 2009; Wang et al., 2004). Although these 
observations clearly suggest the involvement of PPARβ/δ in the transition of muscle 
fibres from type II to type I, it is yet to be determined if the switch is dependent on the 
transcriptional activity of PPARβ/δ (Yan et al., 2010).  
The study of exercise-induced muscle fibre type transition can be heavily influenced by 
the methodology used in each individual study. Myofibrillar myosin ATPase 
histochemistry is commonly used to determine muscle fibre composition, and is 
significantly different from various antibody based analyses which are also commonly 
used in similar studies with these two methods potentially producing differing results 
(Chin et al., 1998; Naya et al., 2000; Pogozelski et al., 2009; Wang et al., 2004). Differing 
conclusions have been drawn from similar studies, warranting caution in the 
interpretation of results (Geng et al., 2009; Potthoff et al., 2007). Nevertheless, 
physiological models appear to be the most reliable sources in the search for the regulators 
of fibre type switching in skeletal muscle at the current time. 
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ERK1/2 is a MAPK involved in the switch from type II to type I fibres in skeletal muscle. 
ERK1/2 have been found to be redox sensitive, with levels of ROS at rest, as well as 
following exercise, adequate for activation of the enzyme and thus increased activation 
seen following exercise (Kefaloyianni, Gaitanaki, & Beis, 2006). Animal models have 
suggested that the activation of ERK2 but not ERK1 is required for the switch to a more 
oxidative and fatigue-resistant fibre type, although this may be due to the relative 
abundance of the two ERK isoforms in skeletal muscle (Boyer et al., 2019). The 
mechanism of ERK1/2 activation is through an upstream GTPase called Ras. Activation 
of Ras in the plasma membrane leads to the recruitment and phosphorylation of Raf-1 
kinase (a MAPKKK), which phosphorylates and activates MEK1/2 (a MAPKK) which 
then phosphorylates and activates ERK1/2 (a MAPK) (Mandal, Becker, & Strebhardt, 
2016; Migliaccio et al., 2013). Early studies suggested that ROS was required for the 
activation of ERK1/2 in skeletal muscle (Gomez-Cabrera et al., 2008). The reduction in 
ROS, specifically reactive oxygen and nitrogen species (RONS), produced following XO 
inhibition, blunted ERK1/2 activation, suggesting that the ROS produced by XO play a 
key role in the activation of ERK1/2 signalling pathways. Subsequent studies showed the 
activation of ERK1/2 by ROS at resting concentrations (Kefaloyianni et al., 2006). More 
recently, work with animal models has shown that ERK1/2 signalling is directly 
responsible for the switch towards type II slow fibre types in vivo (Boyer et al., 2019). In 
cardiac muscle it has already been established that ERK1/2 is involved at multiple levels 
alongside MEK1 and calcineurin/NFAT signalling pathways (Sanna, Bueno, Dai, 
Wilkins, & Molkentin, 2005).  
Hypoxia-inducible factor 2 (HIF-2) is a transcription factor, closely related to HIF-1, and 
present in skeletal muscle, which controls many aspects of the cell’s response to hypoxia. 
HIF-2 may be involved in long-term adaptations to hypoxia rather than acute changes in 
gene expression seen during exercise (Lendahl, Lee, Yang, & Poellinger, 2009). 
Importantly, HIF-2 expression increases following exercise and increases the expression 
of a wide variety of genes associated with slow-twitch oxidative muscle fibres such as 
myosin heavy chain I (MHCI), myoglobin and calmodulin2 (Lindholm & Rundqvist, 
2016; Rasbach et al., 2010). This induction of genes by HIF-2 is also required for PGC-
1α induced fibre type switching. PGC-1α specifically increases the expression of HIF-2 




The process of fibre type switching following exercise is complex and required a wide 
range of molecular adaptations to take place. These type I fibres are referred to as being 
slow twitch oxidative fibres and are characterised by having higher mitochondrial content 
and increased capillary density when compared to more glycolytic fibre types (Wen et 
al., 2014). PGC-1α plays a key role in the switching of fibres towards a more oxidative 
type I composition following endurance exercise. One of the primary characteristics of 
oxidative fibres is greater expression of MHCI which when compared to MHCII. The 
MHCI isoform of the motor protein has a lower ATP consumption rate, due to lower 
ATPase activity, and produces slower contractions (Han, Geiger, Cody, Macken, & 
Sieck, 2003; He, Bottinelli, Pellegrino, Ferenczi, & Reggiani, 2000). Increased PGC-1α 
expression along with MEF2 and NFAT activation, such as that seen following exercise, 
induces the transcription of MHCI and of multiple other genes, including myoglobin and 
troponin (Lin et al., 2002). The expression of MEF2, induced by PGC-1α activity, 
feedbacks to further increase PGC-1α expression, leading to greater increases in regulated 
genes. Higher levels of myoglobin are a key characteristic of oxidative type I fibres. 
Myoglobin levels are known to increase following endurance training and this is once 
again due to the increase in expression of PGC-1α which induces myoglobin expression 
(Lin et al., 2002; Ordway & Garry, 2004). These increased myoglobin levels within the 
muscle favour greater oxygen delivery to the tissue (Gros, Wittenberg, & Jue, 2010). 
Additionally, increased PGC-1α expression results in oxidative and angiogenic 
improvement (Figure 5), complementing these adaptations and the transition towards a 
more oxidative fibre type.  
Type I fibres have higher mitochondrial density than other fibre types, meaning that the 
induction of mitochondrial biogenesis is key to the transition from glycolytic to more 
oxidative fibre compositions within the muscle. As previously described, the upregulation 
of PGC-1α following endurance exercise promotes the expression of genes involved in 
mitochondrial biogenesis. A greater mitochondrial density directly increases the oxidative 
capacity of the fibre contributing to the fatigue resistance of the muscle. Enzymes 
involved in ATP production through the Kerbs cycle and β-oxidation are also upregulated 
in type I fibres. PPARδ, a key regulator of fatty acid transport and oxidation, expression 
is markedly increased in type I fibres (Janani & Ranjitha Kumari, 2015; Wang et al., 
2004). As lipid oxidation for ATP synthesis increases as exercise duration extends, 
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PPARδ activity along with increases in fatty acid transporters, allows for greater 
endurance in exercise (Bradley et al., 2012).  
Along with myoglobin, vascular endothelial growth factor (VEGF) aids in enhancing 
oxygen delivery required in type I muscle fibres. VEGF directly increases the oxygen 
availability to the muscle by promoting the development of new blood vessels, increasing 
total blood flow (Wagner, 2011). PGC-1α is a powerful regulator of VEGF, increasing its 
expression in both cultured muscle cells an in vivo (Arany et al., 2008). The control of 
VEGF by PGC-1α provides another layer to the involvement of PGC-1α in fibre type 
switching towards type I fibres following endurance exercise.  
A wide range of factors contribute to the switching of skeletal muscle fibre type towards 
more oxidative fibre type compositions. The lower ATP consumption rate by MHCI and 
enhanced oxidative capacity through mitochondrial biogenesis increases fatigue 
resistance during endurance exercise. The MHCI isoform generates a lower mechanical 
power output but is more efficient in its utilisation of ATP in comparison to other isoforms 
found in type II fibres (Guth & Samaha, 1969; Leonardini et al., 2009; Mukund & 
Subramaniam, 2020; Rivero, Talmadge, & Edgerton, 1998). Type I fibres also have 
higher levels of antioxidant enzyme activity, such as SOD1, allowing ROS to be 
controlled over longer periods such as during endurance exercise (Criswell et al., 1993; 
Powers et al., 1994; Powers et al., 2011). The elevated expression of metabolic enzymes 
such as those involved in the Krebs cycle and β-oxidation, along with higher oxygen 
availability due to greater levels of myoglobin as well as VEGF regulated angiogenesis, 
facilitate extended periods of consistent aerobic contraction. The increased activity of 
PGC-1α following endurance exercise triggers many of these metabolic adaptations 
(Figure 5), contributing towards the switching to more oxidative and fatigue resistant 




Figure 5. PGC-1α is a key regulator of skeletal muscle adaptation. Its expression and 
activity are both increased in following exercise. This can trigger a wide range of 
physiological and metabolic adaptations depending on the transcription factors with 
which PGC-1α interacts. The activation of NRF1 and 2 causes an increase in mtDNA 
replication and results in mitochondrial biogenesis. PPAR transcription factors activated 
by PGC-1α increase the muscle’s oxidative capacity. PGC-1α can also increase the 
activity of the MEF2 transcription factor which has downstream effects in both the uptake 
of glucose into muscle through increased GLUT4 expression, as well as promoting a fibre 
type switch towards type I oxidative fibres 
2.8.7 Angiogenesis 
Angiogenesis, the growth of new blood vessels, is an important adaptation of skeletal 
muscle. Following exercise, upregulated expression of VEGF plays a key role in 
increasing the capillary/fibre ratio within muscle. The VEGF-induced capillary formation 
directly leads to an increase in exercise capacity (Olfert, Howlett, Wagner, & Breen, 
2010), allowing for a greater amount of blood flow to muscle, improved delivery of 
nutrients and oxygen, as well as clearance of metabolites, increasing performance in later 
bouts of exercise. Conversely, a decrease in VEGF expression, such as during extended 
periods of inactivity, leads to reduced capillarity (Wagner, 2011). 
VEGF is an important target for various clinical applications such as cancer treatment 
(Cardones & Banez, 2006). The idea of targeted VEGF reduction within tumour cells and 
therefore restricting blood flow is well researched yet there are still many complications 
and side-effects associated with current treatments. Along with PGC-1α, mentioned in 
the above section, the interactions of ROS and antioxidant systems have been found to 
affect VEGF expression. This opens a new area of investigation surrounding VEGF-
mediated redox sensitive molecular processes (Neves et al., 2018).  
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HIF-1 is a transcription factor found is most human cells including skeletal muscle that 
acts as a master regulator controlling genes involved in the cellular response to hypoxia 
(Hoppeler, Vogt, Weibel, & Fluck, 2003). The two subunits, HIF-1α and HIF-1β/ARNT 
are present in both the nucleus and cytosol and are able to shuttle between the two 
(Gassmann, Chilov, & Wenger, 2002). HIF-1 levels are primarily regulated through the 
adjustment of the rate of protein degradation of the HIF-1α subunit (M. E. Lindholm & 
Rundqvist, 2016). At rest, when the cell is in a state of normoxia, HIF-1α is hydroxylated 
by HIF-prolyl hydroxylase domain-containing enzymes (PHD). The now present oxygen-
dependent degradation domain (ODDD) is targeted by Von Hippel-Lindau E3 ubiquitin-
ligases (VHL) for degradation through the ubiquitin-proteasome pathway (Zhu & Bunn, 
1999). During periods of hypoxia, such as those induced by both acute and endurance 
exercise, the lack of oxygen no longer activates the ODDD and HIF-1α is not 
hydroxylated. The now stable HIF-1 accumulates within the nucleus of the cell (Ameln 
et al., 2005; Jewell et al., 2001). This then allows HIF-1α to dimerise with the HIF-
1β/ARNT subunit also present within the nucleus. The HIF-1 dimer is then able to bind 
to DNA and induce the expression of a range of genes involved in the muscle’s response 
to hypoxia such as VEGF (Ameln et al., 2005; Gassmann et al., 2002) 
HIF-1α is stabilised by MAPKs under hypoxic conditions. This process requires 
mitochondria-derived ROS, specifically H2O2, in order to take place (Gassmann et al., 
2002; Zhu & Bunn, 1999). Overexpression of catalase, which catalyses the dismutation 
of H2O2 into H2O and O2, inhibits the stabilisation of HIF-1α by MAPK (Emerling et al., 
2005; Lindholm & Rundqvist, 2016). This along with other studies, show that MAPK 
activation, HIF-1α accumulation and the expression of VEGF are controlled by and 
require ROS generated within the mitochondria during exercise (Emerling et al., 2005; 
Emerling et al., 2009; Levy, Levy, Wegner, & Goldberg, 1995). 
2.8.8 Improved Antioxidant Potential 
The antioxidant activity and capacity of body tissues is closely related to the oxygen 
consumption and ROS production of that tissue. For example, brain tissue, which has 
some of the highest oxygen consumption rates, has one of the highest levels of antioxidant 
enzyme activity of any tissues. This is also true for skeletal muscles, with some having a 
higher antioxidant enzyme activity than others. Long-term or chronic exposure of skeletal 
muscle to higher levels of oxidants triggers an increase in expression and activity of 
antioxidant systems, counteracting the higher ROS levels in the cell (Oberley, St Clair, 
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Autor, & Oberley, 1987). Muscle GSH content, along with overall antioxidant enzyme 
activity, is known to increase following regular endurance exercise (Ji, Leeuwenburgh, 
& Powers, 1999; Leeuwenburgh et al., 1997). The degree to which this level is increased 
is suggested to be muscle fibre type specific. 
The oxidant/antioxidant balance which is maintained in muscle cells is perturbed during 
strenuous exercise when ROS production is increased, triggering an upregulation of 
antioxidants by the cell. This acute response has also been shown to cause a longer-term 
adaptation increasing the antioxidant potential of the muscle. As well as short bouts of 
exercise, endurance exercise also causes long-term changes in antioxidant enzyme levels 
including basal levels at rest (Higuchi, Cartier, Chen, & Holloszy, 1985; Quintanilha & 
Packer, 1983). Similar adaptations have been observed in other tissues, such as heart and 
liver, suggesting that the mechanism responsible for the long-term increase in antioxidant 
potential is not tissue specific (Kanter, Hamlin, Unverferth, Davis, & Merola, 1985; Sen, 
Marin, Kretzschmar, & Hanninen, 1992).  
It has been shown that the activity of SOD, catalase, and GPx in skeletal muscle increase 
following exercise (Berzosa et al., 2011; Powers, Ji, & Leeuwenburgh, 1999). The degree 
to which these increases occur depends on the intensity and duration of the exercise. High-
intensity exercise increased GPx activity more so than low-to-moderate activity. 
Furthermore, longer duration exercise led to greater increases in GPx activity in 
comparison to short-duration exercise. Along with GPx, SOD has been shown to increase 
following long-duration exercise. A study by Ji, Gomez-Cabrera, and Vina (2007) 
suggests that ROS produced during and following exercise is involved in the activation 
of NF-κB and MAPK pathways and that these are likely to be involved in the increased 
activity of antioxidant enzymes including SOD and GPx. Catalase has also been shown 
to significantly increase following both high intensity and lower continuous exercise in 
comparison to levels at rest, likely in response to elevated ROS levels (Berzosa et al., 
2011). 
The activity of extracellular GPx and SOD is also known to rise following exercise. This 
increase in activity was measured directly following an acute bout of exercise before they 
returned to basal levels one hour later. Interestingly, enzymatic activity increased again 
24 hours post-exercise. This is suggested to be due to possible genetic upregulation of 




The generation of ROS is closely associated with intracellular signalling, both at rest and 
during exercise, with a range of antioxidant enzymes and molecules, such as GSH, 
involved in the maintenance of the cellular oxidant-antioxidant balance. (Powers et al., 
2011). Chronic elevation of ROS and oxidative damage to proteins, DNA, and cell 
membranes can contribute to complications of a range of pathologies, including diabetes 
and cancer. On the other hand, at rest and during acute bursts, such as during exercise 
(Davies et al., 1982), ROS are maintained at a level where they act as important signalling 
molecules while causing minimal or reversible oxidative damage. ROS themselves are 
involved in signalling pathways which lead to the improvement of antioxidant potential, 
mitochondrial biogenesis, and fibre type switch. Antioxidants work to reduce this 
oxidative damage though the maintenance of the oxidant/antioxidant balance but, under 
acute or short-term oxidative stress, antioxidant molecules also play an active role in 
signalling. One example is GSH, which can cause the glutathionylation of important 
enzymes controlling muscle adaptations in response to exercise (Thirupathi & Pinho, 
2018), but the extent to which GSH is involved in this adaptation is poorly understood. 
Therefore, the study aims to provide further understanding on the involvement of 
endogenous GSH in the molecular adaptation of skeletal muscle to contractions induced 
by ES. 
3. Materials and Methods 
3.1 Reagents 
High glucose Dulbecco’s Modified Eagle Medium (DMEM) was obtained from Gibco 
by Life Technologies (MA, USA) (ref: 11995-065) along with 2.5% Trypsin (10x) (ref: 
15090-046) and penicillin-streptomycin (ref: 15140-122). Horse serum (ref: 16050-122) 
was bought from Gibco by Life Technologies. Fetal Bovine Serum (FBS) (ref: MG-
FBS0820) was purchased from Moregate Biotech (New Zealand). The Isolate II RNA 
Mini Kit (ref: BIO-52073), High Capacity cDNA Reverse Transcription Kit (ref: 
4368813) and PowerUp SYBR Green Master Mix (ref: A25742) were obtained from 
Applied Biosystems by Thermo Fisher Scientific (MA, USA). Trypan Blue solution (ref: 
93595) was obtained from Fluka Analytical. Glutathione Fluorescent Detection Kit (ref: 
EIAGSHF) and Amplex UltraRed reagent (ref: A36006) were purchased from Invitrogen 
by Thermo Fisher Scientific (MA, USA). Catalase from bovine liver (ref: C1345), L-
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Buthionine sulfoximine (ref: B2515), Type II Horseradish Peroxidase (ref: P8250) and 
Aqueous 5-dihydrate Sulfosalicylic acid (SSA) (ref: S2130) were purchased from Sigma-
Aldrich (Merck) (MO, USA). Primers were purchased from IDT (IA, USA). 
3.2 C2C12 Cell Culture 
C2C12 mouse myoblasts were maintained at 37 oC and 5% CO2, in high glucose DMEM, 
10% (FBS), and 2% Penicillin-Streptomycin, referred to as proliferation medium. Cells 
were routinely cultured in 75 cm2 flasks prior to trypsinisation and seeding onto 6-well 
plates at a density of ~75,000 cells per well for stimulation. When these wells reached 
approximately 60-70% confluency, after between two and three days of incubation, the 
medium was changed to differentiation medium of high glucose DMEM with 2% Horse 
Serum and 2% Penicillin-Streptomycin. The cells were then allowed to differentiate into 
contractile myotubes for 6-7 days before use in experiments (Nedachi, Fujita, & Kanzaki, 
2008; Park et al., 2008).  
3.3 Electrical Stimulation of C2C12 Myotubes 
Prior to stimulation, the medium was changed to 4 ml of fresh differentiation medium per 
well, and again 12 hours into the stimulation when applicable. The 6-well circular C-Dish 
plates were connected to a C-Pace EP cell culture stimulator (IonOptix, MA, USA). The 
lids of the plates were fitted with carbon electrodes which extended into each of the wells, 
contacting the medium, allowing current to flow through the medium in each well. Cells 
were stimulated at 10 V using 1 second trains of pulses (at 50 Hz), every other second, 
for 24 hours at 37 oC and 5% CO2, causing contraction of the differentiated myotubes. 
After stimulation, the cells were extracted on ice, either immediately or after further 
incubation in fresh medium, as required for the experiment. 
3.4 BSO Treatment  
Endogenous GSH was depleted in C2C12 cells by the addition of BSO, an irreversible 
inhibitor of γ-GCS (key enzyme for GSH synthesis), to the differentiation medium at a 
concentration of 1 mM and 50 µM (Ardite et al., 2004). 6-well plates containing 
differentiated C2C12 myoblasts were washed with PBS and selected wells treated with 
differentiation medium containing the higher concentration (1 mM) BSO for 24 hours 
before stimulation. Control wells were incubated with standard differentiation medium. 
At the beginning of stimulation, the medium of all BSO treated wells was switched for 
55 
 
the lower concentration (50 µM) BSO treatment medium. All control wells were given 
fresh medium immediately prior to stimulation.  
The effectiveness of the BSO treatment at depleting GSH was determined using an 
Invitrogen glutathione fluorescent detection kit according to manufactures instructions 
and described below. 
3.5 Glutathione Assay 
Intracellular GSH was measured using a glutathione fluorescent detection kit 
(Invitrogen). In brief, both treated and control cells were extracted in ice-cold 5% SSA 
and lysed using multiple freeze thaw cycles and centrifugation (10 min at 14,000 rpm, 
Eppendorf 5424 R centrifuge, F-45-18-11 rotor), removing the supernatant after each 
cycle while leaving the pellet containing the lysed cells. Following incubation on ice, the 
pellet was centrifuged at top speed (21,130 × g). Pellet was collected and 25 µl of 
detection reagent was added in accordance to the manufacturer’s instructions. The 
detection reagent covalently binds to the free thiol group of GSH, yielding a fluorescent 
product allowing the total amount of GSH to be assayed using a standard curve using an 
excitation wavelength of 390 nm and emission wavelength of 510 nm. An initial 
measurement allowed the detection of all free reduced GSH in the sample, while a second 
reading taken after the addition of the reaction mixture that reduced the remaining GSSG 
to GSH allowed the measurement of both GSSG and total GSH.  
3.6 Cell Viability  
C2C12 cell viability was measured at the end of the 24 hr stimulation period using the 
trypan blue exclusion technique (Strober, 2015). Cells were detached from 6-well plates 
using trypsin and resuspended in proliferation medium. 0.5 mL of Trypan Blue was added 
to 0.5mL of resuspended cells and the viable cells counted using a Countess II FL cell 
counter (Invitrogen, CA, USA). Cell counts were confirmed using a haemocytometer. 
The count was performed within 4 minutes of the cells exposure to trypan blue to avoid 
false positives. All cell viability results are expressed as percentage (%) of viable cells.  
3.7 RT-PCR 
Total RNA was extracted from C2C12 cells in 6-well plates using an Isolate II RNA Mini 
Kit according to the manufacturers protocol immediately after stimulation and one- and 
three-hours post-stimulation, as indicated in the results. Samples from three wells of each 
experimental group were pooled together and considered as one replicate. RNA quality 
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(absorbance at 260/280 nm) and concentration were quantified using a Nanodrop 
Spectrophotometer (ThermoScientific, USA). cDNA was produced by reverse 
transcription using the high-capacity cDNA reverse transcription kit (ref:4368813) 
(ThermoScientific, USA). 1 µg total RNA was used as template according to the 
manufacturer’s instructions.  
Real-Time quantitative Polymerase Chain Reactions (RT-qPCR) were set up using a 
Universal SYBR Green One-Step kit from Applied Biosystems. Each well on the reaction 
plate contained: 0.1 µL forward primer, 0.1 µL reverse primer (10 µM final 
concentration), 3.8 µL nuclease-free water, 5 µL SYBR green, 1 µL cDNA, in a total 
volume per well of 10 µL. A full list of all primers used for this study can be found in 
Appendix 1. PCR reactions were performed using a StepOne RT-PCR instrument 
(Applied Biosystems) using the following parameters; samples heated to 95 °C for 5 
minutes, 95 °C for five seconds followed by 60 °C for 30 seconds (repeated for 40 cycles), 
heated to 95 °C for 15 seconds, 60 °C for 1 minute, heated to 95 °C for 15 seconds.  
RT-PCR analysis was performed using Thermo Fisher StepOne v2.3 software. Results 
were analysed using the 2−ΔΔCT method as described in Livak and Schmittgen (2001). This 
method of analysis allows for the measurement of a target gene’s expression relative to a 
control and normalized by a housekeeping gene, in this case hypoxanthine-guanine 
phosphoribosyl transferase (HPRT). 
3.8 ROS Assay (Hydrogen Peroxide)  
ROS production was measured using a horseradish peroxidase (HRP)-linked Amplex 
UltraRed fluorescence assay (Invitrogen). The Amplex agent is specific for H2O2, this 
specificity is enhanced when in the presence of HRP as is used in this study. When 
Amplex UltraRed is oxidised by H2O2, catalysed by HRP, the reaction produces resorufin. 
This red fluorophore is stable and fluorescent when excited at 540 nm, emitting light at 
612 nm. Accumulation of resorufin is proportional to the release of H2O2 into the medium. 
This allows the measurement of H2O2 produced within the cell which is released into the 
extracellular medium. C2C12 myotubes were incubated in PBS with added 25 mM 
glucose, 0.49 mM magnesium chloride and 0.9 mM calcium chloride, 0.1 U/mL HRP and 
50 µM Amplex UltraRed. Half of the samples were also treated with 1 mM BSO for 24hr 
prior to, and then 50 µM directly before stimulation. A control was performed for each 
group using catalase at a final concentration of 300 U/ml. The catalase was added to one 
57 
 
replicate in both BSO treated and untreated groups for each test plate. Fluorescence was 
measured identically to other samples. These results provide a background reading and 
are subtracted from the relevant sample group to produce the final readings. Samples were 
electrically stimulated as described previously. Aliquots of medium (100 µl) were taken 
from each of the wells containing differentiated C2C12 myotubes at 0, 15, 30 minutes, 1 
and 3 hours into stimulation. Samples were transferred to a 96-well plate and the 
fluorescence measured (excitation 540 nm and emission 612 nm) using a FLUOstar 
OPTIMA fluorescence microplate reader (BMG Labtech, Ortenberg, Germany). H2O2 
concentrations were calculated using a standard curve produced from known H2O2 
concentrations (0.066 µM – 100 µM) and normalised to total cellular protein, measured 
by Bradford Assay (Bradford, 1976). Once the final sample had been taken for the 
Amplex readings, each well was then washed with 300 µl of ice-cold PBS and 300µL of 
a Triton Lysis Buffer (TLB) was added to extract the cells (20 mM HEPES, 137 mM 
NaCl, 25 mM β-glycerophosphate, 2 mM EDTA, 1 mM sodium orthovanadate, 0.5 mM 
DTT, 1 mM PMSF, 10% glycerol, 1% Triton X-100, pH 7.4). Bradford assays were 
performed in clear, 96-well flat-bottom plates. Each well contained 18µL of H2O, 2 µL 
of sample, and 180 µL of Bradford reagent. The plate was incubated in the dark at room 
temperature for 5 minutes before the absorbance at 595 nm was measured from the 
underside of the plate. Protein concentrations were determined using a standard curve 
produced using known concentrations of bovine serum albumin (BSA) following the 
same protocol. 
3.9 Statistical Analysis  
Results are presented as mean ± standard error (SE). Two-way ANOVA was used to 
measure the overall effect of GSH depletion and ES on cell viability, GSH content of cells 
following BSO treatment, and on gene expression. The effect of GSH depletion on the 
accumulation of H2O2 over time during ES was analysed using repeated measures 
ANOVA. Bonferroni post-hoc test was used for specific inter-group comparison. 
Unpaired t-tests were performed to compare results of gene expression in control and 
GSH depleted cells at baseline (without ES). Results were analysed using Graphpad 
Prism 4 (v4.02, GraphPad Software Inc, La Jolla, CA, USA). The significance level was 




In order to test if GSH had a measurable effect on the expression of genes involved in 
muscle adaptation to contraction, differentiated C2C12 myotubes were treated with BSO 
to deplete cellular GSH. Cell viability was determined in order to eliminate the possibility 
of non-viable cells skewing later results. Cells treated with BSO were compared to control 
cells to confirm that the treatment had successfully reduced GSH levels. BSO treated cells 
along with control groups were electrically stimulated to induce contraction. H2O2 content 
and mRNA expression were measured in order to determine the effects of depleting 
endogenous GSH in C2C12 myotubes.  
4.1 Experimental Groups 
In order to evaluate the importance of GSH in the response to contractile activity in 
skeletal muscle, cells were treated with BSO before and during ES. This treatment was 
used to deplete GSH content in the cells before, during, and after the stimulation period. 
The experimental design is summarised in Figure 6.  
The experimental groups were defined as the following, all groups use differentiated 
C2C12 myoblast cells: 
- Control Baseline: Cells in standard medium. No electrical stimulation. 
- Control ES (electrical stimulation): Cells in standard medium submitted to 
electrical stimulation to elicit an exercise response. 
- GSH Depleted Baseline: Cells treated with BSO to allow for analysis of cellular 
response and changes caused by a lack of GSH. No electrical stimulation. 
- GSH Depleted ES: Cells treated with BSO and submitted to the ES protocol for 




Figure 6. Basic outline of the experimental groups used in this study. These groups are 
used primarily when referring to the RT-PCR results. Addition of BSO to the culture 
medium significantly depletes cellular levels of GSH, while DMEM was used as a control 
medium. Electrical stimulation (ES) was performed as described above. Baseline groups 
were those which did not undergo any form of ES and were used as an “at rest” group.  
4.2 Cell Viability 
In order to test if C2C12 myotubes remained viable following BSO treatment and 
electrical stimulation cells from all experimental groups were stained with trypan blue 
and counted using a Countess II. This method uses the exclusion technique as described 
by Strober (2015). Non-viable cells take up the trypan blue dye and show up as a distinct 
dark blue colour while viable cells exclude the dye and appear a lighter blue. Non-viable 
cells would cause later results to be unreliable due to varying H2O2 release, GSH content 
and altered mRNA measurements.  
Cell viability tests were conducted on all experimental groups, as outlined above. The 
results, shown in Figure 7, indicate that neither GSH depletion through treatment with 
BSO (p = 0.0978; two-way ANOVA) nor electrical stimulation as per protocol (p = 
0.7654; two-way ANOVA) had any significant effect on the viability of the differentiated 
C2C12 myotubes used in this experiment. Total cell survival rates had a mean of 96.9% 
± 0.3% across all experimental groups. Control baseline cells, which were not depleted 
of GSH nor subject to electrical stimulation, had a mean survival rate of 95.6% ± 0.9% 
and control ES was similar at 96.8% ± 0.7%. Mean survival rate of the GSH depleted 
baseline group was 98.5% ± 0.3% and GSH depleted ES was 96.8% ± 0.5%. These results 
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show that neither the electrical stimulation protocol nor treatment with BSO, alone or 
combined, cause any significant reduction in cell viability when compared to controls.  
 
Figure 7. Cell viability (% of live cells) of GSH depleted (black) and control (white) cells 
at baseline and following ES. Data presented as mean ± SE. Data analysed by two-way 
ANOVA and Bonferroni post-test. p = 6-12 for all groups. Number of cells/well was 
similar among groups: 5.5x105/mL ± 0.6x105/mL. 
4.3 GSH Depletion in C2C12 myotubes 
GSH had to be significantly depleted in groups of cells in order to test the effects of GSH 
on gene expression. This allows a comparison to be drawn between GSH depleted cells 
and control cells where GSH levels are at normal physiological levels. BSO was used to 
achieve this and, to test the effectiveness of this chemical inhibitor of GSH synthesis, 
total and free GSH levels of cells were measured. Measurements were taken from groups 
of cells which were treated with BSO (GSH depleted) and those which had not (control). 
Cells from both groups were then subjected to ES and compared to baseline 
(unstimulated) cells of the same group.  
As shown in Figure 8, treatment with BSO caused a significant decrease in cellular GSH 
when comparing total GSH concentrations of treated (GSH depleted) and untreated 
(control) cells across both baseline and ES groups (collected immediately after ES). Mean 
total GSH concentrations were 36.4 µM ± 7.8 µM and 36.8 µM ± 9.3 µM for baseline 
and ES control cells respectively. GSH depleted cells had mean concentrations of 5.6 µM 
± 0.9µM for baseline and 6.8 µM ± 0.9 µM for ES cells, significantly lower 
concentrations (p < 0.001; Bonferroni post-test) when compared to control cells showing 
that BSO was effective at depleting GSH. ES was shown to not have a significant effect 
on total GSH content immediately after the protocol (p = 0.8740; two-way ANOVA). 
61 
 
These results show that the BSO treatment used in this study was effective in significantly 
depleting the total cellular GSH in C2C12 myotubes.  
 
Figure 8. Depletion of GSH in C2C12 myotubes. Total GSH concentration (µM) per well 
of control cells (white) and those treated with BSO (black) at baseline and immediately 
following ES. *** p < 0.001, Bonferroni post-test. Number of cells: 5.5x105/mL ± 
0.6x105/mL. Data presented as mean ± SE. Data analysed by two-way ANOVA and 
Bonferroni post-test. n = 7-12 for all groups.   
4.4 H2O2 Release from C2C12 myotubes Measured by Amplex Red 
Fluorescence 
As endogenous GSH plays a key role in the elimination of H2O2 within C2C12 myotubes, 
further tests were conducted in order to determine if GSH depletion caused additional 
H2O2 accumulation when compared to controls. Measurements were taken of C2C12 
myotubes treated with BSO (GSH depleted) and control cells. Some cells from each group 
underwent contraction via ES while some did not (baseline). 
GSH depletion significantly increased H2O2 accumulation, both at baseline and during 
ES (p = 0.0076; repeated measures ANOVA). ES enhanced H2O2 production over time 
when compared to non-stimulated cells (p < 0.001; repeated measures ANOVA), with 
GSH depletion causing a further increase in H2O2 production, in addition to ES, when 




Figure 9. Change in accumulated H2O2 concentration over time in medium from C2C12 
myotubes. H2O2 measurement of GSH depleted and control cells during ES and at 
baseline (no ES). ** p < 0.01 for an overall effect of GSH depletion on H2O2 
concentration over time (repeated measures ANOVA). *** p < 0.001 for an overall effect 
of ES on H2O2 concentration over time (repeated measures ANOVA). Data presented as 
mean ± SE. Data analysed by repeated measures ANOVA and Bonferroni post-test. n = 
4 for all groups. 
4.5 Gene Expression Measured by RT-PCR  
To determine the effect of GSH depletion on contraction-induced changes in gene 
expression, groups of GSH depleted and control cells were subjected to electrical 
stimulation while others were left in a resting state (baseline). The mRNA levels of genes 
were measured using RT-PCR in both GSH depleted and control cells, at three time points 
(0 hr, 1 hr and 3 hrs) following contraction along with a baseline group which was not 
subjected to ES. The results are divided into sections; the first grouping genes which 
showed no response following ES, the second displaying genes, which had expression 
changes at baseline, and finally genes for which mRNA levels changed following ES or 
GSH depletion.  
4.5.1 Genes Not Affected by GSH depletion or ES (CS, HK, GPx1, Tfam, 
NRF1, NRF2, SOD2) 
The genes for CS, HK, GPx1, Tfam, NRF1, NRF2 and SOD2 showed no significant 
change in mRNA expression over time following stimulation, nor did the response vary 
significantly between GSH depleted and control cells (Figures 10, 11). Although Tfam 
had a greater increase in mRNA when compared to other non-responding genes, this 
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increase was still not statistically significant (p = 0.36 for and effect of ES over time, p = 
0.61 for and effect of GSH depletion; two-way ANOVA).  
 
Figure 10. mRNA levels of genes not affected by GSH depletion or ES measured by RT-
PCR. Data presented as mean ± SE. Data analysed by two-way ANOVA and Bonferroni 
post-test. Solid bars = Control, Striped bars = GSH depleted. n = 11 for all genes. Data 
was normalised to the control baseline of each gene. HPRT was the housekeeping gene 
for all measurements.  
 
Figure 11. mRNA levels of genes not affected by GSH depletion or ES measured by RT-
PCR. Data presented as mean ± SE. Data analysed by two-way ANOVA and Bonferroni 
post-test. Solid bars = Control, Striped bars = GSH depleted. n = 11 for NRF1 and SOD2. 
n = 9 for NRF2. Data was normalised to the control baseline of each gene. HPRT was the 




4.5.2 Baseline Effects of GSH Depletion (PPARα, PFK and SOD1) 
The mRNA levels of PPARα, PFK and SOD1 were measured using RT-PCR as described 
in the methods. These genes showed no significant changes in expression when 
comparing GSH treated cells and controls overall or at any specific timepoint following 
the electrical stimulation protocol used in this study (Figure 12A). However, at baseline 
all three showed a tendency (although not statistically significant) for GSH depleted cells 
to have higher expression (SOD1 p = 0.086, PPARα p = 0.0654, PFK p = 0.1149; unpaired 
t-test) (Figure 12B). The GSH depleted values are higher by 36% for SOD1, 27% for 
PPARα and 34% for PFK. These results may suggest that GSH affects the expression of 
SOD1, PFK, and PPARα at baseline already before cells are subjected to electrical 
stimulation.  
 
Figure 12. mRNA levels of PPARα, PFK and SOD1 measured by RT-PCR.  A.) Gene 
expression at baseline and following ES of PPARα, PFK, and SOD. Data analysed by 
two-way ANOVA and Bonferroni post-test. B.) Baseline expression of PPARα; p = 
0.0654 (unpaired t-test). C.) Baseline expression of PFK; p = 0.1149 (unpaired t-test). D.) 
Baseline expression of SOD1; p = 0.086 (unpaired t-test). Data presented as mean ± SE. 
Data analysed using an unpaired t-test. n = 11 for PFK and SOD1. n = 9 for PPARα. Data 
was normalised to the control baseline of each gene. HPRT was the housekeeping gene 
for all measurements. 
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4.5.3 Genes Affected by Interventions (VEGF, CPT-1B, PPARγ, Catalase, 
GLUT4, PGC-1α) 
The mRNA levels of genes were analysed using both two-way ANOVA and Bonferroni 
post-tests. Significant overall effects (p < 0.05) were found for the genes in this section 
using the two-way ANOVA. These effects relate to overall changes in mRNA levels 
either over time following ES (*time) and/or the effect of GSH depletion following 
treatment with BSO (*GSH depletion) when compared to baseline (unstimulated) 
untreated cells. No significant differences were found when comparing between specific 
groups using the Bonferroni post-test.  
4.5.3.1 VEGF  
VEGF expression increased over time following ES for both control and GSH depleted 
cells. Two-way ANOVA analysis showed a significant response for an effect of time 
following ES (p = 0.0394). There was no significant difference in VEGF mRNA levels 
in GSH depleted myotubes compared to controls at any time point (p = 0.4459; two-way 
ANOVA). VEGF mRNA levels peaked at the one-hour time point for both GSH depleted 
and control cells with increases of 11.3% and 26.1% respectively, before both decreased 
approximately back to baseline values at the three-hour time point (Figure 13). These RT-
PCR results show that VEGF mRNA increases following electrical stimulation, whether 
or not endogenous GSH has been depleted.  
 
Figure 13. VEGF mRNA levels measured by RT-PCR.  Data presented as mean ± SE. 
Data analysed by two-way ANOVA and Bonferroni test. *p < 0.05 for an overall effect 
of ES over time. n = 11. Data was normalised to the control baseline of each gene. HPRT 




4.5.3.2 CPT-1B  
CPT-1B expression was measured in GSH depleted and control cells at baseline and at 
multiple timepoints following a 24-hour electrical stimulation period as described in the 
methods. There was a strong, although not statistically significant, tendency for CPT-1B 
expression to increase over time following ES (p = 0.0580; two-way ANOVA) with no 
difference between control and GSH depleted groups (p = 0.1732; two-way ANOVA). 
There was an increase in CPT-1B mRNA expression from the baseline reading to the one-
hour timepoint for GSH depleted cells, before a decrease to baseline levels at the three-
hour time point. GSH depleted cells peaked at the one-hour time point with an increase 
of 56.3% while control peaked after three hours with an increase of 32.8%, although this 
was similar to the zero and one-hour values of 32.3% and 32.7% respectively (Figure 14). 
Following electrical stimulation CPT-1B expression increased over time and was 
unaffected by the depletion of endogenous GSH.  
 
Figure 14. CPT-1B mRNA levels measured by RT-PCR.  Data presented as mean ± SE. 
Data analysed by two-way ANOVA and Bonferroni post-test; *p = 0.0580 for an overall 
effect of ES over time. n = 11. Data was normalised to the control baseline of each gene. 
HPRT was the housekeeping gene for all measurements. 
4.5.3.3 PPARγ 
GSH depletion caused an increase in PPARγ expression when all time points are 
considered (p = 0.0427; two-way ANOVA). This effect was greatest at baseline and the 
three-hour post-stimulation timepoint where PPARγ expression was 22.2% and 31.9% 
higher in GSH depleted samples in comparison to controls, respectively. ES had no 
significant effect on PPARγ mRNA levels as no large changes in expression were seen 
when comparing baseline results to any timepoint following stimulation. (p = 0.7622; 
two-way ANOVA) (Figure 15). These results show that depleting endogenous GSH of 
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C2C12 myotubes causes a baseline increase in PPARγ mRNA levels which persists 
following contraction.  
 
Figure 15. PPARγ mRNA levels measured by RT-PCR.  Data presented as mean ± SE. 
Data analysed by two-way ANOVA and Bonferroni post-test. *p < 0.05 for an overall 
effect of GSH depletion. n = 11. Data was normalised to the control baseline of each gene. 
HPRT was the housekeeping gene for all measurements.  
4.5.3.4 Catalase  
Catalase expression was measured in GSH depleted and control myotubes at baseline and 
at multiple timepoints following a 24-hour electrical stimulation period as previously 
described in the methods. Catalase expression was upregulated by GSH depletion and, at 
the same time, was increased by ES. Untreated control cells also showed an increase in 
catalase mRNA from baseline to the one-hour timepoint (45.4%), before flattening off to 
the three-hour point remaining 23.3% higher at the three-hour point than at baseline. GSH 
depleted cells also showed a steady increase in catalase expression from baseline to the 
three-hour point peaking at 43.3% above baseline. However, mRNA levels of GSH 
depleted cells were higher than that of control cells at every timepoint. Statistical analysis 
showed a significant effect of both ES (time) and treatment (GSH depletion) over the 
entirety of the time course with values of p = 0.0027 and p = 0.0281 respectively (two-
way ANOVA). (Figure 16). These results show that the depletion of endogenous GSH of 
C2C12 myotubes causes an increase in catalase mRNA levels both at baseline and 
following contraction, while the responsiveness of catalase to ES remains similar 




Figure 16. mRNA levels of catalase measured by RT-PCR. Data presented as mean ± 
SE. Data analysed by two-way ANOVA and Bonferroni post-test. *p < 0.05 for an overall 
effect of GSH depletion. **p < 0.01 for an overall effect of ES over time. n = 11. Data 
was normalised to the control baseline of each gene. HPRT was the housekeeping gene 
for all measurements. 
4.5.3.5 GLUT4  
There was a significant effect of ES on the expression of GLUT4 in both GSH depleted 
and control cells (p = 0.0016; two-way ANOVA). GLUT4 expression increased over time 
following electrical stimulation for both test groups, regardless of GSH levels cells (p = 
0.3369; two-way ANOVA) (Figure 17). At the three-hour post-ES time point both groups 
saw their peak in GLUT4 expression, increasing from baseline 108% for GSH depleted 
and 113.7% for control cells. These results show that GSH depletion has no effect on 
GLUT4 mRNA, while electrical stimulation caused an increase in GLUT4 expression 
over time following contraction.  
 
Figure 17. GLUT4 mRNA levels measured by RT-PCR. Data presented as mean ± SE. 
Data analysed by two-way ANOVA and Bonferroni post-test. **p < 0.01 for an overall 
effect of ES over time. n = 11. Data was normalised to the control baseline of each gene. 
HPRT was the housekeeping gene for all measurements. 
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4.5.3.6 PGC-1α  
Two-way ANOVA analysis showed a significant effect of ES on the expression of PGC-
1α across both GSH depleted and control groups when all timepoints are considered (p = 
0.0249; two-way ANOVA). PGC-1α expression increased over time following ES for 
both GSH depleted and control groups alike cells (p = 0.7323; two-way ANOVA). GSH 
depleted cells showed an increase in PGC-1α gene expression from baseline to three hours 
post-ES, peaking 43.6% higher after 1 hour, before decreasing to the final timepoint 
(+27.4% from baseline). Control groups where GSH production was not impaired showed 
an increase of 75% (1.032-1.798) from baseline to its peak at the zero-hour point, before 
decreasing at a slower rate with a final reading still of 1.494, 44.8% above baseline. 
(Figure 18). These results show electrical stimulation increases PGC-1α mRNA levels in 
C2C12 myotubes. GSH depletion had no significant effect on PGC-1α mRNA as 
expression did similarly increase following electrical stimulation, regardless of treatment.   
 
Figure 18. PGC-1α mRNA levels measured by RT-PCR. Data presented as mean ± SE. 
Data analysed by two-way ANOVA and Bonferroni post-test. *p < 0.05 for an overall 
effect of ES over time. n = 11. Data was normalised to the control baseline of each gene. 
HPRT was the housekeeping gene for all measurements. 
5. Discussion 
5.1 Overall Effects 
This study aimed to evaluate the involvement of endogenous GSH in the molecular 
adaptation of skeletal muscle myotubes to contractions induced by ES in vitro. The results 
gathered suggest that there is no marked effect of GSH depletion on gene expression 
following contraction (Figure 19). Previous studies have shown the effects of ROS on 
signalling pathways involved in muscle adaptation following exercise, but the current 
study focused on the potential role of GSH in this signalling. The current results suggest 
that although GSH may not hold the key to ROS mediated muscle adaptation, it still plays 
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an important role in controlling the redox state of cells and may influence gene expression 
through a mechanism that has not yet been elucidated. 
Despite observing a significant difference between the levels of GSH and H2O2 produced 
in control and cells treated with BSO (blocking GSH synthesis), no measurable difference 
was observed in the expression of markers of muscle adaptation following ES. All cells 
were treated to similar proliferation and differentiation times allowing for myotubes to 
form before treatment and stimulation took place. Other factors may have a more 
significant effect on adaptation signalling in comparison to the involvement of GSH. 
Therefore, although the depletion of GSH may have had an effect on the signalling 
involved in muscle adaptation, it may not have been of sufficient magnitude to be 
detectable without the suppression of other, more prominent, signalling pathways 
activated during exercise, such as those involving AMPK, MAPK, CaMK or NF-κB. 
Additionally, due to the minimal changes in expression observed following muscle 
contraction the ability to ascertain the role of GSH in these changes is limited.  
 
Figure 19. The effects of GSH depletion and ES on genes for which mRNA expression 
increased following electrical stimulation (ES), GSH depletion or both, as measured by 
RT-PCR. Genes represented outside of both circles were unaffected. *p = 0.058. **Effect 
at baseline only; SOD1 p = 0.086, PPARα p = 0.0654, PFK p = 0.1149. 
5.2 The Effect of BSO on ROS Generation in Muscle 
The depletion of GSH through inhibition of γ-GCS by BSO on differentiated C2C12 
myotubes resulted in a significant reduction of total GSH levels. This is in line with 
previous studies and was consistently reproduced over time (Ardite et al., 2004; Griffith 
& Meister, 1979; Savini et al., 2005). GSH acts as an antioxidant molecule and is one of 
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the main scavengers of H2O2 in skeletal muscle (Blokhina et al., 2003; Meister & 
Anderson, 1983; Pizzorno, 2014). Therefore, the lack of GSH is likely to reduce myotube 
antioxidant potential, inhibiting the ability of GPx to catalyse the oxidation of GSH by 
H2O2. 
Control cells that were not subjected to contraction were able to stabilise the H2O2 signal 
after one hour, while GSH depleted cells continued to release H2O2 causing an increase 
in the Amplex signal over time. This may illustrate the importance of GSH on the redox 
balance of muscle cells even at rest, although it was not possible to evaluate the effect 
GSH depletion had on other antioxidant molecules. A wide range of other antioxidants 
contribute to the maintenance of intracellular redox status, including enzymes such as 
catalase and SOD1/2 as well as molecules such as peroxiredoxin and glutaredoxin. 
Although GSH is the most abundant of these, together the other antioxidants may be 
capable of controlling H2O2 levels under baseline conditions, irrespective of whether 
GSH is depleted.  
This study demonstrates the increase in ROS production during contraction, like many 
others described (Davies et al., 1982; Powers et al., 2011; Reid, 2001b). The accumulation 
of H2O2 from GSH depleted cells was even more prominent during ES than at baseline. 
Cells where GSH levels were lowered produced a significant increase in H2O2 during ES, 
greater than that seen by ES alone. This indicates that these myotubes were less able to 
balance H2O2 production and elimination in comparison to control cells. This emphasises 
the importance of GSH (or the GSH-GPx-GR system) and its role in maintaining the 
redox balance of muscle. 
5.3 Mitochondrial Biogenesis and Fatty Acid Metabolism 
Mitochondrial biogenesis and fatty acid metabolism are controlled by a similar range of 
signalling pathways and transcription factors. Controlling the expression of transcription 
factors such as PPARα and PGC-1α, the AMPK pathway plays a central role in regulating 
mitochondrial biogenesis and fatty acid metabolism in muscle cells. AMPK in known to 
be sensitive to AMP/ADP ratios within the cell but may also be stimulated by H2O2 
(Hinchy et al., 2018). GSH depletion significantly increased concentrations of H2O2, 
which may have led to an increase in the expression of PPARα mRNA in cells prior to 
contraction when compared to controls. While this increase was clear at baseline, 
following contraction there was no significant difference in PPARα expression. This is in 
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contrast to PGC-1α mRNA expression which increased over time following contraction 
yet GSH depletion did not alter this response further. These inconsistencies between 
genes at baseline and following ES are likely due to the variety and crosstalk of signalling 
pathways activated by ROS and ES. Interestingly, PGC-1α peaked at zero hours in control 
cells while GSH depleted cells peaked one hour following stimulation. Although there is 
no statistical significance, along with the lack of more prominent response of PGC-1α to 
stimulation, this difference shows a possible influence of GSH depletion on the level of 
PGC-1α expression following contraction which cannot be ruled out.  
As with many genes measured in this study, other signals, such as those triggered by 
exercise, are likely to affect the expression of PGC-1α. Shown in Figures 3 and 4, a wide 
range of factors directly and indirectly influence PGC-1α expression, stability and 
activity. Since these pathways were not monitored in this study, it is possible that they 
may contribute to PGC-1α regulation, alongside H2O2 and GSH. PGC-1α expression is 
controlled by multiple upstream activators which act independently of ROS, activated by 
signalling trough Ca2+, cAMP, AMP and more. The measurement of these pathways 
including p38 MAPK, CaMKII, AMPK, PKA, and calcineurin may provide further 
insight into the different signalling pathways activated in GSH depleted C2C12 cells 
compared to controls. This would also provide a clearer insight into PGC-1α’s role in the 
expression of other genes involved in all aspects of muscle adaptation following 
contraction. 
Much like PGC-1α and PPARα, the expression of CPT-1B mRNA after ES was not 
affected by GSH depletion and, similar to PGC-1α, there was a significant increase in 
CPT-1B expression following contraction, regardless of GSH levels. CPT-1B dictates the 
rate of β-oxidation and its expression is known to be linked to AMPK, as well as p38 
MAPK. Further research may provide an explanation for the small difference between 
control and GSH depleted groups if this is mirrored in the activity of either AMPK or p38 
MAPK signalling (Ronnett, Kleman, Kim, Landree, & Tu, 2006). Results from the 
current study do not provide any evidence to suggest a significant effect of GSH depletion 
on CPT-1B expression.  
Although the majority of genes involved in the adaptation of fatty acid metabolism 
following contraction were unaffected by GSH depletion, PPARγ and PPARα showed 
significant changes in expression. PPARγ mRNA expression did not respond to 
73 
 
contraction but was increased in GSH depleted groups when compared to controls. 
Similarly, PPARα mRNA expression increased at baseline in response to GSH depletion, 
while no change was seen when comparing control and GSH depleted groups following 
contraction. These results suggest that some aspects of fatty acid metabolism may be 
affected by either GSH depletion or the resulting increase in H2O2 during rest. Although 
PPARγ and PPARα are both known targets of PGC-1α activation, the increased 
expression of PGC-1α over time following ES did not correlate with changes in PPARγ 
or PPARα mRNA levels and may be a result of other signalling pathways activated by 
ROS and contraction.  
There is a clear link between fatty acid metabolism and mitochondrial biogenesis in 
skeletal muscle. One of the aims of this study was to investigate the effect of GSH 
depletion on genes involved in the adaptive changes to these processes both at rest and in 
the exercise response. The results described above suggest that GSH depletion has no 
significant effect on these adaptations following contraction, although further 
investigation is required to elucidate the mechanisms responsible for changes in PPARγ 
and PPARα expression at rest after GSH depletion.  
5.4 Glucose Metabolism 
The results in this study also suggest that increased GLUT4 expression in response to ES 
is not impaired by GSH depletion, as both control and GSH depleted cells showed a 
significant increase in expression of GLUT4 over time following ES. Both groups 
followed a similar trend, peaking first immediately following ES and then again after 
three hours. This is in line with similar studies which showed little increase in GLUT4 
immediately after ES followed by a significant increase in the subsequent hours (Kuo, 
Browning, & Ivy, 1999).  
Although GLUT4 expression has previously been shown to be stimulated by ROS (Katz, 
2016; Pinheiro, Silveira, Nachbar, Vitzel, & Curi, 2010), results from the current study 
show no significant increase at baseline where ROS is increased in GSH depleted cells. 
A wide range of signals elicited by exercise such as activation of AMPK, MAPK, and 
CaMK are known to affect GLUT4 expression (Holmes et al., 2005; Kuo et al., 1999; 
Ojuka, Jones, Nolte, et al., 2002). These pathways are mainly active during stimulation 
but are also redox sensitive, and therefore may be activated by the elevated levels of ROS 
in GSH depleted cells although no such effect was observed in this study. Analysing the 
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activation of these pathways may provide some insight into the many factors controlling 
GLUT4 expression both at baseline and following ES. 
GSH depletion increased PFK expression prior to contraction when compared to control 
cells. This suggests that the lack of GSH or increase in H2O2, at least for a short duration 
(i.e., 24 hours) may have beneficial effect on glucose metabolism in the muscle cells. PFK 
was the only gene tested that is directly involved in glucose metabolism and displayed 
any change following GSH depletion. Although PGC-1α is involved in the regulation of 
glucose metabolism in muscle, it only displayed an increase as a result of muscle 
contraction, as did GLUT4. Therefore, the interplay between ROS and exercise appear to 
be important to improve glucose metabolism, while reduced levels of GSH for a short 
period have no effect on the metabolic indicators used in this study.  
5.5 Antioxidant Capacity 
Muscle cells which have significantly lowered antioxidants would be expected to produce 
higher levels of ROS during exercise. This has been shown in studies where GSH levels 
were depleted in skeletal muscle and ROS levels, such as H2O2, increased when compared 
to controls following exercise (Dam, Mitchell, Rush, & Quadrilatero, 2012). Similarly, 
in GSH depleted cells, the activity of other antioxidants in the cell could increase and 
compensate for the reduced GSH. The activity of antioxidant enzymes such as GPx1 and 
SOD2 are known to be tied to the expression of PGC-1α, which was not affected by GSH 
depletion, and other signalling pathways, such as NF-κB and MAPK. NF-κB signalling 
has been shown to be both increased and decreased by ROS, although the most recent 
evidence supports NF-κB as being activated by exercise-induced ROS (Ji, 2008; Ji et al., 
2007; Kabe, Ando, Hirao, Yoshida, & Handa, 2005; Pantano, Reynaert, van der Vliet, & 
Janssen-Heininger, 2006). The PGC-1α promotor contains a binding site for NF-κB, 
suggesting that ROS produced during contraction may lead to PGC-1α expression via 
NF-κB signalling.  
Although ROS, PGC-1α and NF-κB activation being implicated in the expression of 
GPx1 and SOD2, the current study showed no response of SOD2 and GPx1, despite 
changes in H2O2 levels and PGC-1α expression. This highlights the complex crosstalk 
between signalling pathways activated by ROS and exercise that defines gene expression. 
Our findings are partially in contrast to findings from a previous study by Strobel et al. 
(2014). In line with the current study, Strobel et al. (2014) showed no change in SOD2 
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expression following ES in control and GSH depleted groups. However, their results also 
showed an increase in GPx1 following exercise in control groups while expression 
decreased in GSH depleted groups, contrasting the results from current study. The Strobel 
et al. (2014) study used live animal models along with an alternative method of depleting 
muscle glutathione (diethyl maleate). These differences in findings may be due to 
variation in protocol between the studies. 
Interestingly, multiple genes showed changes in expression at baseline when no 
contraction was undergone. One of these was the tendency for SOD1 mRNA to be 
increased in GSH depleted cells (p = 0.086). This is likely due to the increased levels of 
ROS and oxidative stress at baseline resulting from the lower levels of the key antioxidant 
GSH. This is supported by a previous study which showed that the promoter activity of 
the SOD1 gene is increased by H2O2 in skeletal muscle (Yoo, Chang, & Rho, 1999). The 
lack of a difference in SOD1 mRNA levels between control and GSH depleted cells 
following exercise may be due to the upregulation of other antioxidant mechanisms 
within the cell, such as catalase. 
The expression of catalase was increased following both GSH depletion and ES, with 
incremental effects. Catalase mRNA was significantly higher in GSH depleted cells than 
control groups across all time-points, including baseline. Despite that, GSH depletion did 
not improve the responsiveness of catalase to ES, as the magnitude of increase in gene 
expression was similar between GSH depleted cells and control. Catalase expression in 
skeletal muscle is known to be controlled, in part, by the activation of p38 MAPK. The 
significant increase in catalase mRNA seen following both ES and GSH depletion may 
therefore be a result of p38 MAPK activation. Exercise is known to induce p38 MAPK 
signalling in skeletal muscle (Goodyear, Chang, Sherwood, Dufresne, & Moller, 1996). 
A previous study suggested that p38 MAPK is a key step in controlling the upregulation 
of catalase following increased levels of H2O2 (Sen, Chakraborty, & Raha, 2005). This 
study exposed lung fibroblasts to low levels of H2O2, resulting in increased p38-MAPK 
and catalase expression, while groups with silenced p38MAPK signalling, attenuated the 
increase in catalase expression. The decreased catalase expression observed in the study 
provides further evidence of a link between p38-MAPK activation and catalase 
expression. P38-MAPK may have been activated in the cells in the current study resulting 
in increased catalase mRNA.  
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However, those are not the only mechanisms involved in catalase expression. 
Independent of contraction and ROS signalling, Luo and Rando (2003) suggests that the 
transcriptional regulator NF-Y is a strong inducer of catalase expression, binding to two 
CCAAT boxes in the promoter of the gene, an effect that may be muscle cell specific and 
with an unclear mechanism of stimulation. It is therefore possible that NF-Y may be 
responsible for the increased activation of catalase seen in the current study. Other studies 
have shown that mutations to the CAAT boxes present in the human catalase gene 
significantly decrease its activation, although this was carried out on HP100 myeloid 
leukemia cells.  
PGC-1α is also known to regulate catalase expression (St-Pierre et al., 2006). In the 
current study, PGC-1α and catalase expression showed very similar trends in GSH 
depleted cells, steadily increasing from baseline to the 1-hour timepoint (Figures 16 and 
18). The similarity of these results and those of St-Pierre et al. (2006) indicate that PGC-
1α may be, in part, responsible for the increased expression of catalase when GSH is 
absent.  
GSH depletion may have reduced antioxidant capacity of the C2C12 myotubes, as 
displayed by greater H2O2 at baseline and during contraction. On the other hand, the lack 
of GSH caused an increase in the expression of catalase and SOD1, with no detrimental 
effects over the response of the genes to exercise. This suggests that GSH may be 
involved in the regulation of some antioxidant genes, although it is not necessary to elicit 
normal responses to elevated ROS or contraction. Furthermore, the increase in 
antioxidant gene expression at baseline was not great enough to counterbalance the lack 
of GSH, as ROS levels were consistently higher in the absence of GSH. Thus, long-term 
depletion of GSH, such as is seen in type 2 diabetes (Calabrese et al., 2012), may promote 
chronic oxidative stress and damage to cellular structures, becoming a relevant 
pathological factor of diseases.  
5.6 Angiogenesis 
The current study found that expression of VEGF mRNA in C2C12 cells increased over 
time following ES with no additional effect of GSH depletion. VEGF is known to be 
transcriptionally controlled by a range of pathways which can be activated by exercise, 
including p38 MAPK, ERK, and the PI3k-Akt pathways (Karar & Maity, 2011; Pagès & 
Pouysségur, 2005; Pogozelski et al., 2009). VEGF expression is also regulated by PGC-
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1α following exercise (Leick et al., 2009). Therefore, the increase in VEGF expression 
observed following stimulation may be due, at least in part, to the changes seen in PGC-
1α expression. 
Previous studies have suggested that VEGF may be redox sensitive with its expression 
being stimulated by ROS (Kosmidou, Xagorari, Roussos, & Papapetropoulos, 2001). 
Results from the current study suggest that VEGF expression in skeletal muscle is not 
affected directly by a lack of GSH nor by a perturbed redox state due to increased H2O2 
concentrations, but measurement of the activity of the pathways mentioned above could 
shed more light on the regulation of VEGF seen in this study. 
6. Limitations and Future Directions 
Although some significant changes in gene expression were measured in this study 
following contraction and GSH depletion, the pathways involved or mechanisms which 
brought about these changes were not determined. This is due to the use of RT-PCR as 
the primary measure of effect. Although this measures changes in mRNA levels, the 
effects of GSH depletion and contraction are likely to be much broader. Changes in 
protein expression, measured through Western Blotting, and activity of key enzymes 
would broaden the scope of this study and provide further insight into the mechanisms 
and pathways involved in the changes in mRNA reported herein. MAPK, CaMK, NF-κB, 
activator protein-1 (AP-1) and AMPK pathways are likely to play a significant role and 
their measurement would likely shed further light on the involvement of GSH in muscle 
adaptation following contraction. Furthermore, the monitoring of functional changes in 
enzyme activity, glucose uptake, glucose oxidation, and fatty acid oxidation would 
provide a clearer picture of the effects of GSH depletion on wider cell function. 
Additionally, experiments involving the measurement of the extent of S-glutathionylation 
of these proteins would help to identify if any changes in activity were due to direct 
modification by GSH. 
The size of effects on gene expression brought about by the stimulation protocol used in 
this study the ability to compare the effects of GSH depletion on cells which had been 
subjected to contraction with those which had not.  
The inclusion of additional control groups through treatment of GSH depleted cells with 
GSH reduced ethyl ester (GSHEE) would provide more robust evidence of the 
involvement of GSH in adaptation following exercise. GSHEE is permeable to the cell 
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membrane and can be used to deliver GSH and restore physiological levels of intracellular 
GSH in myotubes treated with BSO. Any changes that occur in GSH depleted cells which 
are the direct result of a lack of GSH should return to levels measured in control cells. 
This would provide further evidence that changes in gene expression are in fact due to a 
lack of GSH and less likely a result of other indirect factors.  
In the current study H2O2 was used as a marker of overall redox status of myotubes with 
only the level of H2O2 released from cells being measured. This applies another limitation 
on the study as without the measurement of the specific sources of ROS or the 
compartmentalised redox status, it is not possible to obtain a clear picture of the specific 
redox pathways being activated or supressed.   
Contraction is known to activate many signalling pathways in C2C12 cells and therefore 
causes changes in gene expression not directly linked to redox stress. To isolate the effect 
of GSH on redox signalling pathways, instead of being subjected to ES, cells could be 
challenged with H2O2. This partially mimics the redox stress placed upon cells during and 
following contraction, without the activation of pathways by exercise. This methodology 
would also enable the H2O2 levels to be made consistent between experimental groups, 
reducing variability in comparison to the current study. Further investigation is required 
in order to clarify the specific role of GSH depletion, along with an increase in H2O2, 
without the influence of other pathways activated by contraction. This will allow for a 
greater understanding of how these two factors affect the expression of the genes of 
interest.    
7. Conclusion 
GSH depletion did not interfere with gene expression following myotube electrical 
stimulation and contraction. Increases in the expression of PPARα and γ, PFK, SOD1, 
and catalase were seen at baseline, suggesting an effect on glucose metabolism, fatty acid 
metabolism, and antioxidant potential. These alterations may be due to acute changes in 
ROS signalling. Further investigation into the specific mechanisms of these effects is 
required in order to identify other contributing factors such as the MAPK, AMPK, CaMK 
and NF-κB signalling pathways which are activated by contraction, can be modulated by 






Abadi, A., Crane, J. D., Ogborn, D., Hettinga, B., Akhtar, M., Stokl, A., . . . 
Tarnopolsky, M. (2013). Supplementation with alpha-lipoic acid, CoQ10, and 
vitamin E augments running performance and mitochondrial function in female 
mice. PLoS One, 8(4), e60722. doi:https://doi.org/10.1371/journal.pone.0060722 
Abernethy, P. J., Thayer, R., & Taylor, A. W. (1990). Acute and Chronic Responses of 
Skeletal Muscle to Endurance and Sprint Exercise. Sports Medicine, 10(6), 365-
389. doi:https://doi.org/10.2165/00007256-199010060-00004 
Abrigo, J., Elorza, A. A., Riedel, C. A., Vilos, C., Simon, F., Cabrera, D., . . . Cabello-
Verrugio, C. (2018). Role of Oxidative Stress as Key Regulator of Muscle 
Wasting during Cachexia. Oxid Med Cell Longev, 2018, 2063179. 
doi:https://doi.org/10.1155/2018/2063179 
Allen, R. G., & Tresini, M. (2000). Oxidative stress and gene regulation. Free Radic 
Biol Med, 28(3), 463-499. doi:https://doi.org/10.1016/s0891-5849(99)00242-7 
Ameln, H., Gustafsson, T., Sundberg, C. J., Okamoto, K., Jansson, E., Poellinger, L., & 
Makino, Y. (2005). Physiological activation of hypoxia inducible factor-1 in 
human skeletal muscle. Faseb j, 19(8), 1009-1011. 
doi:https://doi.org/10.1096/fj.04-2304fje 
Aranda, B., Achuthan, P., Alam-Faruque, Y., Armean, I., Bridge, A., Derow, C., . . . 
Hermjakob, H. (2009). The IntAct molecular interaction database in 2010. 
Nucleic Acids Research, 38(suppl_1), D525-D531. doi:10.1093/nar/gkp878 
Arany, Z., Foo, S. Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., . . . 
Spiegelman, B. M. (2008). HIF-independent regulation of VEGF and 
angiogenesis by the transcriptional coactivator PGC-1alpha. Nature, 451(7181), 
1008-1012. doi:https://doi.org/10.1038/nature06613 
Ardite, E., Barbera, J. A., Roca, J., & Fernández-Checa, J. C. (2004). Glutathione 
depletion impairs myogenic differentiation of murine skeletal muscle C2C12 
cells through sustained NF-kappaB activation. The American journal of 
pathology, 165(3), 719-728. doi:https://doi.org/10.1016/s0002-9440(10)63335-4 
Auciello, F. R., Ross, F. A., Ikematsu, N., & Hardie, D. G. (2014). Oxidative stress 
activates AMPK in cultured cells primarily by increasing cellular AMP and/or 
ADP. FEBS Lett, 588(18), 3361-3366. 
doi:https://doi.org/10.1016/j.febslet.2014.07.025 
Baar, K., & Hargreaves, M. (2011). Understanding the regulation of muscle plasticity. 
Journal of Applied Physiology, 110(1), 256-257. 
doi:https://doi.org/10.1152/japplphysiol.01332.2010 
Baar, K., Song, Z., Semenkovich, C. F., Jones, T. E., Han, D. H., Nolte, L. A., . . . 
Holloszy, J. O. (2003). Skeletal muscle overexpression of nuclear respiratory 
factor 1 increases glucose transport capacity. Faseb j, 17(12), 1666-1673. 
doi:https://doi.org/10.1096/fj.03-0049com 
Backs, J., Backs, T., Bezprozvannaya, S., McKinsey, T. A., & Olson, E. N. (2008). 
Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II 
responsiveness by oligomerization with histone deacetylase 4. Mol Cell Biol, 
28(10), 3437-3445. doi:https://doi.org/10.1128/mcb.01611-07 
Bajotto, G., & Shimomura, Y. (2006). Determinants of disuse-induced skeletal muscle 
atrophy: exercise and nutrition countermeasures to prevent protein loss. J Nutr 
Sci Vitaminol (Tokyo), 52(4), 233-247. doi:https://doi.org/10.3177/jnsv.52.233 
Baker, J. S., McCormick, M. C., & Robergs, R. A. (2010). Interaction among Skeletal 
Muscle Metabolic Energy Systems during Intense Exercise. Journal of Nutrition 
and Metabolism, 2010, 905612. doi:https://doi.org/10.1155/2010/905612 
80 
 
Baldwin, K. M., & Haddad, F. (2002). Skeletal muscle plasticity: cellular and molecular 
responses to altered physical activity paradigms. Am J Phys Med Rehabil, 81(11 
Suppl), S40-51. doi:10.1097/01.phm.0000029723.36419.0d 
Bassel-Duby, R., & Olson, E. N. (2006). Signaling pathways in skeletal muscle 
remodeling. Annu Rev Biochem, 75, 19-37. 
doi:10.1146/annurev.biochem.75.103004.142622 
Bauer, C. E., Elsen, S., & Bird, T. H. (1999). Mechanisms for redox control of gene 
expression. Annu Rev Microbiol, 53, 495-523. 
doi:https://doi.org/10.1146/annurev.micro.53.1.495 
Bentley, D. J., Ackerman, J., Clifford, T., & Slattery, K. S. (2015). Acute and Chronic 
Effects of Antioxidant Supplementation on Exercise Performance. In M. 
Lamprecht (Ed.), Antioxidants in Sport Nutrition. Boca Raton (FL): CRC 
Press/Taylor & Francis. 
Berchtold, M. W., Brinkmeier, H., & Müntener, M. (2000). Calcium Ion in Skeletal 
Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease. Physiol 
Rev, 80(3), 1215-1265. doi:10.1152/physrev.2000.80.3.1215 
Berzosa, C., Cebrián, I., Fuentes-Broto, L., Gómez-Trullén, E., Piedrafita, E., Martínez-
Ballarín, E., . . . García, J. J. (2011). Acute exercise increases plasma total 
antioxidant status and antioxidant enzyme activities in untrained men. Journal of 
biomedicine & biotechnology, 2011, 540458-540458. 
doi:https://doi.org/10.1155/2011/540458 
Beyfuss, K., Erlich, A. T., Triolo, M., & Hood, D. A. (2018). The Role of p53 in 
Determining Mitochondrial Adaptations to Endurance Training in Skeletal 
Muscle. Scientific Reports, 8(1), 14710. doi:https://doi.org/10.1038/s41598-018-
32887-0 
Bickel, C. S., Slade, J., Mahoney, E., Haddad, F., Dudley, G. A., & Adams, G. R. 
(2005). Time course of molecular responses of human skeletal muscle to acute 
bouts of resistance exercise. J Appl Physiol (1985), 98(2), 482-488. 
doi:https://doi.org/10.1152/japplphysiol.00895.2004 
Black, B. L., & Olson, E. N. (1998). Transcriptional control of muscle development by 
myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol, 14, 167-
196. doi:https://doi.org/10.1146/annurev.cellbio.14.1.167 
Blokhina, O., Virolainen, E., & Fagerstedt, K. V. (2003). Antioxidants, oxidative 
damage and oxygen deprivation stress: a review. Annals of botany, 91 Spec 
No(2), 179-194. doi:https://doi.org/10.1093/aob/mcf118 
Booth, F. W., Laye, M. J., Lees, S. J., Rector, R. S., & Thyfault, J. P. (2008). Reduced 
physical activity and risk of chronic disease: the biology behind the 
consequences. Eur J Appl Physiol, 102(4), 381-390. doi:10.1007/s00421-007-
0606-5 
Boyer, J. G., Prasad, V., Song, T., Lee, D., Fu, X., Grimes, K. M., . . . Molkentin, J. D. 
(2019). ERK1/2 signaling induces skeletal muscle slow fiber-type switching and 
reduces muscular dystrophy disease severity. JCI insight, 5(10), e127356. 
doi:https://doi.org/10.1172/jci.insight.127356 
Braakhuis, A. J., & Hopkins, W. G. (2015). Impact of Dietary Antioxidants on Sport 
Performance: A Review. Sports Med, 45(7), 939-955. 
doi:https://doi.org/10.1007/s40279-015-0323-x 
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical 




Bradley, N. S., Snook, L. A., Jain, S. S., Heigenhauser, G. J., Bonen, A., & Spriet, L. L. 
(2012). Acute endurance exercise increases plasma membrane fatty acid 
transport proteins in rat and human skeletal muscle. Am J Physiol Endocrinol 
Metab, 302(2), E183-189. doi:https://doi.org/10.1152/ajpendo.00254.2011 
Brigelius-Flohe, R. (1999). Tissue-specific functions of individual glutathione 
peroxidases. Free Radic Biol Med, 27(9-10), 951-965. 
doi:https://doi.org/10.1016/s0891-5849(99)00173-2 
Brigelius-Flohé, R., & Maiorino, M. (2013). Glutathione peroxidases. Biochimica et 
Biophysica Acta (BBA) - General Subjects, 1830(5), 3289-3303. 
doi:https://doi.org/10.1016/j.bbagen.2012.11.020 
Brigelius-Flohe, R., & Traber, M. G. (1999). Vitamin E: function and metabolism. 
Faseb j, 13(10), 1145-1155.  
Bruton, J. D., Place, N., Yamada, T., Silva, J. P., Andrade, F. H., Dahlstedt, A. J., . . . 
Westerblad, H. (2008). Reactive oxygen species and fatigue-induced prolonged 
low-frequency force depression in skeletal muscle fibres of rats, mice and SOD2 
overexpressing mice. J Physiol, 586(1), 175-184. 
doi:https://doi.org/10.1113/jphysiol.2007.147470 
Buettner, G. R. (1993). The pecking order of free radicals and antioxidants: lipid 
peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys, 300(2), 
535-543. doi:https://doi.org/10.1006/abbi.1993.1074 
Burkholder, T. J. (2007). Mechanotransduction in skeletal muscle. Frontiers in 
bioscience : a journal and virtual library, 12, 174-191. 
doi:https://doi.org/10.2741/2057 
Butterfield, D. A., Yatin, S. M., Varadarajan, S., & Koppal, T. (1999). Amyloid beta-
peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's 
disease. Methods Enzymol, 309, 746-768. doi:https://doi.org/10.1016/s0076-
6879(99)09050-3 
Calabrese, V., Cornelius, C., Leso, V., Trovato-Salinaro, A., Ventimiglia, B., Cavallaro, 
M., . . . Castellino, P. (2012). Oxidative stress, glutathione status, sirtuin and 
cellular stress response in type 2 diabetes. Biochimica et Biophysica Acta (BBA) 
- Molecular Basis of Disease, 1822(5), 729-736. 
doi:https://doi.org/10.1016/j.bbadis.2011.12.003 
Calvo, J. A., Daniels, T. G., Wang, X., Paul, A., Lin, J., Spiegelman, B. M., . . . 
Rangwala, S. M. (2008). Muscle-specific expression of PPARγ coactivator-1α 
improves exercise performance and increases peak oxygen uptake. Journal of 
Applied Physiology, 104(5), 1304-1312. 
doi:https://doi.org/10.1152/japplphysiol.01231.2007 
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., . . . 
Auwerx, J. (2009). AMPK regulates energy expenditure by modulating NAD+ 
metabolism and SIRT1 activity. Nature, 458(7241), 1056-1060. 
doi:https://doi.org/10.1038/nature07813 
Cardones, A. R., & Banez, L. L. (2006). VEGF inhibitors in cancer therapy. Curr 
Pharm Des, 12(3), 387-394. doi:https://doi.org/10.2174/138161206775201910 
Carling, D., Mayer, F. V., Sanders, M. J., & Gamblin, S. J. (2011). AMP-activated 
protein kinase: nature's energy sensor. Nat Chem Biol, 7(8), 512-518. 
doi:https://doi.org/10.1038/nchembio.610 
Carson, J. A., & Wei, L. (2000). Integrin signaling's potential for mediating gene 




Cherednichenko, G., Zima, A. V., Feng, W., Schaefer, S., Blatter, L. A., & Pessah, I. N. 
(2004). NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates 
calcium-induced calcium release. Circ Res, 94(4), 478-486. 
doi:https://doi.org/10.1161/01.Res.0000115554.65513.7c 
Chin, E. R. (2004). The role of calcium and calcium/calmodulin-dependent kinases in 
skeletal muscle plasticity and mitochondrial biogenesis. Proc Nutr Soc, 63(2), 
279-286. doi:https://doi.org/10.1079/pns2004335 
Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., . . 
. Williams, R. S. (1998). A calcineurin-dependent transcriptional pathway 
controls skeletal muscle fiber type. Genes Dev, 12(16), 2499-2509. 
doi:https://doi.org/10.1101/gad.12.16.2499 
Chopard, A., Hillock, S., & Jasmin, B. J. (2009). Molecular events and signalling 
pathways involved in skeletal muscle disuse-induced atrophy and the impact of 
countermeasures. J Cell Mol Med, 13(9b), 3032-3050. 
doi:https://doi.org/10.1111/j.1582-4934.2009.00864.x 
Chouchani, E. T., Pell, V. R., Gaude, E., Aksentijevic, D., Sundier, S. Y., Robb, E. L., . 
. . Murphy, M. P. (2014). Ischaemic accumulation of succinate controls 
reperfusion injury through mitochondrial ROS. Nature, 515(7527), 431-435. 
doi:https://doi.org/10.1038/nature13909 
Christie, K. N., & Stoward, P. J. (1979). Catalase in skeletal muscle fibers. J Histochem 
Cytochem, 27(4), 814-819. doi:https://doi.org/10.1177/27.4.376691 
Chromiak, J. A., & Antonio, J. (2008). Skeletal Muscle Plasticity. In J. Antonio, D. 
Kalman, J. R. Stout, M. Greenwood, D. S. Willoughby, & G. G. Haff (Eds.), 
Essentials of Sports Nutrition and Supplements (pp. 21-52). Totowa, NJ: 
Humana Press. 
Corcoran, A., & Cotter, T. G. (2013). Redox regulation of protein kinases. Febs j, 
280(9), 1944-1965. doi:https://doi.org/10.1111/febs.12224 
Criswell, D., Powers, S., Dodd, S., Lawler, J., Edwards, W., Renshler, K., & Grinton, S. 
(1993). High intensity training-induced changes in skeletal muscle antioxidant 
enzyme activity. Med Sci Sports Exerc, 25(10), 1135-1140.  
Cross, J. V., & Templeton, D. J. (2004). Oxidative stress inhibits MEKK1 by site-
specific glutathionylation in the ATP-binding domain. Biochem J, 381(Pt 3), 
675-683. doi:https://doi.org/10.1042/BJ20040591 
Cunha, T. F., Bechara, L. R. G., Bacurau, A. V. N., Jannig, P. R., Voltarelli, V. A., 
Dourado, P. M., . . . Brum, P. C. (2017). Exercise training decreases NADPH 
oxidase activity and restores skeletal muscle mass in heart failure rats. Journal 
of Applied Physiology, 122(4), 817-827. 
doi:https://doi.org/10.1152/japplphysiol.00182.2016 
Dam, A. D., Mitchell, A. S., Rush, J. W. E., & Quadrilatero, J. (2012). Elevated skeletal 
muscle apoptotic signaling following glutathione depletion. Apoptosis, 17(1), 
48-60. doi:https://doi.org/10.1007/s10495-011-0654-5 
Davies, K. J., Quintanilha, A. T., Brooks, G. A., & Packer, L. (1982). Free radicals and 
tissue damage produced by exercise. Biochem Biophys Res Commun, 107(4), 
1198-1205. doi:https://doi.org/10.1016/s0006-291x(82)80124-1 
Davis, J. M., Murphy, E. A., Carmichael, M. D., & Davis, B. (2009). Quercetin 
increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am 
J Physiol Regul Integr Comp Physiol, 296(4), R1071-1077. 
doi:https://doi.org/10.1152/ajpregu.90925.2008 
Di Meo, S., & Venditti, P. (2001). Mitochondria in exercise-induced oxidative stress. 
Biol Signals Recept, 10(1-2), 125-140. doi:https://doi.org/10.1159/000046880 
83 
 
Dominy, J. E., Jr., Lee, Y., Gerhart-Hines, Z., & Puigserver, P. (2010). Nutrient-
dependent regulation of PGC-1alpha's acetylation state and metabolic function 
through the enzymatic activities of Sirt1/GCN5. Biochim Biophys Acta, 1804(8), 
1676-1683. doi:https://doi.org/10.1016/j.bbapap.2009.11.023 
Dong, K., Wu, M., Liu, X., Huang, Y., Zhang, D., Wang, Y., . . . Shi, D. (2016). 
Glutaredoxins concomitant with optimal ROS activate AMPK through S-
glutathionylation to improve glucose metabolism in type 2 diabetes. Free Radic 
Biol Med, 101, 334-347. 
doi:https://doi.org/10.1016/j.freeradbiomed.2016.10.007 
Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol 
Rev, 82(1), 47-95. doi:https://doi.org/10.1152/physrev.00018.2001 
El-Aal, H. A. H. M. A. (2012). Lipid Peroxidation End-Products as a Key of Oxidative 
Stress: Effect of Antioxidant on Their Production and Transfer of Free Radicals. 
In Lipid Peroxidation. 
Elosua, R., Molina, L., Fito, M., Arquer, A., Sanchez-Quesada, J. L., Covas, M. I., . . . 
Marrugat, J. (2003). Response of oxidative stress biomarkers to a 16-week 
aerobic physical activity program, and to acute physical activity, in healthy 
young men and women. Atherosclerosis, 167(2), 327-334. 
doi:https://doi.org/10.1016/s0021-9150(03)00018-2 
Emerling, B. M., Platanias, L. C., Black, E., Nebreda, A. R., Davis, R. J., & Chandel, N. 
S. (2005). Mitochondrial reactive oxygen species activation of p38 mitogen-
activated protein kinase is required for hypoxia signaling. Mol Cell Biol, 25(12), 
4853-4862. doi:https://doi.org/10.1128/MCB.25.12.4853-4862.2005 
Emerling, B. M., Weinberg, F., Snyder, C., Burgess, Z., Mutlu, G. M., Viollet, B., . . . 
Chandel, N. S. (2009). Hypoxic activation of AMPK is dependent on 
mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free 
Radic Biol Med, 46(10), 1386-1391. 
doi:https://doi.org/10.1016/j.freeradbiomed.2009.02.019 
Espinosa, A., Leiva, A., Pena, M., Muller, M., Debandi, A., Hidalgo, C., . . . Jaimovich, 
E. (2006). Myotube depolarization generates reactive oxygen species through 
NAD(P)H oxidase; ROS-elicited Ca2+ stimulates ERK, CREB, early genes. J 
Cell Physiol, 209(2), 379-388. doi:https://doi.org/10.1002/jcp.20745 
Fan, M., Rhee, J., St-Pierre, J., Handschin, C., Puigserver, P., Lin, J., . . . Spiegelman, 
B. M. (2004). Suppression of mitochondrial respiration through recruitment of 
p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes 
Dev, 18(3), 278-289. doi:https://doi.org/10.1101/gad.1152204 
Fernandes, A. P., & Holmgren, A. (2004). Glutaredoxins: glutathione-dependent redox 
enzymes with functions far beyond a simple thioredoxin backup system. 
Antioxidants & redox signaling, 6(1), 63-74. 
doi:https://doi.org/10.1089/152308604771978354 
Fernandez-Marcos, P. J., & Auwerx, J. (2011). Regulation of PGC-1α, a nodal regulator 
of mitochondrial biogenesis. The American journal of clinical nutrition, 93(4), 
884S-890. doi:https://doi.org/10.3945/ajcn.110.001917 
Flanagan, W. M., Corthésy, B., Bram, R. J., & Crabtree, G. R. (1991). Nuclear 
association of a T-cell transcription factor blocked by FK-506 and cyclosporin 
A. Nature, 352(6338), 803-807. doi:https://doi.org/10.1038/352803a0 
Fluck, M., & Hoppeler, H. (2003). Molecular basis of skeletal muscle plasticity--from 




Folz, R. J., & Crapo, J. D. (1994). Extracellular superoxide dismutase (SOD3): tissue-
specific expression, genomic characterization, and computer-assisted sequence 
analysis of the human EC SOD gene. Genomics, 22(1), 162-171. 
doi:https://doi.org/10.1006/geno.1994.1357 
Forman, H. J., Zhang, H., & Rinna, A. (2009). Glutathione: overview of its protective 
roles, measurement, and biosynthesis. Molecular aspects of medicine, 30(1-2), 
1-12. doi:https://doi.org/10.1016/j.mam.2008.08.006 
Frontera, W. R., & Ochala, J. (2015). Skeletal muscle: a brief review of structure and 
function. Calcif Tissue Int, 96(3), 183-195. doi:https://doi.org/10.1007/s00223-
014-9915-y 
Fry, A. (2004). The Role of Resistance Exercise Intensity on Muscle Fibre Adaptations. 
Sports Med, 34, 663-679. doi:https://doi.org/10.2165/00007256-200434100-
00004 
Gaetke, L. M., & Chow, C. K. (2003). Copper toxicity, oxidative stress, and antioxidant 
nutrients. Toxicology, 189(1-2), 147-163. doi:https://doi.org/10.1016/s0300-
483x(03)00159-8 
Galgani, J. E., Johannsen, N. M., Bajpeyi, S., Costford, S. R., Zhang, Z., Gupta, A. K., 
& Ravussin, E. (2012). Role of skeletal muscle mitochondrial density on 
exercise-stimulated lipid oxidation. Obesity (Silver Spring), 20(7), 1387-1393. 
doi:https://doi.org/10.1038/oby.2011.166 
Gan, Z., Fu, T., Kelly, D. P., & Vega, R. B. (2018). Skeletal muscle mitochondrial 
remodeling in exercise and diseases. Cell research, 28(10), 969-980. 
doi:https://doi.org/10.1038/s41422-018-0078-7 
Garcia, D., & Shaw, R. J. (2017). AMPK: Mechanisms of Cellular Energy Sensing and 
Restoration of Metabolic Balance. Mol Cell, 66(6), 789-800. 
doi:https://doi.org/10.1016/j.molcel.2017.05.032 
Gassmann, M., Chilov, D., & Wenger, R. H. (2002). Regulation of the Hypoxia-
Inducible Factor-1α. In S. Lahiri, N. R. Prabhakar, & R. E. Forster (Eds.), 
Oxygen Sensing: Molecule to Man (pp. 87-99). Boston, MA: Springer US. 
Geng, T., Li, P., Okutsu, M., Yin, X., Kwek, J., Zhang, M., & Yan, Z. (2009). PGC-1α 
plays a functional role in exercise-induced mitochondrial biogenesis and 
angiogenesis but not fiber-type transformation in mouse skeletal muscle. 
American Journal of Physiology-Cell Physiology, 298(3), C572-C579. 
doi:https://doi.org/10.1152/ajpcell.00481.2009 
Godenschwege, T., Forde, R., Davis, C. P., Paul, A., Beckwith, K., & Duttaroy, A. 
(2009). Mitochondrial superoxide radicals differentially affect muscle activity 
and neural function. Genetics, 183(1), 175-184. 
doi:https://doi.org/10.1534/genetics.109.103515 
Gomez-Cabrera, M. C., Borras, C., Pallardo, F. V., Sastre, J., Ji, L. L., & Vina, J. 
(2005). Decreasing xanthine oxidase-mediated oxidative stress prevents useful 
cellular adaptations to exercise in rats. J Physiol, 567(Pt 1), 113-120. 
doi:https://doi.org/10.1113/jphysiol.2004.080564 
Gomez-Cabrera, M. C., Domenech, E., Romagnoli, M., Arduini, A., Borras, C., 
Pallardo, F. V., . . . Vina, J. (2008). Oral administration of vitamin C decreases 
muscle mitochondrial biogenesis and hampers training-induced adaptations in 
endurance performance. Am J Clin Nutr, 87(1), 142-149. 
doi:https://doi.org/10.1093/ajcn/87.1.142 
Goodyear, L. J., Chang, P. Y., Sherwood, D. J., Dufresne, S. D., & Moller, D. E. 
(1996). Effects of exercise and insulin on mitogen-activated protein kinase 
signaling pathways in rat skeletal muscle. American Journal of Physiology-
85 
 
Endocrinology and Metabolism, 271(2), E403-E408. 
doi:https://doi.org/10.1152/ajpendo.1996.271.2.E403 
Gouspillou, G., Sgarioto, N., Norris, B., Barbat-Artigas, S., Aubertin-Leheudre, M., 
Morais, J. A., . . . Hepple, R. T. (2014). The relationship between muscle fiber 
type-specific PGC-1α content and mitochondrial content varies between rodent 
models and humans. PLoS One, 9(8), e103044-e103044. 
doi:https://doi.org/10.1371/journal.pone.0103044 
Graham, Z. A., Gallagher, P. M., & Cardozo, C. P. (2015). Focal adhesion kinase and 
its role in skeletal muscle. Journal of muscle research and cell motility, 36(4-5), 
305-315. doi:https://doi.org/10.1007/s10974-015-9415-3 
Grahame Hardie, D. (2016). Regulation of AMP-activated protein kinase by natural and 
synthetic activators. Acta Pharm Sin B, 6(1), 1-19. 
doi:https://doi.org/10.1016/j.apsb.2015.06.002 
Griffith, O. W., & Meister, A. (1979). Potent and specific inhibition of glutathione 
synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J 
Biol Chem, 254(16), 7558-7560.  
Gros, G., Wittenberg, B. A., & Jue, T. (2010). Myoglobin's old and new clothes: from 
molecular structure to function in living cells. The Journal of experimental 
biology, 213(Pt 16), 2713-2725. doi:https://doi.org/10.1242/jeb.043075 
Guth, L., & Samaha, F. J. (1969). Qualitative differences between actomyosin ATPase 
of slow and fast mammalian muscle. Experimental Neurology, 25(1), 138-152. 
doi:https://doi.org/10.1016/0014-4886(69)90077-6 
Han, Y. S., Geiger, P. C., Cody, M. J., Macken, R. L., & Sieck, G. C. (2003). ATP 
consumption rate per cross bridge depends on myosin heavy chain isoform. J 
Appl Physiol (1985), 94(6), 2188-2196. 
doi:https://doi.org/10.1152/japplphysiol.00618.2002 
Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., Lebrasseur, N. K., . . . 
Spiegelman, B. M. (2007). Skeletal muscle fiber-type switching, exercise 
intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J 
Biol Chem, 282(41), 30014-30021. doi:https://doi.org/10.1074/jbc.M704817200 
Handschin, C., Rhee, J., Lin, J., Tarr, P. T., & Spiegelman, B. M. (2003). An 
autoregulatory loop controls peroxisome proliferator-activated receptor gamma 
coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A, 100(12), 
7111-7116. doi:https://doi.org/10.1073/pnas.1232352100 
Handschin, C., & Spiegelman, B. M. (2006). Peroxisome proliferator-activated receptor 
gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr 
Rev, 27(7), 728-735. doi:https://doi.org/10.1210/er.2006-0037 
Hardie, D. G., & Carling, D. (1997). The AMP-activated protein kinase--fuel gauge of 
the mammalian cell? Eur J Biochem, 246(2), 259-273. 
doi:https://doi.org/10.1111/j.1432-1033.1997.00259.x 
Hardie, D. G., Carling, D., & Gamblin, S. J. (2011). AMP-activated protein kinase: also 
regulated by ADP? Trends in Biochemical Sciences, 36(9), 470-477. 
doi:https://doi.org/10.1016/j.tibs.2011.06.004 
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012). AMPK: a nutrient and energy 
sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol, 13(4), 251-
262. doi:https://doi.org/10.1038/nrm3311 
Hargreaves, M., & Spriet, L. L. (2020). Skeletal muscle energy metabolism during 




Harrison, F. E., Meredith, M. E., Dawes, S. M., Saskowski, J. L., & May, J. M. (2010). 
Low ascorbic acid and increased oxidative stress in gulo(-/-) mice during 
development. Brain Res, 1349, 143-152. 
doi:https://doi.org/10.1016/j.brainres.2010.06.037 
Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. 
J., . . . Hardie, D. G. (2012). The ancient drug salicylate directly activates AMP-
activated protein kinase. Science, 336(6083), 918-922. 
doi:https://doi.org/10.1126/science.1215327 
He, Z. H., Bottinelli, R., Pellegrino, M. A., Ferenczi, M. A., & Reggiani, C. (2000). 
ATP consumption and efficiency of human single muscle fibers with different 
myosin isoform composition. Biophys J, 79(2), 945-961. 
doi:https://doi.org/10.1016/s0006-3495(00)76349-1 
Herrero, A., & Barja, G. (1997). ADP-Regulation of Mitochondrial Free Radical 
Production Is Different with Complex I- or Complex II-Linked Substrates: 
Implications for the Exercise Paradox and Brain Hypermetabolism. Journal of 
Bioenergetics and Biomembranes, 29(3), 241-249. 
doi:https://doi.org/10.1023/A:1022458010266 
Herzig, S., & Shaw, R. J. (2018). AMPK: guardian of metabolism and mitochondrial 
homeostasis. Nature Reviews Molecular Cell Biology, 19(2), 121-135. 
doi:https://doi.org/10.1038/nrm.2017.95 
Hickey, M. S., Carey, J. O., Azevedo, J. L., Houmard, J. A., Pories, W. J., Israel, R. G., 
& Dohm, G. L. (1995). Skeletal muscle fiber composition is related to adiposity 
and in vitro glucose transport rate in humans. American Journal of Physiology-
Endocrinology and Metabolism, 268(3), E453-E457. 
doi:https://doi.org/10.1152/ajpendo.1995.268.3.E453 
Hidalgo, C., Sanchez, G., Barrientos, G., & Aracena-Parks, P. (2006). A transverse 
tubule NADPH oxidase activity stimulates calcium release from isolated triads 
via ryanodine receptor type 1 S -glutathionylation. J Biol Chem, 281(36), 26473-
26482. doi:https://doi.org/10.1074/jbc.M600451200 
Higashida, K., Kim, S. H., Higuchi, M., Holloszy, J. O., & Han, D. H. (2011). Normal 
adaptations to exercise despite protection against oxidative stress. Am J Physiol 
Endocrinol Metab, 301(5), E779-784. 
doi:https://doi.org/10.1152/ajpendo.00655.2010 
Higuchi, M., Cartier, L. J., Chen, M., & Holloszy, J. O. (1985). Superoxide dismutase 
and catalase in skeletal muscle: adaptive response to exercise. J Gerontol, 40(3), 
281-286. doi:https://doi.org/10.1093/geronj/40.3.281 
Hinchy, E. C., Gruszczyk, A. V., Willows, R., Navaratnam, N., Hall, A. R., Bates, G., . . 
. Murphy, M. P. (2018). Mitochondria-derived ROS activate AMP-activated 
protein kinase (AMPK) indirectly. J Biol Chem, 293(44), 17208-17217. 
doi:https://doi.org/10.1074/jbc.RA118.002579 
Hoffman, N. J., Parker, B. L., Chaudhuri, R., Fisher-Wellman, K. H., Kleinert, M., 
Humphrey, S. J., . . . James, D. E. (2015). Global Phosphoproteomic Analysis of 
Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and 
AMPK Substrates. Cell Metab, 22(5), 922-935. 
doi:https://doi.org/10.1016/j.cmet.2015.09.001 
Holloszy, J. O. (1967). Biochemical adaptations in muscle. Effects of exercise on 
mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. 
J Biol Chem, 242(9), 2278-2282.  
Holmes, B. F., Sparling, D. P., Olson, A. L., Winder, W. W., & Dohm, G. L. (2005). 
Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by 
87 
 
AMP-activated protein kinase. American Journal of Physiology-Endocrinology 
and Metabolism, 289(6), E1071-E1076. 
doi:https://doi.org/10.1152/ajpendo.00606.2004 
Holmstrom, K. M., & Finkel, T. (2014). Cellular mechanisms and physiological 
consequences of redox-dependent signalling. Nat Rev Mol Cell Biol, 15(6), 411-
421. doi:https://doi.org/10.1038/nrm3801 
Hood, D. A. (2009). Mechanisms of exercise-induced mitochondrial biogenesis in 
skeletal muscle. Applied Physiology, Nutrition, and Metabolism, 34(3), 465-472. 
doi:https://doi.org/10.1139/H09-045 
Hoppeler, H., Vogt, M., Weibel, E. R., & Fluck, M. (2003). Response of skeletal muscle 
mitochondria to hypoxia. Exp Physiol, 88(1), 109-119. 
doi:https://doi.org/10.1113/eph8802513 
Huang, D., Khoe, M., Ilic, D., & Bryer-Ash, M. (2006). Reduced expression of focal 
adhesion kinase disrupts insulin action in skeletal muscle cells. Endocrinology, 
147(7), 3333-3343. doi:https://doi.org/10.1210/en.2005-0382 
Inbar, O., Kaiser, P., & Tesch, P. (1981). Relationships between Leg Muscle Fiber Type 
Distribution and Leg Exercise Performance. Int J Sports Med, 02(03), 154-159. 
doi:https://doi.org/10.1055/s-2008-1034603 
Inui, M., Saito, A., & Fleischer, S. (1987). Purification of the ryanodine receptor and 
identity with feet structures of junctional terminal cisternae of sarcoplasmic 
reticulum from fast skeletal muscle. J Biol Chem, 262(4), 1740-1747.  
Jackson, M. J., Stretton, C., & McArdle, A. (2020). Hydrogen peroxide as a signal for 
skeletal muscle adaptations to exercise: What do concentrations tell us about 
potential mechanisms? Redox Biology, 35, 101484. 
doi:https://doi.org/10.1016/j.redox.2020.101484 
Jäger, S., Handschin, C., St-Pierre, J., & Spiegelman, B. M. (2007). AMP-activated 
protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of 
PGC-1alpha. Proc Natl Acad Sci U S A, 104(29), 12017-12022. 
doi:https://doi.org/10.1073/pnas.0705070104 
Jain, S. S., Paglialunga, S., Vigna, C., Ludzki, A., Herbst, E. A., Lally, J. S., . . . 
Holloway, G. P. (2014). High-fat diet-induced mitochondrial biogenesis is 
regulated by mitochondrial-derived reactive oxygen species activation of 
CaMKII. Diabetes, 63(6), 1907-1913. doi:https://doi.org/10.2337/db13-0816 
Janani, C., & Ranjitha Kumari, B. D. (2015). PPAR gamma gene--a review. Diabetes 
Metab Syndr, 9(1), 46-50. doi:https://doi.org/10.1016/j.dsx.2014.09.015 
Jarvis, R. M., Hughes, S. M., & Ledgerwood, E. C. (2012). Peroxiredoxin 1 functions as 
a signal peroxidase to receive, transduce, and transmit peroxide signals in 
mammalian cells. Free Radic Biol Med, 53(7), 1522-1530. 
doi:https://doi.org/10.1016/j.freeradbiomed.2012.08.001 
Jensen, T. E., Wojtaszewski, J. F. P., & Richter, E. A. (2009). AMP-activated protein 
kinase in contraction regulation of skeletal muscle metabolism: necessary and/or 
sufficient? Acta Physiologica, 196(1), 155-174. 
doi:https://doi.org/10.1111/j.1748-1716.2009.01979.x 
Jeukendrup, A. E. (2002). Regulation of fat metabolism in skeletal muscle. Ann N Y 
Acad Sci, 967, 217-235. doi:https://doi.org/10.1111/j.1749-6632.2002.tb04278.x 
Jewell, U. R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R. H., & Gassmann, M. 
(2001). Induction of HIF-1alpha in response to hypoxia is instantaneous. Faseb 
j, 15(7), 1312-1314. doi:https://doi.org/10.1096/fj.00-0732fje 
Ji, L. L. (2007). Antioxidant signaling in skeletal muscle: A brief review. Exp Gerontol, 
42(7), 582-593. doi:https://doi.org/10.1016/j.exger.2007.03.002 
88 
 
Ji, L. L. (2008). Modulation of skeletal muscle antioxidant defense by exercise: Role of 
redox signaling. Free Radic Biol Med, 44(2), 142-152. 
doi:https://doi.org/10.1016/j.freeradbiomed.2007.02.031 
Ji, L. L., Gomez-Cabrera, M. C., & Vina, J. (2007). Role of nuclear factor kappaB and 
mitogen-activated protein kinase signaling in exercise-induced antioxidant 
enzyme adaptation. Appl Physiol Nutr Metab, 32(5), 930-935. 
doi:https://doi.org/10.1139/h07-098 
Ji, L. L., Leeuwenburgh, C., & Powers, S. (1999). Exercise training-induced alterations 
in skeletal muscle antioxidant capacity: a brief review. Medicine & Science in 
Sports & Exercise, 31(7).  
Ji, L. L., & Yeo, D. (2019). Mitochondrial dysregulation and muscle disuse atrophy. 
F1000Research, 8, F1000 Faculty Rev-1621. 
doi:https://doi.org/10.12688/f1000research.19139.1 
Joseph, J. S., Ayeleso, A. O., & Mukwevho, E. (2017). Role of exercise-induced 
calmodulin protein kinase (CaMK)II activation in the regulation of omega-6 
fatty acids and lipid metabolism genes in rat skeletal muscle. Physiol Res, 66(6), 
969-977. doi:https://doi.org/10.33549/physiolres.933509 
Jung, S., & Kim, K. (2014). Exercise-induced PGC-1α transcriptional factors in skeletal 
muscle. Integrative Medicine Research, 3(4), 155-160. 
doi:https://doi.org/10.1016/j.imr.2014.09.004 
Kabe, Y., Ando, K., Hirao, S., Yoshida, M., & Handa, H. (2005). Redox regulation of 
NF-kappaB activation: distinct redox regulation between the cytoplasm and the 
nucleus. Antioxidants & redox signaling, 7(3-4), 395-403. 
doi:https://doi.org/10.1089/ars.2005.7.395 
Kanter, M. M., Hamlin, R. L., Unverferth, D. V., Davis, H. W., & Merola, A. J. (1985). 
Effect of exercise training on antioxidant enzymes and cardiotoxicity of 
doxorubicin. J Appl Physiol (1985), 59(4), 1298-1303. 
doi:https://doi.org/10.1152/jappl.1985.59.4.1298 
Karar, J., & Maity, A. (2011). PI3K/AKT/mTOR Pathway in Angiogenesis. Frontiers 
in molecular neuroscience, 4, 51-51. 
doi:https://doi.org/10.3389/fnmol.2011.00051 
Katz, A. (2016). Role of reactive oxygen species in regulation of glucose transport in 
skeletal muscle during exercise. J Physiol, 594(11), 2787-2794. 
doi:https://doi.org/10.1113/JP271665 
Kefaloyianni, E., Gaitanaki, C., & Beis, I. (2006). ERK1/2 and p38-MAPK signalling 
pathways, through MSK1, are involved in NF-κB transactivation during 
oxidative stress in skeletal myoblasts. Cellular Signalling, 18(12), 2238-2251. 
doi:https://doi.org/10.1016/j.cellsig.2006.05.004 
Khor, S. C., Abdul Karim, N., Ngah, W. Z. W., Yusof, Y. A. M., & Makpol, S. (2014). 
Vitamin E in sarcopenia: current evidences on its role in prevention and 
treatment. Oxid Med Cell Longev, 2014, 914853-914853. 
doi:https://doi.org/10.1155/2014/914853 
Kiens, B. (2006). Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance. 
Physiol Rev, 86(1), 205-243. doi:https://doi.org/10.1152/physrev.00023.2004 
Kil, I. S., Lee, S. K., Ryu, K. W., Woo, H. A., Hu, M. C., Bae, S. H., & Rhee, S. G. 
(2012). Feedback control of adrenal steroidogenesis via H2O2-dependent, 




Kim, G., & Kim, J. H. (2020). Impact of Skeletal Muscle Mass on Metabolic Health. 
Endocrinology and metabolism (Seoul, Korea), 35(1), 1-6. 
doi:https://doi.org/10.3803/EnM.2020.35.1.1 
Kinfe, H. H., Belay, Y. H., Joseph, J. S., & Mukwevho, E. (2013). Evaluation of the 
Influence of thiosemicarbazone-triazole hybrids on genes implicated in lipid 
oxidation and accumulation as potential anti-obesity agents. Bioorg Med Chem 
Lett, 23(19), 5275-5278. doi:https://doi.org/10.1016/j.bmcl.2013.08.028 
Klaus, A., Zorman, S., Berthier, A., Polge, C., Ramirez, S., Michelland, S., . . . 
Schlattner, U. (2013). Glutathione S-transferases interact with AMP-activated 
protein kinase: evidence for S-glutathionylation and activation in vitro. PLoS 
One, 8(5), e62497. doi:https://doi.org/10.1371/journal.pone.0062497 
Komoda, T., & Matsunaga, T. (2015). Chapter 4 - Metabolic Pathways in the Human 
Body. In T. Komoda & T. Matsunaga (Eds.), Biochemistry for Medical 
Professionals (pp. 25-63). Boston: Academic Press. 
Kosmidou, I., Xagorari, A., Roussos, C., & Papapetropoulos, A. (2001). Reactive 
oxygen species stimulate VEGF production from C2C12 skeletal myotubes 
through a PI3K/Akt pathway. American journal of physiology. Lung cellular 
and molecular physiology, 280, L585-592. 
doi:https://doi.org/10.1152/ajplung.2001.280.4.L585 
Kuiper, H. C., Bruno, R. S., Traber, M. G., & Stevens, J. F. (2011). Vitamin C 
supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites 
in humans. Free Radic Biol Med, 50(7), 848-853. 
doi:https://doi.org/10.1016/j.freeradbiomed.2011.01.004 
Kuo, Browning, & Ivy. (1999). Regulation of GLUT4 protein expression and glycogen 
storage after prolonged exercise. Acta Physiologica Scandinavica, 165(2), 193-
201. doi:https://doi.org/10.1046/j.1365-201x.1999.00489.x 
Kurutas, E. B. (2016). The importance of antioxidants which play the role in cellular 
response against oxidative/nitrosative stress: current state. Nutrition Journal, 
15(1), 71. doi:https://doi.org/10.1186/s12937-016-0186-5 
Lamb, D. R., Peter, J. B., Jeffress, R. N., & Wallace, H. A. (1969). Glycogen, 
hexokinase, and glycogen synthetase adaptations to exercise. American Journal 
of Physiology-Legacy Content, 217(6), 1628-1632. 
doi:https://doi.org/10.1152/ajplegacy.1969.217.6.1628 
Lanner, J. T., Georgiou, D. K., Joshi, A. D., & Hamilton, S. L. (2010). Ryanodine 
receptors: structure, expression, molecular details, and function in calcium 
release. Cold Spring Harbor perspectives in biology, 2(11), a003996-a003996. 
doi:https://doi.org/10.1101/cshperspect.a003996 
Lavorato, S., Andrade, S., Silva, T., Alves, R., & Oliveira, R. (2012). 
Phosphofructokinase: Structural and functional aspects and design of selective 
inhibitors. Med. Chem. Commun., 3, 1219-1227. 
doi:https://doi.org/10.1039/C2MD20122D 
Le Moal, E., Pialoux, V., Juban, G., Groussard, C., Zouhal, H., Chazaud, B., & 
Mounier, R. (2017). Redox Control of Skeletal Muscle Regeneration. 
Antioxidants & redox signaling, 27(5), 276-310. 
doi:https://doi.org/10.1089/ars.2016.6782 
Lee, W. J., Kim, M., Park, H.-S., Kim, H. S., Jeon, M. J., Oh, K. S., . . . Park, J.-Y. 
(2006). AMPK activation increases fatty acid oxidation in skeletal muscle by 




Leeuwenburgh, C., & Heinecke, J. W. (2001). Oxidative Stress and Antioxidants in 
Exercise. Current Medicinal Chemistry, 8(7), 829-838. 
doi:https://doi.org/10.2174/0929867013372896 
Leeuwenburgh, C., Hollander, J., Leichtweis, S., Griffiths, M., Gore, M., & Ji, L. L. 
(1997). Adaptations of glutathione antioxidant system to endurance training are 
tissue and muscle fiber specific. Am J Physiol, 272(1 Pt 2), R363-369. 
doi:https://doi.org/10.1152/ajpregu.1997.272.1.R363 
Leick, L., Hellsten, Y., Fentz, J., Lyngby, S. S., Wojtaszewski, J. F., Hidalgo, J., & 
Pilegaard, H. (2009). PGC-1alpha mediates exercise-induced skeletal muscle 
VEGF expression in mice. Am J Physiol Endocrinol Metab, 297(1), E92-103. 
doi:https://doi.org/10.1152/ajpendo.00076.2009 
Lendahl, U., Lee, K. L., Yang, H., & Poellinger, L. (2009). Generating specificity and 
diversity in the transcriptional response to hypoxia. Nat Rev Genet, 10(12), 821-
832. doi:https://doi.org/10.1038/nrg2665 
Leonardini, A., Laviola, L., Perrini, S., Natalicchio, A., & Giorgino, F. (2009). Cross-
Talk between PPAR and Insulin Signaling and Modulation of Insulin 
Sensitivity. PPAR Research, 2009, 818945. 
doi:https://doi.org/10.1155/2009/818945 
Lerin, C., Rodgers, J. T., Kalume, D. E., Kim, S. H., Pandey, A., & Puigserver, P. 
(2006). GCN5 acetyltransferase complex controls glucose metabolism through 
transcriptional repression of PGC-1alpha. Cell Metab, 3(6), 429-438. 
doi:https://doi.org/10.1016/j.cmet.2006.04.013 
Levy, A. P., Levy, N. S., Wegner, S., & Goldberg, M. A. (1995). Transcriptional 
regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol 
Chem, 270(22), 13333-13340. doi:https://doi.org/10.1074/jbc.270.22.13333 
Li, L., Pan, R., Li, R., Niemann, B., Aurich, A. C., Chen, Y., & Rohrbach, S. (2011). 
Mitochondrial biogenesis and peroxisome proliferator-activated receptor-gamma 
coactivator-1alpha (PGC-1alpha) deacetylation by physical activity: intact 
adipocytokine signaling is required. Diabetes, 60(1), 157-167. 
doi:https://doi.org/10.2337/db10-0331 
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., . . . Abete, P. 
(2018). Oxidative stress, aging, and diseases. Clinical interventions in aging, 13, 
757-772. doi:https://doi.org/10.2147/CIA.S158513 
Lillig, C. H., Berndt, C., & Holmgren, A. (2008). Glutaredoxin systems. Biochimica et 
Biophysica Acta (BBA) - General Subjects, 1780(11), 1304-1317. 
doi:https://doi.org/10.1016/j.bbagen.2008.06.003 
Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., . . . Spiegelman, B. M. 
(2002). Transcriptional co-activator PGC-1 alpha drives the formation of slow-
twitch muscle fibres. Nature, 418(6899), 797-801. 
doi:https://doi.org/10.1038/nature00904 
Lin, K. T., Xue, J. Y., Sun, F. F., & Wong, P. Y. (1997). Reactive oxygen species 
participate in peroxynitrite-induced apoptosis in HL-60 cells. Biochem Biophys 
Res Commun, 230(1), 115-119. doi:https://doi.org/10.1006/bbrc.1996.5897 
Lindholm, D., Eriksson, O., Makela, J., Belluardo, N., & Korhonen, L. (2012). PGC-
1alpha: a master gene that is hard to master. Cell Mol Life Sci, 69(15), 2465-
2468. doi:https://doi.org/10.1007/s00018-012-1043-0 
Lindholm, M. E., & Rundqvist, H. (2016). Skeletal muscle hypoxia-inducible factor-1 
and exercise. Exp Physiol, 101(1), 28-32. doi:https://doi.org/10.1113/EP085318 
Lira, V. A., Benton, C. R., Yan, Z., & Bonen, A. (2010). PGC-1alpha regulation by 
exercise training and its influences on muscle function and insulin sensitivity. 
91 
 
Am J Physiol Endocrinol Metab, 299(2), E145-E161. 
doi:https://doi.org/10.1152/ajpendo.00755.2009 
Livak, K. J., & Schmittgen, T. D. (2001). Analysis of Relative Gene Expression Data 
Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods, 25(4), 
402-408. doi:https://doi.org/10.1006/meth.2001.1262 
Long, Y. C., & Zierath, J. R. (2006). AMP-activated protein kinase signaling in 
metabolic regulation. J Clin Invest, 116(7), 1776-1783. 
doi:https://doi.org/10.1172/jci29044 
Lopez-Soriano, J., Chiellini, C., Maffei, M., Grimaldi, P. A., & Argiles, J. M. (2006). 
Roles of skeletal muscle and peroxisome proliferator-activated receptors in the 
development and treatment of obesity. Endocr Rev, 27(3), 318-329. 
doi:https://doi.org/10.1210/er.2005-0012 
Loureiro, A. C. C., do Rêgo-Monteiro, I. C., Louzada, R. A., Ortenzi, V. H., de Aguiar, 
A. P., de Abreu, E. S., . . . Carvalho, D. P. (2016). Differential Expression of 
NADPH Oxidases Depends on Skeletal Muscle Fiber Type in Rats. Oxid Med 
Cell Longev, 2016, 6738701-6738701. 
doi:https://doi.org/10.1155/2016/6738701 
Luo, D., & Rando, T. A. (2003). The regulation of catalase gene expression in mouse 
muscle cells is dependent on the CCAAT-binding factor NF-Y. Biochem 
Biophys Res Commun, 303(2), 609-618. doi:https://doi.org/10.1016/S0006-
291X(03)00397-8 
Luquet, S., Lopez-Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., 
& Grimaldi, P. A. (2003). Peroxisome proliferator-activated receptor δ controls 
muscle development and oxidative capability. The FASEB Journal, 17(15), 
2299-2301. doi:https://doi.org/10.1096/fj.03-0269fje 
Lushchak, V. I. (2011). Environmentally induced oxidative stress in aquatic animals. 
Aquatic Toxicology, 101(1), 13-30. 
doi:https://doi.org/10.1016/j.aquatox.2010.10.006 
Maddipati, K. R., & Marnett, L. J. (1987). Characterization of the major hydroperoxide-
reducing activity of human plasma. Purification and properties of a selenium-
dependent glutathione peroxidase. Journal of Biological Chemistry, 262(36), 
17398-17403.  
Mandal, R., Becker, S., & Strebhardt, K. (2016). Stamping out RAF and MEK1/2 to 
inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy. 
Oncogene, 35(20), 2547-2561. doi:https://doi.org/10.1038/onc.2015.329 
Mansouri, A., Muller, F. L., Liu, Y., Ng, R., Faulkner, J., Hamilton, M., . . . Van 
Remmen, H. (2006). Alterations in mitochondrial function, hydrogen peroxide 
release and oxidative damage in mouse hind-limb skeletal muscle during aging. 
Mechanisms of Ageing and Development, 127(3), 298-306. 
doi:https://doi.org/10.1016/j.mad.2005.11.004 
Mason, S. A., Morrison, D., McConell, G. K., & Wadley, G. D. (2016). Muscle redox 
signalling pathways in exercise. Role of antioxidants. Free Radical Biology and 
Medicine, 98, 29-45. doi:https://doi.org/10.1016/j.freeradbiomed.2016.02.022 
Mattson, M. P. (2009). Roles of the lipid peroxidation product 4-hydroxynonenal in 
obesity, the metabolic syndrome, and associated vascular and neurodegenerative 
disorders. Exp Gerontol, 44(10), 625-633. 
doi:https://doi.org/10.1016/j.exger.2009.07.003 
Maurya, S. K., Herrera, J. L., Sahoo, S. K., Reis, F. C. G., Vega, R. B., Kelly, D. P., & 
Periasamy, M. (2018). Sarcolipin Signaling Promotes Mitochondrial Biogenesis 
92 
 
and Oxidative Metabolism in Skeletal Muscle. Cell Reports, 24(11), 2919-2931. 
doi:https://doi.org/10.1016/j.celrep.2018.08.036 
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000). Activation of the myocyte 
enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein 
kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci 
U S A, 97(26), 14400-14405. doi:https://doi.org/10.1073/pnas.260501497 
McLeod, M., Breen, L., Hamilton, D. L., & Philp, A. (2016). Live strong and prosper: 
the importance of skeletal muscle strength for healthy ageing. Biogerontology, 
17(3), 497-510. doi:https://doi.org/10.1007/s10522-015-9631-7 
Mecocci, P., Fanó, G., Fulle, S., MacGarvey, U., Shinobu, L., Polidori, M. C., . . . Beal, 
M. F. (1999). Age-dependent increases in oxidative damage to DNA, lipids, and 
proteins in human skeletal muscle. Free Radical Biology and Medicine, 26(3), 
303-308. doi:https://doi.org/10.1016/S0891-5849(98)00208-1 
Meier, P., Renga, M., Hoppeler, H., & Baum, O. (2013). The impact of antioxidant 
supplements and endurance exercise on genes of the carbohydrate and lipid 
metabolism in skeletal muscle of mice. Cell Biochem Funct, 31(1), 51-59. 
doi:https://doi.org/10.1002/cbf.2859 
Meister, A., & Anderson, M. E. (1983). Glutathione. Annu Rev Biochem, 52, 711-760. 
doi:https://doi.org/10.1146/annurev.bi.52.070183.003431 
Melanson, E. L., MacLean, P. S., & Hill, J. O. (2009). Exercise improves fat 
metabolism in muscle but does not increase 24-h fat oxidation. Exercise and 
sport sciences reviews, 37(2), 93-101. 
doi:https://doi.org/10.1097/JES.0b013e31819c2f0b 
Merry, T. L., & Ristow, M. (2016). Do antioxidant supplements interfere with skeletal 
muscle adaptation to exercise training? J Physiol, 594(18), 5135-5147. 
doi:https://doi.org/10.1113/JP270654 
Meydani, M., Fielding, R., & Martin, K. R. (1998). Vitamin E and its effect on skeletal 
muscle. In A. Z. Reznick, L. Packer, C. K. Sen, J. O. Holloszy, & M. J. Jackson 
(Eds.), Oxidative Stress in Skeletal Muscle (pp. 141-156). Basel: Birkhäuser 
Basel. 
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., . . 
. Spiegelman, B. M. (2001). Restoration of insulin-sensitive glucose transporter 
(GLUT4) gene expression in muscle cells by the transcriptional coactivator 
PGC-1. Proc Natl Acad Sci U S A, 98(7), 3820-3825. 
doi:https://doi.org/10.1073/pnas.061035098 
Migliaccio, N., Sanges, C., Ruggiero, I., Martucci, N. M., Rippa, E., Arcari, P., & 
Lamberti, A. (2013). Raf kinases in signal transduction and interaction with 
translation machinery. Biomol Concepts, 4(4), 391-399. 
doi:https://doi.org/10.1515/bmc-2013-0003 
Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R. J., . . . 
Karin, M. (1994). Differential activation of ERK and JNK mitogen-activated 
protein kinases by Raf-1 and MEKK. Science, 266(5191), 1719-1723. 
doi:https://doi.org/10.1126/science.7992057 
Minnich, A., Tian, N., Byan, L., & Bilder, G. (2001). A potent PPARalpha agonist 
stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. 
Am J Physiol Endocrinol Metab, 280(2), E270-279. 
doi:https://doi.org/10.1152/ajpendo.2001.280.2.E270 
Miyamoto, S., Teramoto, H., Coso, O. A., Gutkind, J. S., Burbelo, P. D., Akiyama, S. 
K., & Yamada, K. M. (1995). Integrin function: molecular hierarchies of 
93 
 
cytoskeletal and signaling molecules. J Cell Biol, 131(3), 791-805. 
doi:https://doi.org/10.1083/jcb.131.3.791 
Mootha, V. K., Handschin, C., Arlow, D., Xie, X., St Pierre, J., Sihag, S., . . . 
Spiegelman, B. M. (2004). Erralpha and Gabpa/b specify PGC-1alpha-
dependent oxidative phosphorylation gene expression that is altered in diabetic 
muscle. Proc Natl Acad Sci U S A, 101(17), 6570-6575. 
doi:https://doi.org/10.1073/pnas.0401401101 
Mukund, K., & Subramaniam, S. (2020). Skeletal muscle: A review of molecular 
structure and function, in health and disease. Wiley interdisciplinary reviews. 
Systems biology and medicine, 12(1), e1462-e1462. 
doi:https://doi.org/10.1002/wsbm.1462 
Mukwevho, E. (2017). Exercise-induced Calmodulin dependent protein kinase 
(CaMK)II activation regulates saturated and unsaturated fatty acids in rat 
skeletal muscle. The FASEB Journal, 31(1_supplement), 883.885-883.885. 
doi:https://doi.org/10.1096/fasebj.31.1_supplement.883.5 
Mukwevho, E., Kohn, T. A., Lang, D., Nyatia, E., Smith, J., & Ojuka, E. O. (2008). 
Caffeine induces hyperacetylation of histones at the MEF2 site on the Glut4 
promoter and increases MEF2A binding to the site via a CaMK-dependent 
mechanism. American Journal of Physiology-Endocrinology and Metabolism, 
294(3), E582-E588. doi:https://doi.org/10.1152/ajpendo.00312.2007 
Nagahisa, H., Okabe, K., Iuchi, Y., Fujii, J., & Miyata, H. (2016). Characteristics of 
Skeletal Muscle Fibers of SOD1 Knockout Mice. Oxid Med Cell Longev, 2016, 
9345970. doi:https://doi.org/10.1155/2016/9345970 
Naya, F. J., Mercer, B., Shelton, J., Richardson, J. A., Williams, R. S., & Olson, E. N. 
(2000). Stimulation of slow skeletal muscle fiber gene expression by calcineurin 
in vivo. J Biol Chem, 275(7), 4545-4548. 
doi:https://doi.org/10.1074/jbc.275.7.4545 
Nedachi, T., Fujita, H., & Kanzaki, M. (2008). Contractile C2C12 myotube model for 
studying exercise-inducible responses in skeletal muscle. American Journal of 
Physiology-Endocrinology and Metabolism, 295(5), E1191-E1204. 
doi:https://doi.org/10.1152/ajpendo.90280.2008 
Nelson, B. R., Wu, F., Liu, Y., Anderson, D. M., McAnally, J., Lin, W., . . . Olson, E. 
N. (2013). Skeletal muscle-specific T-tubule protein STAC3 mediates voltage-
induced Ca2+ release and contractility. Proc Natl Acad Sci U S A, 110(29), 
11881-11886. doi:https://doi.org/10.1073/pnas.1310571110 
Neuzil, J., Witting, P. K., & Stocker, R. (1997). Alpha-tocopheryl hydroquinone is an 
efficient multifunctional inhibitor of radical-initiated oxidation of low density 
lipoprotein lipids. Proc Natl Acad Sci U S A, 94(15), 7885-7890. 
doi:https://doi.org/10.1073/pnas.94.15.7885 
Neves, K. B., Rios, F. J., van der Mey, L., Alves-Lopes, R., Cameron, A. C., Volpe, M., 
. . . Touyz, R. M. (2018). VEGFR (Vascular Endothelial Growth Factor 
Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive 
Processes. Hypertension, 71(4), 638-647. 
doi:https://doi.org/10.1161/hypertensionaha.117.10490 
Nisimoto, Y., Diebold, B. A., Cosentino-Gomes, D., & Lambeth, J. D. (2014). Nox4: a 
hydrogen peroxide-generating oxygen sensor. Biochemistry, 53(31), 5111-5120. 
doi:https://doi.org/10.1021/bi500331y 
Novelli, G. P., Bracciotti, G., & Falsini, S. (1990). Spin-trappers and vitamin E prolong 




Oberley, L. W., St Clair, D. K., Autor, A. P., & Oberley, T. D. (1987). Increase in 
manganese superoxide dismutase activity in the mouse heart after X-irradiation. 
Arch Biochem Biophys, 254(1), 69-80. doi:https://doi.org/10.1016/0003-
9861(87)90082-8 
Ojuka, E. O., Jones, T. E., Han, D.-H., Chen, M., Wamhoff, B. R., Sturek, M., & 
Holloszy, J. O. (2002). Intermittent increases in cytosolic Ca2+stimulate 
mitochondrial biogenesis in muscle cells. American Journal of Physiology-
Endocrinology and Metabolism, 283(5), E1040-E1045. 
doi:https://doi.org/10.1152/ajpendo.00242.2002 
Ojuka, E. O., Jones, T. E., Nolte, L. A., Chen, M., Wamhoff, B. R., Sturek, M., & 
Holloszy, J. O. (2002). Regulation of GLUT4 biogenesis in muscle: evidence for 
involvement of AMPK and Ca2+. American Journal of Physiology-
Endocrinology and Metabolism, 282(5), E1008-E1013. 
doi:https://doi.org/10.1152/ajpendo.00512.2001 
Olfert, I. M., Howlett, R. A., Wagner, P. D., & Breen, E. C. (2010). Myocyte vascular 
endothelial growth factor is required for exercise-induced skeletal muscle 
angiogenesis. Am J Physiol Regul Integr Comp Physiol, 299(4), R1059-1067. 
doi:https://doi.org/10.1152/ajpregu.00347.2010 
Olsen, L. A., Nicoll, J. X., & Fry, A. C. (2019). The skeletal muscle fiber: a 
mechanically sensitive cell. European Journal of Applied Physiology, 119(2), 
333-349. doi:https://doi.org/10.1007/s00421-018-04061-x 
Ordway, G. A., & Garry, D. J. (2004). Myoglobin: an essential hemoprotein in striated 
muscle. Journal of Experimental Biology, 207(20), 3441. 
doi:https://doi.org/10.1242/jeb.01172 
Oteiza, P. I. (2012). Zinc and the modulation of redox homeostasis. Free Radic Biol 
Med, 53(9), 1748-1759. doi:https://doi.org/10.1016/j.freeradbiomed.2012.08.568 
Packer, L., Cadenas, E., & Davies, K. J. (2008). Free radicals and exercise: an 
introduction. Free Radic Biol Med, 44(2), 123-125. 
doi:https://doi.org/10.1016/j.freeradbiomed.2007.05.031 
Padayatty, S. J., Katz, A., Wang, Y., Eck, P., Kwon, O., Lee, J. H., . . . Levine, M. 
(2003). Vitamin C as an antioxidant: evaluation of its role in disease prevention. 
J Am Coll Nutr, 22(1), 18-35. 
doi:https://doi.org/10.1080/07315724.2003.10719272 
Pagès, G., & Pouysségur, J. (2005). Transcriptional regulation of the Vascular 
Endothelial Growth Factor gene–a concert of activating factors*. 
Cardiovascular Research, 65(3), 564-573. 
doi:https://doi.org/10.1016/j.cardiores.2004.09.032 
Pantano, C., Reynaert, N. L., van der Vliet, A., & Janssen-Heininger, Y. M. (2006). 
Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. 
Antioxidants & redox signaling, 8(9-10), 1791-1806. 
doi:https://doi.org/10.1089/ars.2006.8.1791 
Park, H., Bhalla, R., Saigal, R., Radisic, M., Watson, N., Langer, R., & Vunjak-
Novakovic, G. (2008). Effects of electrical stimulation in C2C12 muscle 
constructs. J Tissue Eng Regen Med, 2(5), 279-287. 
doi:https://doi.org/10.1002/term.93 
Park, J. Y., Wang, P. Y., Matsumoto, T., Sung, H. J., Ma, W., Choi, J. W., . . . Hwang, 
P. M. (2009). p53 improves aerobic exercise capacity and augments skeletal 




Paulsen, G., Cumming, K. T., Holden, G., Hallen, J., Ronnestad, B. R., Sveen, O., . . . 
Raastad, T. (2014). Vitamin C and E supplementation hampers cellular 
adaptation to endurance training in humans: a double-blind, randomised, 
controlled trial. J Physiol, 592(8), 1887-1901. 
doi:https://doi.org/10.1113/jphysiol.2013.267419 
Pérez-Schindler, J., Summermatter, S., Santos, G., Zorzato, F., & Handschin, C. (2013). 
The transcriptional coactivator PGC-1α is dispensable for chronic overload-
induced skeletal muscle hypertrophy and metabolic remodeling. Proc Natl Acad 
Sci U S A, 110(50), 20314-20319. doi:https://doi.org/10.1073/pnas.1312039110 
Peter, A. K., Cheng, H., Ross, R. S., Knowlton, K. U., & Chen, J. (2011). The 
costamere bridges sarcomeres to the sarcolemma in striated muscle. Progress in 
pediatric cardiology, 31(2), 83-88. 
doi:https://doi.org/10.1016/j.ppedcard.2011.02.003 
Pette, D., & Staron, R. S. (1990). Cellular and molecular diversities of mammalian 
skeletal muscle fibers. Rev Physiol Biochem Pharmacol, 116, 1-76.  
Phua, W. W., Wong, X. M., Liao, Z., & Tan, S. N. (2018). An aPPARent Functional 
Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-
Activated Receptors. International Journal of Molecular Sciences, 19(5). 
doi:https://doi.org/10.3390/ijms19051425 
Piao, Y. J., Seo, Y. H., Hong, F., Kim, J. H., Kim, Y. J., Kang, M. H., . . . Kim, S. S. 
(2005). Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. 
Free Radic Biol Med, 38(8), 989-1001. 
doi:https://doi.org/10.1016/j.freeradbiomed.2004.11.011 
Pilegaard, H., Keller, C., Steensberg, A., Helge, J. W., Pedersen, B. K., Saltin, B., & 
Neufer, P. D. (2002). Influence of pre-exercise muscle glycogen content on 
exercise-induced transcriptional regulation of metabolic genes. J Physiol, 541(Pt 
1), 261-271. doi:https://doi.org/10.1113/jphysiol.2002.016832 
Pinheiro, C. H. d. J., Silveira, L. R., Nachbar, R. T., Vitzel, K. F., & Curi, R. (2010). 
Regulation of glycolysis and expression of glucose metabolism-related genes by 
reactive oxygen species in contracting skeletal muscle cells. Free Radical 
Biology and Medicine, 48(7), 953-960. 
doi:https://doi.org/10.1016/j.freeradbiomed.2010.01.016 
Pizzorno, J. (2014). Glutathione! Integrative medicine (Encinitas, Calif.), 13(1), 8-12.  
Pogozelski, A. R., Geng, T., Li, P., Yin, X., Lira, V. A., Zhang, M., . . . Yan, Z. (2009). 
p38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle 
metabolic adaptation in mice. PLoS One, 4(11), e7934. 
doi:https://doi.org/10.1371/journal.pone.0007934 
Potthoff, M. J., Wu, H., Arnold, M. A., Shelton, J. M., Backs, J., McAnally, J., . . . 
Olson, E. N. (2007). Histone deacetylase degradation and MEF2 activation 
promote the formation of slow-twitch myofibers. J Clin Invest, 117(9), 2459-
2467. doi:https://doi.org/10.1172/jci31960 
Powers, S. K., Criswell, D., Lawler, J., Ji, L. L., Martin, D., Herb, R. A., & Dudley, G. 
(1994). Influence of exercise and fiber type on antioxidant enzyme activity in rat 
skeletal muscle. Am J Physiol, 266(2 Pt 2), R375-380. 
doi:https://doi.org/10.1152/ajpregu.1994.266.2.R375 
Powers, S. K., & Jackson, M. J. (2008). Exercise-induced oxidative stress: cellular 




Powers, S. K., Ji, L. L., Kavazis, A. N., & Jackson, M. J. (2011). Reactive oxygen 
species: impact on skeletal muscle. Comprehensive Physiology, 1(2), 941-969. 
doi:https://doi.org/10.1002/cphy.c100054 
Powers, S. K., Ji, L. L., & Leeuwenburgh, C. (1999). Exercise training-induced 
alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci 
Sports Exerc, 31(7), 987-997. doi:https://doi.org/10.1097/00005768-199907000-
00011 
Powers, S. K., Nelson, W. B., & Hudson, M. B. (2011). Exercise-induced oxidative 
stress in humans: cause and consequences. Free Radic Biol Med, 51(5), 942-
950. doi:https://doi.org/10.1016/j.freeradbiomed.2010.12.009 
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. 
(1998). A cold-inducible coactivator of nuclear receptors linked to adaptive 
thermogenesis. Cell, 92(6), 829-839. doi:https://doi.org/10.1016/s0092-
8674(00)81410-5 
Quintanilha, A. T., & Packer, L. (1983). Vitamin E, physical exercise and tissue 
oxidative damage. Ciba Found Symp, 101, 56-69. 
doi:https://doi.org/10.1002/9780470720820.ch5 
Rasbach, K. A., Gupta, R. K., Ruas, J. L., Wu, J., Naseri, E., Estall, J. L., & 
Spiegelman, B. M. (2010). PGC-1alpha regulates a HIF2alpha-dependent switch 
in skeletal muscle fiber types. Proc Natl Acad Sci U S A, 107(50), 21866-21871. 
doi:https://doi.org/10.1073/pnas.1016089107 
Reid, M. B. (2001a). Invited Review: redox modulation of skeletal muscle contraction: 
what we know and what we don't. J Appl Physiol (1985), 90(2), 724-731. 
doi:https://doi.org/10.1152/jappl.2001.90.2.724 
Reid, M. B. (2001b). Nitric oxide, reactive oxygen species, and skeletal muscle 
contraction. Med Sci Sports Exerc, 33(3), 371-376. 
doi:https://doi.org/10.1097/00005768-200103000-00006 
Reid, M. B. (2016). Reactive Oxygen Species as Agents of Fatigue. Med Sci Sports 
Exerc, 48(11), 2239-2246. doi:https://doi.org/10.1249/mss.0000000000001006 
Reid, M. B., Khawli, F. A., & Moody, M. R. (1993). Reactive oxygen in skeletal 
muscle. III. Contractility of unfatigued muscle. J Appl Physiol (1985), 75(3), 
1081-1087. doi:https://doi.org/10.1152/jappl.1993.75.3.1081 
Rios, E., & Brum, G. (1987). Involvement of dihydropyridine receptors in excitation-
contraction coupling in skeletal muscle. Nature, 325(6106), 717-720. 
doi:https://doi.org/10.1038/325717a0 
Ristow, M. (2014). Unraveling the truth about antioxidants: mitohormesis explains 
ROS-induced health benefits. Nat Med, 20(7), 709-711. 
doi:https://doi.org/10.1038/nm.3624 
Rivero, J. L., Talmadge, R. J., & Edgerton, V. R. (1998). Fibre size and metabolic 
properties of myosin heavy chain-based fibre types in rat skeletal muscle. 
Journal of muscle research and cell motility, 19(7), 733-742. 
doi:https://doi.org/10.1023/a:1005482816442 
Rockl, K. S., Hirshman, M. F., Brandauer, J., Fujii, N., Witters, L. A., & Goodyear, L. 
J. (2007). Skeletal muscle adaptation to exercise training: AMP-activated protein 
kinase mediates muscle fiber type shift. Diabetes, 56(8), 2062-2069. 
doi:https://doi.org/10.2337/db07-0255 
Rohling, M., Herder, C., Stemper, T., & Mussig, K. (2016). Influence of Acute and 




Ronnett, G. V., Kleman, A. M., Kim, E. K., Landree, L. E., & Tu, Y. (2006). Fatty acid 
metabolism, the central nervous system, and feeding. Obesity (Silver Spring), 14 
Suppl 5, 201s-207s. doi:https://doi.org/10.1038/oby.2006.309 
Rose, A. J., Kiens, B., & Richter, E. A. (2006). Ca2+–calmodulin-dependent protein 
kinase expression and signalling in skeletal muscle during exercise. J Physiol, 
574(3), 889-903. doi:https://doi.org/10.1113/jphysiol.2006.111757 
Rossi, A. E., & Dirksen, R. T. (2006). Sarcoplasmic reticulum: the dynamic calcium 
governor of muscle. Muscle Nerve, 33(6), 715-731. 
doi:https://doi.org/10.1002/mus.20512 
Rowe, G. C., El-Khoury, R., Patten, I. S., Rustin, P., & Arany, Z. (2012). PGC-1alpha is 
dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. 
PLoS One, 7(7), e41817. doi:https://doi.org/10.1371/journal.pone.0041817 
Ryder, J. W., Bassel-Duby, R., Olson, E. N., & Zierath, J. R. (2003). Skeletal muscle 
reprogramming by activation of calcineurin improves insulin action on 
metabolic pathways. J Biol Chem, 278(45), 44298-44304. 
doi:https://doi.org/10.1074/jbc.M304510200 
Saborido, A., Naudi, A., Portero-Otin, M., Pamplona, R., & Megias, A. (2011). 
Stanozolol treatment decreases the mitochondrial ROS generation and oxidative 
stress induced by acute exercise in rat skeletal muscle. J Appl Physiol (1985), 
110(3), 661-669. doi:https://doi.org/10.1152/japplphysiol.00790.2010 
Safdar, A., Little, J. P., Stokl, A. J., Hettinga, B. P., Akhtar, M., & Tarnopolsky, M. A. 
(2011). Exercise Increases Mitochondrial PGC-1α Content and Promotes 
Nuclear-Mitochondrial Cross-talk to Coordinate Mitochondrial Biogenesis. 
Journal of Biological Chemistry, 286(12), 10605-10617. 
doi:https://doi.org/10.1074/jbc.M110.211466 
Sahlin, K., Tonkonogi, M., & SÖDerlund, K. (1998). Energy supply and muscle fatigue 
in humans. Acta Physiologica Scandinavica, 162(3), 261-266. 
doi:https://doi.org/10.1046/j.1365-201X.1998.0298f.x 
Sakamoto, K., & Goodyear, L. J. (2002). Invited Review: Intracellular signaling in 
contracting skeletal muscle. Journal of Applied Physiology, 93(1), 369-383. 
doi:https://doi.org/10.1152/japplphysiol.00167.2002 
Sakellariou, G. K., Vasilaki, A., Palomero, J., Kayani, A., Zibrik, L., McArdle, A., & 
Jackson, M. J. (2013). Studies of mitochondrial and nonmitochondrial sources 
implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the 
increased skeletal muscle superoxide generation that occurs during contractile 
activity. Antioxidants & redox signaling, 18(6), 603-621. 
doi:https://doi.org/10.1089/ars.2012.4623 
Sakuma, K., & Yamaguchi, A. (2010). The functional role of calcineurin in 
hypertrophy, regeneration, and disorders of skeletal muscle. Journal of 
biomedicine & biotechnology, 2010, 721219-721219. 
doi:https://doi.org/10.1155/2010/721219 
Saleem, A., Carter, H. N., Iqbal, S., & Hood, D. A. (2011). Role of p53 within the 
regulatory network controlling muscle mitochondrial biogenesis. Exerc Sport Sci 
Rev, 39(4), 199-205. doi:https://doi.org/10.1097/JES.0b013e31822d71be 
Sanna, B., Bueno, O. F., Dai, Y. S., Wilkins, B. J., & Molkentin, J. D. (2005). Direct 
and indirect interactions between calcineurin-NFAT and MEK1-extracellular 
signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression 




Sano, M., Tokudome, S., Shimizu, N., Yoshikawa, N., Ogawa, C., Shirakawa, K., . . . 
Fukuda, K. (2007). Intramolecular control of protein stability, subnuclear 
compartmentalization, and coactivator function of peroxisome proliferator-
activated receptor gamma coactivator 1alpha. J Biol Chem, 282(35), 25970-
25980. doi:https://doi.org/10.1074/jbc.M703634200 
Santacatterina, F., Chamorro, M., de Arenas, C. N., Navarro, C., Martín, M. A., Cuezva, 
J. M., & Sánchez-Aragó, M. (2015). Quantitative analysis of proteins of 
metabolism by reverse phase protein microarrays identifies potential biomarkers 
of rare neuromuscular diseases. J Transl Med, 13, 65. 
doi:https://doi.org/10.1186/s12967-015-0424-1 
Savini, I., Valeria Catani, M., Duranti, G., Ceci, R., Sabatini, S., & Avigliano, L. 
(2005). Vitamin C homeostasis in skeletal muscle cells. Free Radical Biology 
and Medicine, 38(7), 898-907. 
doi:https://doi.org/10.1016/j.freeradbiomed.2004.12.009 
Schuler, M., Ali, F., Chambon, C., Duteil, D., Bornert, J. M., Tardivel, A., . . . Metzger, 
D. (2006). PGC1alpha expression is controlled in skeletal muscles by 
PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 
diabetes. Cell Metab, 4(5), 407-414. 
doi:https://doi.org/10.1016/j.cmet.2006.10.003 
Schulz, R. A., & Yutzey, K. E. (2004). Calcineurin signaling and NFAT activation in 
cardiovascular and skeletal muscle development. Developmental Biology, 
266(1), 1-16. doi:https://doi.org/10.1016/j.ydbio.2003.10.008 
Seip, R. L., & Semenkovich, C. F. (1998). Skeletal muscle lipoprotein lipase: molecular 
regulation and physiological effects in relation to exercise. Exerc Sport Sci Rev, 
26, 191-218.  
Sen, C. K., Marin, E., Kretzschmar, M., & Hanninen, O. (1992). Skeletal muscle and 
liver glutathione homeostasis in response to training, exercise, and 
immobilization. J Appl Physiol (1985), 73(4), 1265-1272. 
doi:https://doi.org/10.1152/jappl.1992.73.4.1265 
Sen, P., Chakraborty, P. K., & Raha, S. (2005). p38 mitogen-activated protein kinase 
(p38MAPK) upregulates catalase levels in response to low dose H2O2 treatment 
through enhancement of mRNA stability. FEBS Letters, 579(20), 4402-4406. 
doi:https://doi.org/10.1016/j.febslet.2005.06.081 
Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., . . . Krause, K. H. 
(2007). NOX4 activity is determined by mRNA levels and reveals a unique 
pattern of ROS generation. Biochem J, 406(1), 105-114. 
doi:https://doi.org/10.1042/bj20061903 
Shao, D., Oka, S., Liu, T., Zhai, P., Ago, T., Sciarretta, S., . . . Sadoshima, J. (2014). A 
redox-dependent mechanism for regulation of AMPK activation by 
Thioredoxin1 during energy starvation. Cell Metab, 19(2), 232-245. 
doi:https://doi.org/10.1016/j.cmet.2013.12.013 
Sidossis, L. S., Gastaldelli, A., Klein, S., & Wolfe, R. R. (1997). Regulation of plasma 
fatty acid oxidation during low- and high-intensity exercise. Am J Physiol, 272(6 
Pt 1), E1065-1070. doi:https://doi.org/10.1152/ajpendo.1997.272.6.E1065 
Siu, P. M., Donley, D. A., Bryner, R. W., & Alway, S. E. (2003). Citrate synthase 
expression and enzyme activity after endurance training in cardiac and skeletal 
muscles. Journal of Applied Physiology, 94(2), 555-560. 
doi:https://doi.org/10.1152/japplphysiol.00821.2002 
Song, S., Attia, R. R., Connaughton, S., Niesen, M. I., Ness, G. C., Elam, M. B., . . . 
Park, E. A. (2010). Peroxisome proliferator activated receptor alpha 
99 
 
(PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine 
palmitoyltransferase IA (CPT-1A) via independent gene elements. Mol Cell 
Endocrinol, 325(1-2), 54-63. doi:https://doi.org/10.1016/j.mce.2010.05.019 
Spangenburg, E. E., Brown, D. A., Johnson, M. S., & Moore, R. L. (2009). Alterations 
in peroxisome proliferator-activated receptor mRNA expression in skeletal 
muscle after acute and repeated bouts of exercise. Molecular and cellular 
biochemistry, 332(1-2), 225-231. doi:https://doi.org/10.1007/s11010-009-0195-1 
Spriet, L. L., & Watt, M. J. (2003). Regulatory mechanisms in the interaction between 
carbohydrate and lipid oxidation during exercise. Acta Physiologica 
Scandinavica, 178(4), 443-452. doi:https://doi.org/10.1046/j.1365-
201X.2003.01152.x 
Srere, P. A. (1969). Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-
acetylating)]. In Methods Enzymol (Vol. 13, pp. 3-11): Academic Press. 
St-Pierre, J. (2003). Exercise For Mitochondria. Journal of Experimental Biology, 
206(5), 789. doi:https://doi.org/10.1242/jeb.00152 
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., . . . Spiegelman, B. 
M. (2006). Suppression of reactive oxygen species and neurodegeneration by the 
PGC-1 transcriptional coactivators. Cell, 127(2), 397-408. 
doi:https://doi.org/10.1016/j.cell.2006.09.024 
Steinbacher, P., & Eckl, P. (2015). Impact of oxidative stress on exercising skeletal 
muscle. Biomolecules, 5(2), 356-377. doi:https://doi.org/10.3390/biom5020356 
Stevens, F. C. (1983). Calmodulin: an introduction. Canadian Journal of Biochemistry 
and Cell Biology, 61(8), 906-910. doi:https://doi.org/10.1139/o83-115 
Strobel, Peake, J. M., Matsumoto, A., Marsh, S. A., Coombes, J. S., & Wadley, G. D. 
(2011). Antioxidant supplementation reduces skeletal muscle mitochondrial 
biogenesis. Med Sci Sports Exerc, 43(6), 1017-1024. 
doi:https://doi.org/10.1249/MSS.0b013e318203afa3 
Strobel, N., Matsumoto, A., Peake, J. M., Marsh, S. A., Peternelj, T.-T., Briskey, D., . . . 
Wadley, G. D. (2014). Altering the redox state of skeletal muscle by glutathione 
depletion increases the exercise-activation of PGC-1α. Physiological reports, 
2(12), e12224. doi:https://doi.org/10.14814/phy2.12224 
Strober, W. (2015). Trypan Blue Exclusion Test of Cell Viability. Curr Protoc 
Immunol, 111, A3.B.1-a3.B.3. 
doi:https://doi.org/10.1002/0471142735.ima03bs111 
Sullivan-Gunn, M. J., & Lewandowski, P. A. (2013). Elevated hydrogen peroxide and 
decreased catalase and glutathione peroxidase protection are associated with 
aging sarcopenia. BMC Geriatrics, 13(1), 104. doi:https://doi.org/10.1186/1471-
2318-13-104 
Swindells, M. B., & Ikura, M. (1996). Pre-formation of the semi-open conformation by 
the apo-calmodulin C-terminal domain and implications binding IQ-motifs. Nat 
Struct Biol, 3(6), 501-504.  
Takebe, G., Yarimizu, J., Saito, Y., Hayashi, T., Nakamura, H., Yodoi, J., . . . 
Takahashi, K. (2002). A Comparative Study on the Hydroperoxide and Thiol 
Specificity of the Glutathione Peroxidase Family and Selenoprotein P. Journal 
of Biological Chemistry, 277(43), 41254-41258. 
doi:https://doi.org/10.1074/jbc.M202773200 
Takekoshi, K., Fukuhara, M., Quin, Z., Nissato, S., Isobe, K., Kawakami, Y., & 
Ohmori, H. (2006). Long-term exercise stimulates adenosine monophosphate-
activated protein kinase activity and subunit expression in rat visceral adipose 
100 
 
tissue and liver. Metabolism, 55(8), 1122-1128. 
doi:https://doi.org/10.1016/j.metabol.2006.04.007 
Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N., . 
. . et al. (1989). Primary structure and expression from complementary DNA of 
skeletal muscle ryanodine receptor. Nature, 339(6224), 439-445. 
doi:https://doi.org/10.1038/339439a0 
Tang, B. L. (2016). Sirt1 and the Mitochondria. Mol Cells, 39(2), 87-95. 
doi:https://doi.org/10.14348/molcells.2016.2318 
Taylor, S. S., Yang, J., Wu, J., Haste, N. M., Radzio-Andzelm, E., & Anand, G. (2004). 
PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta, 1697(1-2), 
259-269. doi:https://doi.org/10.1016/j.bbapap.2003.11.029 
Thai, M. V., Guruswamy, S., Cao, K. T., Pessin, J. E., & Olson, A. L. (1998). Myocyte 
enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression 
in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-
deficient diabetes. J Biol Chem, 273(23), 14285-14292. 
doi:https://doi.org/10.1074/jbc.273.23.14285 
Thirupathi, A., & Pinho, R. A. (2018). Effects of reactive oxygen species and interplay 
of antioxidants during physical exercise in skeletal muscles. J Physiol Biochem, 
74(3), 359-367. doi:https://doi.org/10.1007/s13105-018-0633-1 
Thomson, D. M. (2018). The Role of AMPK in the Regulation of Skeletal Muscle Size, 
Hypertrophy, and Regeneration. Int J Mol Sci, 19(10). 
doi:https://doi.org/10.3390/ijms19103125 
Traverso, N., Menini, S., Cosso, L., Odetti, P., Albano, E., Pronzato, M. A., & Marinari, 
U. M. (1998). Immunological evidence for increased oxidative stress in diabetic 
rats. Diabetologia, 41(3), 265-270. doi:https://doi.org/10.1007/s001250050902 
Tveden-Nyborg, P., & Lykkesfeldt, J. (2009). Does vitamin C deficiency result in 
impaired brain development in infants? Redox Rep, 14(1), 2-6. 
doi:https://doi.org/10.1179/135100009x392412 
Van Der Vliet, A., & Janssen-Heininger, Y. M. (2014). Hydrogen peroxide as a damage 
signal in tissue injury and inflammation: murderer, mediator, or messenger? J 
Cell Biochem, 115(3), 427-435. doi:https://doi.org/10.1002/jcb.24683 
Vigelso, A., Andersen, N. B., & Dela, F. (2014). The relationship between skeletal 
muscle mitochondrial citrate synthase activity and whole body oxygen uptake 
adaptations in response to exercise training. Int J Physiol Pathophysiol 
Pharmacol, 6(2), 84-101.  
Wadley, A. J., Aldred, S., & Coles, S. J. (2016). An unexplored role for Peroxiredoxin 
in exercise-induced redox signalling? Redox Biology, 8, 51-58. 
doi:https://doi.org/10.1016/j.redox.2015.10.003 
Wadley, G. D., Nicolas, M. A., Hiam, D. S., & McConell, G. K. (2013). Xanthine 
oxidase inhibition attenuates skeletal muscle signaling following acute exercise 
but does not impair mitochondrial adaptations to endurance training. Am J 
Physiol Endocrinol Metab, 304(8), E853-862. 
doi:https://doi.org/10.1152/ajpendo.00568.2012 
Wagner, P. D. (2011). The critical role of VEGF in skeletal muscle angiogenesis and 
blood flow. Biochemical Society Transactions, 39(6), 1556-1559. 
doi:https://doi.org/10.1042/BST20110646 
Wang, X., & Quinn, P. J. (1999). Vitamin E and its function in membranes. Prog Lipid 
Res, 38(4), 309-336.  
Wang, Y. X., Zhang, C. L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. 
R., . . . Evans, R. M. (2004). Regulation of muscle fiber type and running 
101 
 
endurance by PPARdelta. PLoS Biol, 2(10), e294. 
doi:https://doi.org/10.1371/journal.pbio.0020294 
Wen, X., Wu, J., Chang, J. S., Zhang, P., Wang, J., Zhang, Y., . . . Zhang, Y. (2014). 
Effect of Exercise Intensity on Isoform-Specific Expressions of NT-PGC-1α 
mRNA in Mouse Skeletal Muscle. BioMed Research International, 2014, 
402175. doi:https://doi.org/10.1155/2014/402175 
Winder, W. W., & Hardie, D. G. (1996). Inactivation of acetyl-CoA carboxylase and 
activation of AMP-activated protein kinase in muscle during exercise. Am J 
Physiol, 270(2 Pt 1), E299-304. 
doi:https://doi.org/10.1152/ajpendo.1996.270.2.E299 
Wu, H., Kanatous, S. B., Thurmond, F. A., Gallardo, T., Isotani, E., Bassel-Duby, R., & 
Williams, R. S. (2002). Regulation of mitochondrial biogenesis in skeletal 
muscle by CaMK. Science, 296(5566), 349-352. 
doi:https://doi.org/10.1126/science.1071163 
Wu, H., Rothermel, B., Kanatous, S., Rosenberg, P., Naya, F. J., Shelton, J. M., . . . 
Williams, R. S. (2001a). Activation of MEF2 by muscle activity is mediated 
through a calcineurin-dependent pathway. The EMBO journal, 20(22), 6414-
6423. doi:https://doi.org/10.1093/emboj/20.22.6414 
Wu, H., Rothermel, B., Kanatous, S., Rosenberg, P., Naya, F. J., Shelton, J. M., . . . 
Williams, R. S. (2001b). Activation of MEF2 by muscle activity is mediated 
through a calcineurin-dependent pathway. The EMBO journal, 20(22), 6414-
6423. doi:10.1093/emboj/20.22.6414 
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., . . . 
Spiegelman, B. M. (1999). Mechanisms controlling mitochondrial biogenesis 
and respiration through the thermogenic coactivator PGC-1. Cell, 98(1), 115-
124. doi:https://doi.org/10.1016/s0092-8674(00)80611-x 
Xiao, B., Sanders, M. J., Carmena, D., Bright, N. J., Haire, L. F., Underwood, E., . . . 
Gamblin, S. J. (2013). Structural basis of AMPK regulation by small molecule 
activators. Nat Commun, 4, 3017. doi:https://doi.org/10.1038/ncomms4017 
Yan, M., Dai, T., Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J. R., & Templeton, 
D. J. (1994). Activation of stress-activated protein kinase by MEKK1 
phosphorylation of its activator SEK1. Nature, 372(6508), 798-800. 
doi:https://doi.org/10.1038/372798a0 
Yan, Z., Okutsu, M., Akhtar, Y. N., & Lira, V. A. (2010). Regulation of exercise-
induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in 
skeletal muscle. Journal of Applied Physiology, 110(1), 264-274. 
doi:https://doi.org/10.1152/japplphysiol.00993.2010 
Yang, Y., Creer, A., Jemiolo, B., & Trappe, S. (2005). Time course of myogenic and 
metabolic gene expression in response to acute exercise in human skeletal 
muscle. J Appl Physiol (1985), 98(5), 1745-1752. 
doi:https://doi.org/10.1152/japplphysiol.01185.2004 
Yfanti, C., Akerstrom, T., Nielsen, S., Nielsen, A. R., Mounier, R., Mortensen, O. H., . . 
. Pedersen, B. K. (2010). Antioxidant supplementation does not alter endurance 
training adaptation. Med Sci Sports Exerc, 42(7), 1388-1395. 
doi:https://doi.org/10.1249/MSS.0b013e3181cd76be 
Yoo, H. Y., Chang, M. S., & Rho, H. M. (1999). The activation of the rat copper/zinc 
superoxide dismutase gene by hydrogen peroxide through the hydrogen 
peroxide-responsive element and by paraquat and heat shock through the same 




Yoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H., Itoh, H., Kang, D., & Kohno, K. 
(2003). P53 physically interacts with mitochondrial transcription factor A and 
differentially regulates binding to damaged DNA. Cancer Res, 63(13), 3729-
3734.  
Zhang, C. S., Hawley, S. A., Zong, Y., Li, M., Wang, Z., Gray, A., . . . Lin, S. C. 
(2017). Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by 
AMPK. Nature, 548(7665), 112-116. doi:https://doi.org/10.1038/nature23275 
Zhu, H., & Bunn, H. F. (1999). Oxygen sensing and signaling: impact on the regulation 
of physiologically important genes. Respir Physiol, 115(2), 239-247. 
doi:https://doi.org/10.1016/s0034-5687(99)00024-9 
Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R., & Abraham, E. 
(2010). Exposure to hydrogen peroxide induces oxidation and activation of 
AMP-activated protein kinase. J Biol Chem, 285(43), 33154-33164. 
doi:https://doi.org/10.1074/jbc.M110.143685 
Appendix 
Mouse primers used for RT-PCR 
  Sense (forward) Primer Antisense (reverse) Primer 
Catalase 5’-AGCGACCAGATGAAGCAGTG-3’   5’-TCCGCTCTCTGTCAAAGTGTG-3’   
CPT-1B 5’-GCACACCAGGCAGTAGCTTT-3’   5’-CAGGAGTTGATTCCAGACAGGTA-3’   
CS 5’-TGCCCACACAAGCCATTTG-3’   5’-CTGACACGTCTTTGCCAACTT-3’   
GLUT4 5’-GTTGGTCTCGGTGCTCTTAGT-3’   5’-ATAGCATCCGCAACATACTGG-3’   
GPx1 5’-CTACACCGAGATGAACGATCTG-3’  5’-TCCGAACTGATTGCACGGG-3’   
HK2 5’-GGGCATGAAGGGCGTGTCCC-3’   5’-TCTTCACCCTCGCAGCCGGA-3’   
HPRT1 5’-AGTCCCAGCGTCGTGATTAG-3’   5’-TTTCCAAATCCTCGGCATAATGA-3’   
NRF1 5’-CCCCCGAGGACACTTCTTATGATG-3’   5’-GGCCGTTTCCGTTTCTTCCCTGTT-3’   
NRF2 5’-GGCACAGTGCTCCTATGCGTG-3’  5’-CCAGCTCGACAATGTTCTCCAGC-3’   
PFK 5’-GCCACGGTTTCCAATAACGT-3’   5’-AAGTCGTGCAGATGGTGTTCAG-3’   
PPARα 5’-GCCTGTCTGTCGGGATGT-3’   5’-GGCTTCGTGGATTCTCTTG-3’   
PPARγ 5’-CAAGAATACCAAAGTGCGATC-3’   5’-GAGCTGGGTCTTTTCAGAATAATAAG-3’   
SOD1 5’-CCAGTGCAGGACCTCATTTTAAT-3’   5’-TCTCCAACATGCCTCTCTTCATC-3’   
SOD2 5’-GCCCCCTGAGTTGTTGAATA-3’   5’-AGACAGGCAAGGCTCTACCA-3’   
Tfam 5’-CTGATGGGTATGGAGAAGGAGG-3’   5’-CCAACTTCAGCCATCTGCTCTTC-3’   
PGC-1α 5’-TGATGTGAATGACTTGGATACAGACA-
3’   
5’-GCTCATTGTTGTACTGGTTGGATATG-3’   
VEGF-A 5’-GGAGATCCTTCGAGGAGCACTT-3’   5’-GGCGATTTAGCAGCAGATATAAGAA-3’   
 
